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Abstract 
 
Neck pain is one of the most common debilitating musculoskeletal complaints 
seen in physiotherapy practice. It is often associated with headache, upper 
back and shoulder/arm pain (cervico-brachial pain) and such patients are 
more disabled than patients with neck pain only.  Cervico-brachial pain 
syndrome is an upper quarter pain syndrome in which neural tissue sensitivity 
to mechanical stimulus is thought to play a role.  
Neuropathic pain is a problem associated with and prevalent in neck and arm 
pain. Psychosocial factors, such as fear-avoidance beliefs and 
catastrophising, have been shown to play an important role in treatment 
outcomes. 
Neural mobilisation (NM) is often used to influence the neural structures in 
conditions with signs of neural involvement or neural mechano-sensitivity. It 
seems reasonable to use neural mobilisation in cervico-brachial pain as 
neural structures play an important role in this condition 
 
The optimal treatment intervention for cervico-brachial pain is yet to be 
established. The prevalence of cervico-brachial pain in a South African 
population is also unknown. 
Aims of the study 
The aims of the study were to: 
 
i. To establish the prevalence of cervico-brachial pain in patients being 
seen in physiotherapy practices in Pretoria, South Africa. 
ii. To establish the effect of neural mobilisation on the pain, function and 
quality of life of patients with acute and sub-acute cervico-brachial pain. 
iii. To establish the influence of high catastrophising scores and 
neuropathic pain on treatment outcomes. 
iv. To establish the effect of demographic factors on the pain, function and 
quality of life of patients with cervico-brachial pain. 
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Methods 
Research Question 1. 
A retrospective survey of physiotherapy patient records dated 1 January 2011 
to 31 December 2011 was conducted. The prevalence of patients with neck 
pain in relation to other musculoskeletal complaints was calculated and 
expressed as a percentage. Symptoms recorded included the following; 
headache, dizziness, pins and needles, feeling of weakness, other 
sensations, more than one symptom and pain in other area/s. Based on body 
charts, areas of pain were coded as neck pain only, pain in the shoulder, 
shoulder and upper arm, shoulder to elbow, lower arm, hand, neck and arm 
up to wrist, neck and arm including hand. 
Research Questions 2, 3 and 4 
A single blind randomised clinical trial was conducted to establish the effect of 
neural mobilisation on cervico-brachial pain. The intervention group (IG) 
received cervical and thoracic mobilisation exercises, advice and NM. The 
usual care (UC) had the same treatment without NM.  Outcomes were 
assessed at 3 weeks, 6 weeks, 6 months and 12 months. 
The Numerical Pain Rating Scale was used to determine the effect of NM on 
pain. The Patient Specific Functional Scale was used to determine the effect 
of NM on function and the EuroQual5 instrument was used to establish the 
effect of NM on the quality of life. At 6 weeks the Global Rating of Change 
was administered to measure patient’s perception of recovery. 
The Neuropathic Diagnostic Questionnaire (DN4) was used to classify 
patients with neuropathic pain and the Pain Catastrophising Scale to identify 
catastrophisers. 
Results and Discussion   
Prevalence of neck and radiating arm pain in physiotherapy private 
practice, Pretoria South Africa 
The prevalence of neck pain in private physiotherapy practices in Pretoria, SA 
is high (46.4% of the total musculoskeletal complaints) with radiating arm pain 
(52.2% of neck pain population) and pain in other areas (22.6% of neck pain 
population) being commonly associated with neck pain. Furthermore, other 
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symptoms such as headache (25.4% of the neck pain population) and 
paraesthesia (11.2%) are also frequently present. Neck pain is multi-faceted 
and this has implications for its management. Future studies with a bigger, 
representative population sample are needed to establish the prevalence of 
neck pain in SA.  
The effect of neural mobilisation on cervico-brachial pain 
All patients improved significantly in terms of pain, function and quality of life 
over the 12-month period. However, the IG had significantly less pain than the 
UC group at 6 months (p=0.03 95% CI 0.96 - 2.03) and this difference was 
more pronounced in patients with neuropathic pain (IG 2.91 95%CI 1.74 - 
4.08 and CG 5.5 95% CI 3.45 - 7.55 p=0.01). There were no significant 
differences between groups in terms of function or quality of life.  
Patients with neuropathic pain had significantly more pain at 6 months 
(positive neuropathic pain 3.71 95%CI 2.57 – 4.84; negative neuropathic pain 
1.44    95% CI 0.93 – 1.96 p=0.0001) and 12 months (positive neuropathic 
pain 3.23 95% CI 1.74 – 4.71; negative neuropathic pain 1.38 95% CI 0.88 – 
1.91 p=0.01) compared to those without neuropathic pain. At 12 months 
function was also negatively affected by the presence of neuropathic pain 
(positive neuropathic pain 23.91 95%CI 20.96 – 26.86; negative neuropathic 
pain 27.15 95% CI 25.95 – 28.36 p=0.04). It did not have an effect on quality 
of life. 
Catastrophisers had more pain at 6 months (catastrophisers 4.25 95% CI -
1.90 – 10.40; non-catastrophisers 1.70 95% CI 1.22 – 2.17 p=0.02) and 12 
months (catastrophisers 3.56 95% CI 1.10 – 6.02) compared to non-
catastrophisers (1.47     95% CI 0.96 – 1.99 p=0.02). There was no difference 
in their function at any time, however at baseline they reported a lower quality 
of life (Catastrophisers 61.96 95% CI 52.04 – 71.87; non-catastrophisers 
75.79 95% CI 71.91 – 79.66 p=0.002). 
Conclusion 
The addition of NM to cervical and thoracic mobilisation, exercises and advice 
to stay active, in the management of cervico-brachial pain, resulted in less 
pain at 6-month follow-up. For patients with neuropathic pain the positive 
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effect was more pronounced. Adding NM as an adjunct to usual care is 
effective to improve pain for patients with cervico-brachial pain especially for 
those with a neuropathic pain component. The presence of neuropathic pain 
and catastrophising resulted in poor pain-related outcomes. 
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1 Chapter One – Introduction to the study 
 
This chapter serves as an introduction and justification for the study.  
 
1.1 Introduction 
Neck pain is one of the most common debilitating musculoskeletal complaints 
seen in physiotherapy practice (Picavet and Schouten, 2003, Binder, 2007, 
Lindgren, 2008). In a systematic review on the prevalence of neck pain in the 
adult population, Fejer et al. (2006) found the point prevalence to be 7.6% and 
the lifetime prevalence to be 48.6%. In the 2015 global burden of disease 
report, low back pain and neck pain were the leading causes of disability (Vos 
et al., 2016). 
The Bone and Joint decade task force on neck pain, classifies neck pain into 
four grades (Guzman et al., 2009) namely Grade I - no signs of major 
pathology and no or little interference with daily activities; Grade II – neck pain 
with no signs of major pathology, but interference with daily activities; Grade 
III - neck pain with neurologic signs of nerve compression; Grade IV – neck 
pain with signs of major pathology. Neck pain is often associated with 
headache, upper back and shoulder/arm pain (Lindgren, 2008, Salt et al., 
2011).  A study by Daffner et al. (2003) showed that 65.4% of the neck pain 
population included in their study had arm pain associated with their neck 
pain, and that  the patients with neck and arm pain were more disabled than 
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patients with only neck pain. Disability is defined as product of functioning, 
activity limitations and participation restriction and is influenced by contextual 
factors such as environmental and personal factors (Jette, 2006, World Health 
Organization, 2001). It considers the person as a whole, and the influence, for 
instance functioning, will have on the person. 
Different terms are often used to describe patients with upper quadrant pain 
such as cervico-brachial pain (Allison et al., 2002), nerve-related neck and 
arm pain (Nee et al., 2012b), complaints of the arm neck and shoulder (van 
Hulst et al., 2016) and cervical radiculopathy (Young et al., 2009, Salt et al., 
2011). Cervico-brachial pain syndrome is an upper quadrant pain syndrome in 
which neural tissue sensitivity to mechanical stimulus is thought to play a role 
(Hall and Elvey, 1999, Jull et al., 2008). The diagnosis of cervico-brachial pain 
is made clinically and there is often no overt neural involvement (Hall and 
Elvey, 1999). Neural involvement can be assumed if a cluster of clinical 
findings is present, such as active and passive movement dysfunction, 
adverse response to neurodynamic testing and evidence of a local cause of 
neuropathic pain (Hall and Elvey, 1999, Jull et al., 2008). 
Neuropathic pain is described as pain initiated or caused by a primary lesion 
or dysfunction in the nervous system (International Association for the Study 
of Pain, 2011). The Neuropathic Pain Special Interest Group of the 
International Association for the Study of Pain, classifies neuropathic pain in 
three different categories: possible neuropathic pain – anatomical region of 
symptoms plausible, and history of nerve injury; probable neuropathic pain – 
negative or positive sensory changes or diagnostic tests positive; definite 
neuropathic pain – sensory changes and positive diagnostic tests (Haanpää 
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et al., 2011). Neuropathic pain is a problem associated with and prevalent in 
many musculoskeletal conditions such as low back pain (Freynhagen and 
Baron, 2009), chronic radiculopathy (Tampin et al., 2013b)  and whiplash 
associated disorders (Sterling and Pedler, 2009). Neuropathic pain is 
consistently linked to high levels of pain, disability, poor quality of life and poor 
response to treatment (Dworkin et al., 2007, Smith et al., 2007, Sterling and 
Pedler, 2009) and therefore is a difficult condition to treat successfully 
(Dworkin et al., 2007, Smith et al., 2007).  
Psychosocial factors have been shown to play an important role in treatment 
outcomes (Karels et al., 2010, Pool et al., 2010, Verhagen et al., 2010, Walton 
et al., 2009). Pool et al. (2010) examined the influence of different 
psychosocial factors on treatment outcome and found fear of movement to be 
significantly correlated with poor outcomes in the short and long term. In 
another study (Karels et al., 2007) catastrophising was significantly linked to 
persistent symptoms of neck pain over a six-month period. Verhagen et al. 
(2010) explored the influence of various factors on treatment outcome in neck 
pain and found pain severity and catastrophising to be the most important 
determinants of poor recovery. Similar to these findings Thompson et al. 
(2010) found catastrophising and poor self-efficacy to be associated with 
higher pain and disability. Catastrophising is a cognitive process that includes 
elements of magnification, helplessness, rumination and is an important 
predictor of poor pain-related outcomes (Sullivan et al., 1995). In a study to 
examine factors influencing return to work in patients with neck/arm/shoulder 
pain, the authors also concluded that psychosocial factors should be taken 
into account when interventions are planned (Karels et al., 2010). Other 
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factors that have been shown to influence treatment outcomes are pain 
intensity at baseline, high disability at baseline, the presence of low back pain 
and increasing age (Schellingerhout et al., 2008, Walton et al., 2013a). 
Most clinical guidelines do not differentiate between treatment for neck pain 
and neck and arm pain such as radiculopathy (Childs et al., 2008, Côté et al., 
2016). The American Physical Therapy Association recommends mobilisation/ 
manipulation of the neck and thoracic spine, exercises and education (Childs 
et al., 2008). The findings of recent Cochrane reviews confirm the above 
recommendations (Gross et al., 2016, Gross et al., 2015, Miller et al., 2010). 
The American guidelines (Childs et al., 2008) also recommend that neural 
mobilisation should be considered for patients with neck and arm pain (level B 
evidence). 
Neural mobilisation (NM) is often used to influence the neural structures in 
conditions with signs of neural involvement or neural mechano-sensitivity 
(Allison et al., 2002, Nee et al., 2012b). The axoplasmic flow can be 
influenced by NM (Shacklock, 2005). Furthermore, NM can have an effect on 
movement of the nerve and its connective tissue (Coppieters and Alshami, 
2007) and the circulation of the nerve by alteration of the pressure in the 
nervous system and dispersion of intraneural oedema (Brown et al., 2011, 
Schmid et al., 2012).  The excitability of dorsal horn cells can be decreased 
with NM (Bialosky et al., 2009b). Other effects that have been found are short 
term hyperalgesia (Beneciuk et al., 2009) and a change in neural tissue 
mechano-sensitivity (Vicenzino et al., 1996). 
NM is defined as an intervention aimed at influencing the neural structures or 
surrounding tissue (interface) directly or indirectly through manual techniques 
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or exercise (Coppieters and Alshami, 2007). The interface can be mobilised 
by mobilising tissue surrounding the nerve along the course of the nerve 
(Butler, 2000) or using foraminal opening techniques such as the cervical 
lateral glide (Langevin et al., 2015). Although mobilisation along the course of 
the nerve is a technique used in clinical practice, the use thereof in the 
literature could only be identified in one case report of a patient with cervical 
radiculopathy (Costello, 2009). The treatment was combined with manual 
therapy and exercises, both of which have been shown to be effective for 
cervical radiculopathy (Côté et al., 2016). It is therefore difficult to know 
whether the NM contributed to the treatment effect. The effectiveness of this 
form of NM has therefore yet to be established. In cervico-brachial pain neural 
tissue sensitivity to mechanical stimulus is thought to play a role (Hall and 
Elvey, 1999). It can therefore be reasoned that targeting the neural structures 
specifically should be an important aim of treatment in patients with cervico-
brachial pain.  
The efficacy of NM has been studied in various conditions such as low back 
pain (Cleland et al., 2007a), carpal tunnel syndrome (Baysal et al., 2006), 
lateral epicondalalgia (Vincenzino et al., 1996) and cervico-brachial pain 
(Allison et al., 2002, Cowell and Philips, 2002, Nee et al., 2012b). The NM 
techniques used for cervico-brachial pain are mainly cervical lateral glides and 
neural gliding exercises (Allison et al., 2002, Coppieters et al., 2003b, Gupta 
and Sharma, 2012). According to systematic reviews of NM, the evidence for 
the efficacy of NM is limited (Ellis and Hing, 2008, Medina McKeon and 
Yancosek, 2008, Su et al., 2016). 
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1.2 Significance of the study 
There is a paucity of studies on acute neck / shoulder / arm pain (cervico-
brachial pain) (Bono et al., 2011, Boyles et al., 2011, Thoomes et al., 2013). 
Neuropathic pain can be a feature in patients with cervico-brachial pain (Salt 
et al., 2011); these patients have higher levels of pain and disability (Daffner 
et al., 2003) and have poor treatment outcomes (Nee et al., 2011). There are 
a limited number of studies with small study populations that have 
investigated the effect of NM for cervico-brachial pain (Allison et al., 2002, 
Coppieters et al., 2003b, Gupta and Sharma, 2012, Nee et al., 2012b) and a 
systematic review on NM concluded that there is limited evidence for the use 
of NM (Ellis & Hing, 2008). The optimal treatment intervention for cervico-
brachial pain has yet to be established (Salt et al., 2011). No literature could 
be identified on prevalence of neck and radiating arm pain in a South African 
population. As cervico-brachial pain has a set number of criteria, which cannot 
be established from patient records, only the prevalence of neck and radiating 
arm could be investigated. 
 
1.3 Research questions  
1.3.1 Research question one 
What is the prevalence of neck and radiating arm pain among patients being 
treated in physiotherapy practices in Pretoria, Gauteng, South Africa? 
1.3.2 Research question two 
What is the effect of NM on the pain, function and quality of life of patients 
with acute cervico-brachial pain? 
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1.3.3 Research question three 
Does the presence of high catastrophising scores and neuropathic pain have 
an influence on treatment outcome? 
1.3.4 Research Question four 
What is the influence of demographic factors such as age, gender, headache, 
dizziness, paraesthesia, injury, previous pain, exercise and education on pain, 
function and quality of life in patients with cervico-brachial pain? 
 
1.4 Hypotheses (H0 and H1) 
1.4.1 Null Hypothesis 1a 
Neural mobilisation does not have an effect on pain in cervico-brachial pain 
1.4.2 Alternative Hypothesis 1a 
Neural mobilisation has an effect on pain in cervico-brachial pain 
1.4.3 Null hypothesis 1b 
Neural mobilisation does not have an effect on function in cervico-brachial 
pain. 
1.4.4 Alternative hypothesis 1b 
Neural mobilisation has an effect on function in cervico-brachial pain. 
1.4.5 Null hypothesis 1c 
Neural mobilisation does not have an effect on the quality of life in cervico-
brachial pain. 
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1.4.6 Alternative hypotheses 1c 
Neural mobilisation has an effect on the quality of life in cervico-brachial pain.  
 
1.5 Aims of the study 
1.4.1 To establish the prevalence of neck and radiating arm pain among 
patients being treated in physiotherapy practices in Gauteng, South Africa. 
1.4.2 To establish the effect of NM on the pain, function and quality of life of 
patients with acute and sub-acute cervico-brachial pain. 
1.4.3 To establish the influence of high catastrophising scores and 
neuropathic pain on treatment outcomes. 
1.4.4 To establish the effect of demographic factors on the pain, function and 
quality of life of patients with cervico-brachial pain 
 
1.6 Objectives  
1.6.1 Research aim one 
To establish the prevalence of neck and radiating arm pain, among patients 
being treated in physiotherapy practices in Pretoria, South Africa. 
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1.6.1.1 To determine the one year prevalence of patients with 
neck pain and radiating arm pain in private 
physiotherapy practices in Pretoria 
1.6.1.2 To document the areas of pain and associated 
symptoms in patients with neck and radiating arm pain 
1.6.2 Research aim two 
1.6.2.1 To establish the effect of NM on the: 
 pain of patients with cervico-brachial pain.  
 function of patients with cervico-brachial pain.  
 quality of life of patients with cervico-brachial pain.  
1.6.2.2 To compare: 
  the effect of NM added to usual care (UC) on the above factors with 
a control group that receives UC only. 
 the number of treatment sessions between the NM group (IG) and 
UC group. 
 the effect of NM added to UC on the elbow range of movement of the 
upper limb neurodynamic test compared to UC only. 
 the patient perception of change in pain, function and quality of life 
between groups 
1.6.3 Research aim three 
1.6.3.1 To determine: 
 the influence of neuropathic pain on treatment outcomes in patients 
with cervico-brachial pain.  
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 the effect of high catastrophising scores on treatment outcomes in 
patients with cervico-brachial pain. 
1.6.4 Research aim four 
1.6.4.1 To determine: 
 The effect of demographic factors such as age, gender, headache, 
dizziness, paraesthesia, injury, previous pain, exercise and education 
on the pain, function and quality of life in patients with cervico-brachial 
pain 
 
1.7 Outline of Chapters 
 
Chapter two  –  Literature review 
Chapter three –  Prevalence of neck and radiating arm pain in 
physiotherapy private practice in Pretoria, South 
Africa 
Chapter four –  Outcomes measures 
Chapter five  –  Method of the randomised controlled trial 
Chapter six  –  Results of the randomised controlled trial 
Chapter seven –  Discussion of the randomised clinical trial 
Chapter eight   –  Concluding comments and recommendations  
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2 Chapter Two - Literature review 
 
A systematic review of the literature on the effectiveness of neural 
mobilisation (NM) for neuro-musculoskeletal conditions is presented in this 
chapter. The effect of different NM techniques on neuro-musculoskeletal 
conditions was investigated. 
 
2.1 Introduction 
The 2010 Global Burden of Disease study revealed that musculoskeletal 
disorders are the second biggest contributor to disability worldwide (Vos et al., 
2012). Low back and neck pain account for 70% of musculoskeletal disability. 
Low back-related leg pain and nerve-related neck and arm pain might arise as 
a direct consequence of a lesion or disease affecting the peripheral nervous 
system (Leaver et al., 2013b, Schafer et al., 2009). The peripheral nervous 
system is also compromised in common entrapment neuropathies, such as 
carpal tunnel syndrome (CTS), and may be affected in conditions, such as 
lateral epicondylalgia (Coombes et al., 2014) and plantar heel pain (Alshami 
et al., 2008).  
Five systematic reviews evaluated the effectiveness of NM. Two reviews 
(Ballestero-Pérez et al., 2016, Medina McKeon and Yancosek, 2008) focused 
on CTS (6 studies and 10 studies). It observed a possible trend toward 
improved outcomes following NM, but concluded that the efficacy of NM in 
CTS was unclear. Another review (Ellis and Hing, 2008) included various 
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musculoskeletal conditions (11 studies) and concluded that although there 
was support for NM, the evidence was limited. A recent review (Su et al., 
2016) (20 studies) assed the effect of NM for chronic conditions and 
concluded that NM is not superior to other interventions. Another review 
assessed the effect of NM for lower quadrant problems (10 studies) and 
concluded that there is some evidence for it’s effectiveness (Neto et al., 
2017). These reviews had different inclusion and exclusion criteria to the 
current review. A narrative review of NM for spinal radiculopathy concluded 
that NM might be beneficial for certain subgroups of patients (Efstathiou et al., 
2015).  
Neural mobilisation (NM) or neurodynamics is an intervention aimed at 
restoring the homeostasis in and around the nervous system, by mobilisation 
of the nervous system itself or the structures that surround the nervous 
system (Coppieters and Butler, 2008). NM facilitates movement between 
neural structures and its surroundings (interface) through manual techniques 
or exercise (Nee and Butler, 2006). Human and animal studies reveal that NM 
reduces intraneural oedema, (Schmid et al., 2012) improves intraneural fluid 
dispersion (Brown et al., 2011, Gilbert et al., 2015), reduces thermal and 
mechanical hyperalgesia (Song et al., 2006), and reverses the increased 
immune responses (Santos et al., 2012, Song et al., 2006) following a nerve 
injury.  
Since the publication of these reviews, additional randomized trials have been 
published on the effectiveness of NM. The objective of this systematic review 
was to assess the effectiveness of NM for neuro-musculoskeletal conditions. 
We hypothesized that an updated systematic review along with meta-
  13 
analyses would provide more definite answers regarding the effectiveness of 
NM for neuro-musculoskeletal conditions.  
 
2.2 Methods 
2.2.1 Protocol and registration 
The systematic review and meta-analysis protocols were reviewed and 
published by the Joanna Briggs Institute Database of Systematic Reviews and 
Implementation Reports (Basson et al., 2015a).  
2.2.2 Eligibility criteria 
2.2.2.1 Studies 
Randomised clinical trials, published in English, which evaluated the effect of 
NM in participants over the age of 18 with neuro-musculoskeletal conditions 
indicative of neural tissue dysfunction, were considered for inclusion. Cohort 
studies and case or case-control studies were excluded. Studies that 
evaluated the effect of NM in systemic diseases (e.g. fibromyalgia (Torres et 
al., 2015) and leprosy (Veras et al., 2012b)), central nervous system disorders 
(e.g., traumatic brain injury (Lorentzen et al., 2012)) and polyneuropathies 
were excluded. Animal studies or studies on healthy participants were also 
excluded.  
2.2.2.2 Interventions 
Studies were included that evaluated NM techniques used for the treatment of 
disorders of the peripheral nervous system (spinal nerve roots and peripheral 
nerves) where neurodynamic dysfunction was implicated. NM could be 
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achieved through active exercises or passive manual therapy techniques. 
Included techniques could be directed to the nervous system itself e.g., sliding 
and tensioning techniques (Coppieters and Butler, 2008, Coppieters et al., 
2009), or to the structures that surround the nervous system e.g., cervical 
lateral glide (Elvey, 1986) or techniques clinically described as lumbar 
foraminal opening techniques (Shacklock, 2005).  
2.2.2.3 Outcome measures 
Outcome measures of primary interest were pain (numerical pain rating scale, 
visual analogue scale), disability and or function (Disability of the Arm, 
Shoulder and Hand Symptom Scale, Neck Disability Index, Oswestry, Patient 
Specific Functional Scale). Secondary outcomes included quality of life (e.g. 
WHOQOLF Physical Domain Score), range of motion (ROM) (inclinometer, 
goniometer), specific diagnostic tests (Tinel’s sign, Phalen’s manoeuvre), 
neurodynamic test outcomes Upper Limb Neurodynamic Test 1, 2a, 2b, 3, 
Straight Leg Raise, Slump), sensation (two point discrimination), muscle force 
(Dynamometer) and neurophysiological changes.  
2.2.3 Search strategy  
The databases searched included: MEDLINE (Pubmed), CINAHL Plus, 
Cochrane Controlled Trials Registered, Physiotherapy Evidence Database 
(PEDro), ProQuest Central (Family Health, Health and Medical Complete), 
Nursing and Allied Health Source, EBSCO MasterFile Premier, Science 
Direct, SCOPUS. The search for unpublished studies included: EBSCO 
MegaFile Premier. The reference lists of all identified articles were searched 
for additional studies. The search was conducted to include articles from 
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January 1980 to April 2016. One previous review (Ellis and Hing, 2008) 
searched from 1830 and the oldest article included in their review was 1996. 
The search terms included: neural, nerve, mobilisation, manipulation, physical 
therapy, physiotherapy, manual therapy, glide exercises, treatment, 
intervention, management, modality, stretching, tension, neurodynamics. 
(Appendix 2.1) 
2.2.4 Methodological quality 
Two independent reviewers considered records for inclusion and full text were 
reviewed after identifying relevant titles and abstracts (AB & BO). Articles 
which fitted the inclusion criteria were assessed by two independent reviewers 
for methodological quality (AB & BO) using the Joanna Briggs Institute Meta 
Analysis of Statistics Assessment and Review Instrument for critical appraisal 
(JBI-MAStARI) (Joanna Briggs Institute, 2014) (Appendix 2. 2). The JBI-
MAStARI was developed by experts, and reviewed and ratified by the JBI’s 
International Scientific Committee. The JBI-MAStARI was used to establish 
the quality of studies and for meta-analysis. Disagreements were discussed 
between the primary and secondary reviewer. Any unresolved issues were 
resolved through discussion with a third reviewer (RE). Risk of bias was 
assessed using the GRADE guidelines (Guyatt et al., 2011). This takes into 
account random sequence generation, concealment of allocation, blinding of 
outcomes assessment, incomplete outcome data, selective reporting and 
other bias such as stopping early for benefit or the use of unvalidated 
outcome measures (Guyatt et al., 2011).  Agreement between reviewers was 
evaluated using Cohen’s kappa. 
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2.2.5 Data collection 
Data extracted from studies were grouped together in terms of patient 
subgroup, patient demographics, interventions, outcome measures, timing of 
assessments and main results. Authors were contacted where possible for 
clarification or missing data. Data were subject to double data entry to avoid 
entry errors. 
2.2.6 Data synthesis 
Quantitative data, where possible, were pooled in statistical meta-analysis 
using JBI-MAStARI. Effect sizes expressed as odds ratio (for categorical data) 
and weighted mean differences (for continuous data) and their 95% 
confidence intervals (CI) were calculated for analysis. Heterogeneity was 
assessed statistically using a standard Chi-square test. Meta-analyses were 
not performed when the Chi-square test had a p-value of less than 0.1 
(Joanna Briggs Institute, 2014). The DerSimonian-Laird random effects 
method was used due to the heterogeneity of studies (Borenstein et al., 
2009). Where statistical pooling was not possible the findings are presented in 
a narrative form.   
2.2.7 Levels of Evidence 
The JBI grades for level of evidence (The Joanna Briggs Institute Levels of 
Evidence and Grades of Recommendation Working Party, 2014) were used 
for making recommendations about treatment efficacy (Appendix 2.3). 
 
2.3 Results 
Forty-one articles (21 qualitative and 19 quantitative analysis), including 1759 
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participants, were included in the review (Figure 2.1). Primary and secondary 
outcome measures for one study were reported separately in 2 papers, and 
these 2 papers were therefore treated as one (Coppieters et al., 2003a, 
Coppieters et al., 2003b). There were 12 studies for carpal tunnel syndrome 
(CTS), and 11 for nerve-related low back pain (N-LBP), 10 studies for nerve-
related neck and arm pain (N-NAP), three for lateral epicondylalgia and one 
each for cubital and tarsal tunnel syndrome, plantar heel pain and post-
operative low back pain. Meta-analysis could be performed for pain and 
disability in N-LBP; pain in N-NAP; pain, handgrip strength, Phalen’s sign, 
disability, and two-point discrimination in CTS. It was not possible to perform 
meta-analysis for lateral epicondylalgia, cubital tunnel syndrome, post-lumbar 
surgery, tarsal tunnel syndrome or plantar heel pain. The excluded studies are 
listed in Appendix 2.4. 
2.3.1 Risk of bias across studies 
The overall level of agreement between the primary and secondary reviewers 
was 0.615 (Cohen’s kappa (95% CI 0.412; 0.818)). Outstanding issues were 
resolved through discussion with a third reviewer. The main areas of 
disagreement were blinding of participants, whether groups were treated 
equally and whether appropriate statistical analyses was performed. 
Seventeen studies had a low risk of bias and 23 studies had an unclear or 
high risk of bias. The most problematic domains were blinding of assessors 
and concealed allocation. Incomplete outcome data and high dropout rates 
were commonly listed as other forms of bias. (Table 2.1) (See study 
descriptions for risk of bias judgment). Blinding of participants is often difficult 
in clinical trials although some of the studies used a sham intervention that 
  18 
successfully blinded participants (Bialosky et al., 2009b, Kavlak and Uygur, 
2011). 
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Figure 2.1. Flow diagram of search results and studies included. 
 
3871 articles identified through 
database searching 
3 articles identified through reference lists 
1 article from co-author 
3875 articles 
60 duplicates removed 
3815 article titles screened 
96 article abstracts screened for 
inclusion 
31 articles excluded after review 
of abstracts 
65 of full text articles assessed for 
eligibility 
24 articles excluded 
- 2 other language 
- 6 not randomised trials 
- 4 not neural mobilisation 
- 5 not neuro-
musculoskeletal condition 
- 5 healthy population 
- 2 treatment not aimed at 
peripheral nervous system 
 
41 articles included in review (1 
duplicate study population) – 40 
studies 
20 articles included in qualitative 
synthesis 
 
20 articles included in quantitative 
analysis (meta-analysis) 
Searched: MEDLINE (Pubmed), CINAHL Plus, Cochrane Controlled Trials 
Registered, Physiotherapy Evidence Database (PEDro), ProQuest Central 
(Family Health, Health and Medical Complete), Nursing and Allied Health 
Source, EBSCO MasterFile Premier, Science Direct, SCOPUS 
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Table 2.1. Results of study appraisals 
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 
Ahmed et al. (2013) Y N Y U N Y Y Y Y Y 
Akalin et al. (2002) U N U U U Y Y Y Y Y 
Ali et al. (2015) Y N N U U Y Y Y Y Y 
Allison et al. (2002)  Y U U U Y Y Y Y Y Y 
Anwar et al. (2015)  Y N N U N Y Y Y Y N 
Bardak et al. (2009) Y U Y U Y N Y Y Y Y 
Baysal et al. (2006) Y U Y U U Y Y Y Y Y 
Bialosky et al. (2009b) Y Y Y N Y Y Y Y Y Y 
Brininger et al. (2007) Y N U N Y Y Y Y Y Y 
Cleland et al. (2007a) Y U Y Y Y Y Y Y Y Y 
Coppieters et al. (2003a) Y Y Y U Y Y N Y Y Y 
Coppieters et al. (2003b) Y Y Y U Y Y N Y Y Y 
Dabholkar et al. (2013) U N U N N U Y Y Y U 
Drechsler et al. (1997) Y N U U U U Y Y Y Y 
Dwornik et al. (2009) Y N N U U U Y Y Y Y 
Gupta and Sharma (2012) Y N U N N Y N Y Y Y 
Heebner and Roddey 
(2008) 
Y U U N U Y Y Y Y Y 
Horng et al. (2011) Y N Y N Y Y U Y Y Y 
Jain et al. (2012) Y U U U U Y Y Y Y Y 
Kaur and Sharma (2011) Y U U U U Y Y Y Y Y 
Kavlak and Uygur (2011) N Y Y Y N Y Y Y Y Y 
Kumar (2010) Y U U U U U Y Y Y Y 
Langevin et al. (2015) Y N Y Y Y Y Y Y Y Y 
Marks et al. (2011) Y U N Y N N Y Y Y Y 
Mehta et al. (2014) Y U U Y U U Y Y Y Y 
Nagrale et al. (2012) Y N Y Y Y Y Y Y Y Y 
Nar (2014) Y U U Y U Y Y Y Y N 
Nee et al. (2012b) Y N Y N Y U Y Y Y Y 
Oskouei et al. (2014) Y Y Y U Y Y Y Y Y Y 
Patel (2014) Y N U U U Y Y Y Y Y 
Pinar et al. (2005) Y N U Y Y Y Y Y Y Y 
Ragonese (2009) Y N Y N Y N Y Y Y Y 
Rezk-Allah et al. (2011) Y N N U U Y Y Y Y Y 
Saban et al. (2014) Y U Y Y Y Y Y Y Y Y 
Schmid et al. (2012) Y N Y N Y Y N Y Y Y 
Scrimshaw and Maher 
(2001) 
Y N N Y Y Y Y Y Y Y 
Svernlov et al. (2009) Y U U N Y U U Y Y Y 
Tal-Akabi and Rushton 
(2000) 
Y U U Y Y Y Y Y Y Y 
Vincenzino et al. (1996) U Y Y Y Y U Y Y Y Y 
Waleed Salah El-din 
(2015) 
Y N N Y N Y N Y Y Y 
Wolny et al. (2016) Y N Y N Y N Y Y Y Y 
Legend: Y – Yes; N – No; U – Unclear. Q – questions (see Appendix 2.2) 
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2.3.2 Meta-analysis 
Meta-analyses were conducted for CTS (outcomes: pain intensity, Tinel’s test, 
Phalen’s test, grip strength, functional status, two-point discrimination and the 
Disability of Hand and Shoulder Symptom Scale), N-LBP (outcomes: modified 
Oswestry Disability Questionnaire and pain intensity) and N-NAP (outcome: 
pain intensity). Narrative description of the remaining studies is provided, as 
meta-analysis could not be done on remaining studies. Additional information 
was requested of nine authors (Allison et al., 2002, Heebner and Roddey, 
2008, Horng et al., 2011, Jain et al., 2012, Kumar, 2010, Marks et al., 2011, 
Scrimshaw and Maher, 2001, Sharma et al., 2011b, Tal-Akabi and Rushton, 
2000) of whom one could not be reached (Sharma et al., 2011b). 
2.3.3 Techniques used as NM 
The NM techniques that were assessed most frequently were nerve gliding 
exercises for CTS, cervical lateral glides for N-NAP and lateral epicondylalgia, 
slump mobilisation for N-LBP, and SLR mobilisation for N-LBP, tarsal tunnel 
syndrome, plantar heel pain and post-operative low back pain. In CTS the 
terminology used was mostly “nerve gliding exercises”  
2.3.4 Carpal Tunnel Syndrome (CTS). 
Five studies had a low risk of bias (Bialosky et al., 2009b, Horng et al., 2011, 
Oskouei et al., 2014, Pinar et al., 2005, Schmid et al., 2012). Four studies had 
an unclear risk of bias (Baysal et al., 2006, Brininger et al., 2007, Tal-Akabi 
and Rushton, 2000, Wolny et al., 2016) and the other three had a high risk of 
bias (Akalin et al., 2002, Bardak et al., 2009, Heebner and Roddey, 2008). 
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Seven studies (Akalin et al., 2002, Bardak et al., 2009, Baysal et al., 2006, 
Brininger et al., 2007, Heebner and Roddey, 2008, Horng et al., 2011, Pinar et 
al., 2005) used nerve gliding exercises as outlined by Totten and Hunter 
(1991) (which can be considered nerve tensioning exercises), and tendon 
gliding exercises. The other studies (Bialosky et al., 2009b, Oskouei et al., 
2014, Tal-Akabi and Rushton, 2000, Schmid et al., 2012) used a variety of 
different techniques. 
The majority of studies had one intervention where exercises were shown to 
patients and then instructed to continue for a period of one week, (Schmid et 
al., 2012) three weeks, (Baysal et al., 2006) four weeks, (Akalin et al., 2002, 
Brininger et al., 2007, Heebner and Roddey, 2008) eight weeks, (Horng et al., 
2011) and ten weeks (Pinar et al., 2005). One study explained the exercises 
and followed patients up once a week for three weeks (Bardak et al., 2009), 
another study treated patients passively for three weeks twice a week 
(Bialosky et al., 2009b) and one study used passive mobilisation three times a 
week for four weeks (Oskouei et al., 2014). One study did not specify length 
of treatment and number of interventions (Tal-Akabi and Rushton, 2000). 
Most studies used splint wearing as part of the intervention (Akalin et al., 
2002, Bardak et al., 2009, Baysal et al., 2006, Brininger et al., 2007, Heebner 
and Roddey, 2008, Horng et al., 2011, Pinar et al., 2005, Bialosky et al., 
2009b, Oskouei et al., 2014). Treatment in comparison groups consisted of 
splint only (Akalin et al., 2002, Pinar et al., 2005, Schmid et al., 2012, 
Brininger et al., 2007), splint and ultrasound therapy (Baysal et al., 2006), 
splint and cortisone injections (Bardak et al., 2009), splint and a sham NM 
(Bialosky et al., 2009b), splint, advice and tendon gliding exercises (Heebner 
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and Roddey, 2008), splint and paraffin therapy (Horng et al., 2011), splint, 
ultrasound and transcutaneous electro-nerve stimulation (Oskouei et al., 
2014). One study compared upper limb neurodynamic test (ULNDT) 
mobilisation to carpal bone mobilisation (Tal-Akabi and Rushton, 2000).  
Another study compared ULNDT mobilisation to ultrasound and laser therapy 
(Wolny et al., 2016). 
Three studies with a low risk of bias reported improved neurophysiological 
effects following NM compared to the control groups (improved temporal 
summation, (Bialosky et al., 2009b) reduced intraneural oedema, (Schmid et 
al., 2012) and improved median nerve latency (Oskouei et al., 2014). Two 
studies (Akalin et al., 2002, Baysal et al., 2006) reported improved patient 
satisfaction and another more rapid improvement in pain in the NM groups 
(Pinar et al., 2005).  
Three studies on CTS measured the Upper Limb Neurodynamic Test 1 
(ULNDT1) (Heebner and Roddey, 2008, Oskouei et al., 2014, Tal-Akabi and 
Rushton, 2000) ROM of which two found no difference between groups 
(Heebner and Roddey, 2008, Oskouei et al., 2014) and the third reported a 
decrease in positive ULNDT1 in the NM group. 
The clinical outcome measures assessed with meta-analyses were non-
significant (p>0.11) for CTS (Table 2.2). Although there were a number of 
studies that reported on Tinel’s sign and the Functional Status Score, the 
heterogeneity was p<0.1 for both and therefore meta-analysis was not done 
on these outcomes (Joanna Briggs Institute, 2014).   
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Table 2.2 contains the study descriptions and Figure 2.2 and 2.3 are 
examples of the forest plots for pain and disability (main outcomes). Table 2.3 
details the findings for the meta-analyses in CTS.
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Table 2.2. Study descriptions CTS 
Author 
Appraisal 
Risk of bias 
Patient 
demographics 
Intervention 
Group (IG) 
Control Group 
(CG) 
Outcome Result 
Akalin et al 
2002 
 
Appraisal 5 
 
High risk of 
bias 
n = 36 (2 male, 
34 female) 
 Age range 38-
64 years  
 Mean age 
51.93 ±5.1 
years 
 Mean group 
age (years)  
CG 52.16 
(±5.6), IG 51.7 
(±5.5) 
 Duration of 
symptoms 
(months) CG 
47.6 (± 6.8), IG 
49.6 (± 5.2) 
IG 18 subjects 
with CTS 
 
Same as control 
plus: 
Tendon glides in 
5 positions. 
Median nerve 
exercises in 6 
positions. (Each 
position was 
maintained for 
5seconds 
10 reps of each 
exercise were 
done 5 times a 
day) 
For 4 weeks  
CG 18 subjects 
with CTS 
 
Custom made 
neutral volar wrist 
splint was 
instructed to be 
worn all night and 
during the day as 
much as possible 
for 4 weeks 
 
 
 
 
Undertaken pre 
treatment and 8 weeks 
post treatment 
1) Phalens sign 
2) Tinels sign 
3) 2 point discrimination 
4) Grip strength 
5) Pinch Strength 
6) Symptom severity 
score 
7) Functional status 
score 
A patient satisfaction 
investigation 
undertaken by 
telephone 8.3 (± 2.5) 
months post treatment 
At the end of treatment a significant 
improvement was obtained in all 
parameters in both groups.  The nerve 
and tendon glide group had slightly 
greater scores but the difference 
between groups was not significant 
except for lateral pinch strength. 
(p=0.026; CG) 30.0±9.3; IG 35.27±9.7) 
 
 
A total of 72% of the control group and 
93% nerve and tendon slide group 
reported good or excellent results in 
the patient satisfaction investigation, 
but the difference between the groups 
was not significant. 
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Bardak et al 
2009 
 
Appraisal 6 
 
High risk of 
bias 
n = 111 
Mean age: 
Group 1 -33 
(9.6) 
Group 2 - 26 
(10.3) 
Group 3 - 22 
(9.9) 
Group 1 n = 40 
with CTS 
Splint 3 weeks 
day and night 
and 3 weeks 
night only 
Cortisone 
injection 
Nerve & tendon 
gliding 
exercises 
(Totten & 
Hunter) followed 
once a week for 
3 weeks 
Group 2 n = 35 
with CTS 
Splint as for 
intervention group 
Cortisone injection 
(Group 3 not 
included in 
analyses 
Group 3 (n= 36) 
had only nerve and 
tendon gliding 
exercises 
Measured pre and post 
treatment 
1) Phalen’s test 
2) Tinel’s test 
3) Reverse Phalen’s 
4) Compression test 
5) Two point 
discrimination 
6) Total Symptom 
Scale 
7) Functional Symptom 
Scale 
All groups improved significantly in 
terms of pain and functionality Group 1 
and 2 were better (p< 0.001) than 
group 3 receiving only nerve and 
tendon gliding exercises (p = 0.02) 
One intervention and follow-up 
telephonically at 12 months 
Within group differences reported as 
percentages and means and standard 
deviations, but no between group 
differences values available 
Baysal et al 
2006 
 
Appraisal 6 
 
Unclear risk 
of bias 
n = 36 (36 
female patients 
– all with clinical 
and 
electrophysiolog
ical evidence of 
CTS 
All with bilateral     
involvement 
 
Mean age – 
Group 1 47.8 ± 
5.5; Group 2 
50.1 ± 7.3; 
Group 1 CTS 
(n=12) custom 
made neutral 
volar splint 
(worn for 3 
weeks); 
exercise therapy 
(nerve and 
tendon gliding 
exercises as 
described by 
Totten & Hunter, 
1991) 5 
sessions daily, 
each exercise 
Group 2 CTS 
(n=12) custom 
made neutral volar 
splint (worn for 3 
weeks); Ultrasound 
(15min/session to 
palmar carpal 
tunnel, 1mhz, 
1.0w/cm2, 1:4, 
5cm2 transducer) 1 
Rx/day, every 5 
days for 3 weeks 
(total 15 Rx’s) 
 
All measures pre-Rx, 
end of Rx, and 8 weeks 
Follow Up 
1) VAS 
2) Tinel’s sign 
3) Phalen’s sign 
4) Mean static two-
point discrimination – 
pulp of radial three 
digits 
5) Hand-grip strength – 
hand-held 
No significant differences between 
groups at the end of treatment and 8 
weeks follow up of all measures of 
Treatment Effect (measures 1, 5, 6, 7, 
8, 9, 10) 
 
Significant improvement seen in all 3 
groups in Tinel’s and Phalen’s signs at 
end of treatment and 8 week follow up 
 
Significant improvement seen in all 3 
groups in grip and pinch strength at 
8week follow up. (Group 1: 1.9±2.7 
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Group 3 51.4 ± 
5.2 
Mean duration 
of symptoms 
(years) – Group 
1 1.5 ± 1.6; 
Group 2 1.4 ± 
0.8; Group 3 1.4 
± 0.8 
8 eventual 
dropouts 
repeated 
10x/session –for 
3 weeks 
Group 3 - 
(n=12) custom 
made neutral 
volar splint 
(worn for 3 
weeks); 
exercise therapy 
(nerve and 
tendon gliding 
exercises as 
described by 
Totten & Hunter, 
1991) 5 
sessions daily, 
each exercise 
repeated 
10x/session – 
continued for 3 
weeks; 
Ultrasound (as 
for control 
group) 
dynamometer 
6) Pinch strength – 
between thumb and 
little finger – 
dynamometer 
7) Symptom-severity 
scale questionnaire (11 
item) 
8) Functional status 
scale questionnaire (8 
item) 
9) Median motor nerve 
conduction – motor 
distal latency EMG of 
abductor pollicis 
10) Sensory distal 
latency – EMG of 
abductor pollicis 
11) Needle EMG of 
abductor pollicis brevis 
– looking for 
denervation  
12) Patient satisfaction 
survey (at 8wks follow-
up only) 
Group2: 1.6±2.5 Group3: 1.0±1.7) and 
pinch (Group 1: 0.8±0.9 Group2: 
0.6±1.4 Group 3: 0.9±0.7) strength at 
8-week follow up (p<0.05). 
 
 
No changes seen in two-point 
discrimination 
 
Significant improvement in pain, 
(Group1: 2.2±3.4 Group 2: 2.5±2.5 
and Group 3: 4.5±3.0), symptom 
(Group 1: 6.3±7.1 Group 2: 5.8±7.2 
Group 3: 8.2±5.2) and functional 
scales (Group 1: 7.8±10.7 Group 2: 
10.5±6.8 Group3: 14.4±9.4) of all 3 
groups at end-Rx and 8 weeks follow 
up. 
Group 3 had the best results at 8 
weeks follow-up patient satisfaction 
questionnaire 
(Group 2: excellent 3 (25.0%) Group 
3: 8 (61.5%) 
Bialosky et al 
2009 
n = 40 CTS 
Females only 
IG with CTS 
Nerve gliding 
exercises and 
CG with CTS 
Sham technique to 
minimise strain on 
Measured at pre and 
post treatment 
Significant improvement in both 
groups immediate post intervention 
and 3 weeks but not intergroup 
  28 
 
Appraisal 9 
 
Low risk of 
bias 
Mean age: NDT 
44.3 (6.97) 
Sham 49.5 
(12.35) 
Follow up 
immediate and 3 
weeks Mean 
duration of 
symptoms 156 
weeks 
splint. Received 
treatment for 3 
weeks 
Cycle 6 
seconds, 5 sets 
of 10 cycles 1st 
3 Rx and 7 sets 
of 10 in Rx 4-6  
nerve and splint. 
Received treatment 
for 3 weeks  
1) NRS 
2) DASH 
3) Grip strength 
4) Pressure pain 
sensitivity 
5) Temporal summation 
differences. Temporal summation only 
changed in NDT group – positive 
neurophysiological effect. 
A mean decrease of self-report of 
temporal summation pain of –8.8 (SD, 
14.7; p=0.02; Cohen’s d=0.35) in IG 
group – positive neurophysiological 
effect. A mean increase of temporal 
summation pain of +4.2 (SD, 16.0; 
p=0.26; Cohen’s d=0.13) in 
participants receiving the sham 
Brininger et 
al 2007 
 
Appraisal 8 
 
Unclear risk 
of bias 
n = 61 – only 51 
completed study 
Mean age: 50 – 
range 21 – 86 
14 male  
47 female  
Follow up 4 
weeks and 8 
weeks 
Group1 n = 16 
CTS completed 
n =13 
Neutral splint + 
nerve gliding 
exercises 
according to 
Totten and 
Hunter 1991 3-5 
times/day 10 
repetitions 
Group 3 n = 16 
completed n = 
13 
Cock-up splint 
and nerve 
gliding 
exercises as 
Group 2 n = 17 
CTS completed n = 
14 
Neutral splint 
 
Group 4 n = 12 
completed n = 11 
Cock-up splint 
Measured at baseline, 
4 weeks in clinic and 8 
weeks by mail 
1) Symptom Specific 
Scale 
2) Functional Status 
Scale 
3) Grip strength 
4) Pinch strength 
 
All groups improved over time 
irrespective of exercise or not – the 
groups with neutral splints had better 
outcomes. 
Symptom specific scale p=0.014; 
F1.14=6.45, 
Functional status scale p=0.029. 
F1.14=5.10. (mean=2.045) 
 
Drop out 10 patients of 61 – influence 
on results. 
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above 
Heebner et 
al 2008 
 
Appraisal 6 
 
High risk of 
bias 
n = 60 
randomised  
Mean age 52 
range 32 – 72 
9 male 
51 female 
 
IG n = 30 
participants with 
CTS 
randomised, 25 
completed  
Standard care 
Nerve gliding 
exercises 
according to 
Sweeney & 
Harms (based 
on Totten & 
Hunter) – 
tensioner. 3-
5x/day 10 
repetitions 
CG n = 30 
participants with 
CTS randomised, 
20 completed 
Standard care 
consisting of 
Advice 
Splint 
Tendon gliding 
exercises 
Outcomes measured 
baseline, 1 month and 
6 months 
1) DASH 
2) Carpal Tunnel 
Symptom 
Questionnaire 
3) Elbow extension 
range of ULNDT 
Nerve gliding exercise did not improve 
outcomes – improvement similar in 
both groups  
Group one (control) had better 
outcomes in functional status scale 
and Carpal Tunnel Symptom 
Questionnaire. (mean 2.2 for CG and 
2.9 for the IG). There were no 
significant between group differences 
in ULNDT p=0.366 (values not 
available) 
Horng et al 
2011 
 
Appraisal 8 
 
Low risk of 
bias 
n = 60 of which 
53 completed 
Mean age  
Group 1 = 48.9 
(8.9) 
Group 2 = 51.9 
(9.3) 
Group 3 = 53.6 
(9.1) 
Gender: 
Group 2 n = 20 
Participants 
randomised, 19 
participants (34 
wrists) 
completed 
Splint 
Paraffin 
Nerve gliding 
exercise Totten 
&Hunter  
Group 1 n = 20 
CTS participants 
randomised; 18 
participants (31 
wrists) completed 
Splint 
Paraffin 
Tendon gliding 
exercise 
Group 3 n = 20 
participants 
Measured pre 
treatment and after 2 
months 
1) DASH 
2) WHO Quality of life 
3) Functional Status 
Scale 
4) Phalen’s 
5) Tinel’s 
6) Boston CTS 
Only Group 1 showed significant 
improvements in their scores on 
functional status; the DASH 
questionnaire; and the physical 
domain of the WHO Quality of Life 
Questionnaire 
Post hoc analyses detected a 
significant difference (p=0.04) (p=0.04; 
Group1: -0.4±0.5 Group 2: 0.1±0.5 
Group 3: 0.2±0.7) In functional status 
scores between groups 1 and 2 
favouring control. 
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male/female 
Group 1 9/51 
Group 2 6/22 
Group 3 3/29 
Received sheet 
with exercises – 
to do 3 times 
daily. Follow up 
at 2 months 
randomised; 16 
participants (24 
wrists) completed 
Splint  
Paraffin 
Treatment as for 
group 2 
7) Sensory testing 
using mono-filament 
8) VAS 
Oskouei et al 
2014 
Appraisal 9 
 
Low risk of 
bias 
n = 20 patients 
32 hands 
 
Age of 46.7±11 
 
Duration of 
symptoms 
19.6±15.9 
months 
IG 
16 hands 
Splint as much 
as possible for 4 
weeks 
TENS 
Ultrasound 
NM starting in 
nerve off 
tension 
progressing into 
tension using 
elbow Flexion 
/Extension 
3 treatments per 
week (15 
repetitions) for 4 
weeks 
CG 
16 hands 
Splint as much as 
possible for 4 
weeks 
TENS 
Ultrasound 
3 treatments per 
week for 4 weeks 
Measured pre and post 
treatment  
 
1) Boston questionnaire 
2) Phalen’s test 
3) VAS 
4) Median nerve 
tension test 
Routine physiotherapy including rest 
splint, TENS, and therapeutic 
ultrasound seems to improve the 
symptom severity scale, visual 
analogue scale, median nerve tension 
test, and Phalen’s sign in patients with 
CTS. (IG: 1.53±0.53 CG: 1.7±0.72), 
VAS (IG: 2.68±1.62 CG:, 3.31±3.05) 
median nerve tension test (IG: 
9.04±9.6 CG: 18.41±11.6) , and 
Phalen’s sign (IG: 19% CG 31%) in 
patients with CTS (p<0.05). 
The neural mobilisation in combination 
with routine physiotherapy improved 
the functional status scale and the 
median nerve distal motor latency. 
This combination can be used as an 
effective non-invasive treatment for 
patients with CTS. 
Pinar et al n = 26 ( female) IG 14 patients 
(19 hands) 
CG 12 patients (16 
hands) patients 
Undertaken before and 
after a 10-week 
Pre and post-treatment intra-group 
analyses of both groups revealed that 
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2005 
 
Appraisal 7  
 
Low risk of 
bias 
 
Age range 35-
55 years 
 
Duration of 
symptoms 
(months) 
CG 47.6 (± 6.8) 
IG 49.6 (± 5.2) 
 
patients 
diagnosed with 
early-middle 
stages CTS 
 
In addition to 
splint wearing 
and patient 
training program 
treated with 
nerve gliding 
exercises 
(Totten & 
Hunter) 10 reps 
5 sets a day for 
10 weeks, 
combined with a 
conservative 
treatment 
program 
diagnosed with 
early-middle stages 
CTS 
 
Treated in volar 
splint in neutral 
worn day & night 
for 6-weeks then 
night only from 
week 6-10, and a 
patient training 
program for the 
modification of 
functional activities 
(avoid repetitive 
activities) with a 
conservative 
treatment program. 
treatment programme.  
 
1) Tinel Test  
2) Phalen Test 
3) Pain (VAS) over a 
day 
4) Motor Function 
manual testing 
5) Grip strength (Jamar 
hand dynamometer) 
6) Sensory evaluation 
(Semmes-Weistein 
monofilament &2-point 
discrimination test 
7) Electrophysiological 
Test – Median & Ulnar 
n. distal latencies 
there were no statistically significant 
differences between the two groups in 
average muscle strength, functional 
sensitivity, normal sensory test, or 
manual muscle tests. 
Significant progress was detected in 
both control and experimental groups 
during the post-treatment phase 
compared with the initial phase (p< 
0.05).  When the 2 groups were 
compared the experimental group, in 
which nerve gliding exercises were 
added, demonstrated more rapid pain 
reduction, and greater functional 
improvement especially in grip 
strength (p< 0.05) 
(IG: 1±1.6 CG: 1.6±1.8) and greater 
functional improvement especially in 
grip strength (IG: 22.0±6.8 CG: 
21.7±4.3)  (p< 0.05). 
Tal-Akabi & 
Rushton 
2000 
 
Appraisal 7 
 
Unclear risk 
of bias 
n = 21 
Age range 29-
85 years 
Mean age 47.1 
(±14.8) 
 
Duration of 
symptoms 
Group 1   n = 7 
with CTS 
received 
ULNDT 2a 
mobilisation 
based on 
physiotherapist 
clinical 
reasoning 
 
Group 3   n = 7 
with CTS received 
no intervention 
 
Group 2 n = 7 with 
CTS received 
Carpal bone 
mobilisation 
(anterior-posterior 
and or posterior-
All taken pre and post 
treatment  
1) Symptoms diary 
(24hr VAS) 
2) Functional box scale 
3) Range of motion 
Wrist flexion/extension 
4) ULNDT2a 
Only pain relief scale demonstrated a 
statistically significant difference 
between the 3 groups (p<0.01). VAS: 
Group 1 mean1.57; Group 2 mean 
0.71; Group 3 mean 0.71. 
No statistically significant difference in 
effectiveness of treatment was 
demonstrated between the two 
intervention groups. The number of 
patients continuing to surgery was 2 in 
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(years) 
2.3 (±2.5, range 
1-3) 
 
All subjects are 
on the waiting 
list for surgery 
Number of 
treatments or 
treatment time 
not mentioned 
anterior) and a 
flexor retinaculum 
stretch 
 Treatment time not 
mentioned 
5) Pain relief scale 
6) Continuing to have 
surgery 
NDT, 1 in carpal bone mobilisation 
and 6 in control group. 
 ULTT – Group 1, 5 of 7 negative; 
Group 2, 4 of 7 negative; Group 3, all 
still positive 
Schmid et al 
2012 
Appraisal 8 
 
Low risk of 
bias 
n = 21 
Age: IG 49.9 
(12.5) Splint 
57.9 (16.3)  
Gender 
(male/female) 
IG 5/5  
CG 7/3 
Symptom 
duration in 
months (SD) 
IG 54.6 (47.6) 
CG 62.8 (56.1)  
CTS severity 
Mild IG 4 
CG 3  
Moderate IG 6  
IG 11 with CTS 
randomised – 1 
dropout  
Received neural 
gliding aimed at 
improving nerve 
excursion - 
exercises 10 
repetitions 10 
times per day 
for one week 
CG 10 with CTS 
randomised 
Received night 
splint for one week  
Measured before, 10 
minutes after and 1 
week after intervention 
1) Signal intensity at 
pisiform, radio ulnar 
and hamate 
2) Ligament bowing at 
hamate 
3) Boston questionnaire 
4) Pain (VAS) 
5) Numbness (VAS) 
5) Patient Specific 
Functional Scale  
 
“The findings of this study suggest that 
a reduction in intraneural oedema is a 
therapeutic mechanism of both nerve 
and tendon gliding exercises and 
splinting. 
The chronicity of the symptoms of the 
patients involved in this study and the 
short treatment period propose that 
the reduction in intraneural oedema is 
associated with the interventions 
rather than the result of the natural 
course of CTS.’ 
Boston questionnaire F(1,17)=16.70; p . 
0.001 
Patient Specific Functional Scale 
F(1,16) . 22.10; p < 0.001 
Post-hoc comparisons revealed that 
both groups improved significantly 
after 1-week intervention (all p < 
0.004). No significant interaction or 
main effects for pain intensity and 
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CG 7 numbness were found (all p > 0.16). 
Signal intensity did not change in 
patients who were not treated 
Wolny et al. 
(2016) 
 
Appraisal 7 
 
Low risk of 
bias 
n=160 initially 
Analysed (male 
18, female 122) 
 
Mean age: 
IG 53.12  
CG 51.51 
 
Gender 
(Male/female) 
IG 8/62 
CG 10/60 
IG n=80 with 
CTS 
Not analysed 
n=10 
 
Manual therapy 
and ULNDT1 
sliders and 
tensioners 
 
2 treatments/ 
week for 10 
weeks  
CG n=80 with CTS 
Not analysed n=10 
 
Ultrasound and 
laser therapy  
 
2 treatments/ week 
for 10 weeks 
Outcomes measured 
before and at the end 
of treatment 
1) Two-point 
discrimination 
The outcomes of treatment on two-
point discrimination demonstrated that 
both methods had a significant 
therapeutic effect (p<0.001). It should 
be noted, however, that the groups 
differed significantly before starting the 
treatment cycle. Larger disturbances 
of two-point discrimination sensation in 
symptomatic extremities occurred in 
the IG group as compared with the CG 
group. After a course of therapy, there 
were no statistically significant (p> 
0.05) intergroup differences, indicating 
greater improvement in the NM group 
(IG: 2.6; 2.25-2.95 CG: 0.5; 0.16-0.84 
p<0.001). 
Legend: IG – Intervention group; CG – Control group; CTS – Carpal tunnel syndrome; VAS – Visual analogue scale; EMG – Electro-myogram; NRS – 
Numeric Rating Scale; DASH – Disability of arm, shoulder, hand symptom scale; ULNDT – Upper limb neurodynamic test; WHO – World Health Organization; 
TENS – Transcutaneous Nerve Stimulation; NM – Neural mobilisation
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Table 2.3. Summary of findings of meta-analyses for carpal tunnel syndrome 
(CTS) 
Outcomes 
(CTS) 
Relative effect (95% 
CI) 
No. participants 
(No. studies) 
p value Quality of 
evidence 
Pain (VAS) -0.22 (-0.74, 0.3) 
Favours intervention 
126 (5) 
(Bialosky et al., 
2009b, Baysal et 
al., 2006, Pinar 
et al., 2005, Tal-
Akabi and 
Rushton, 2000, 
Schmid et al., 
2012) 
p = 0.52 4 low risk of bias 
Hand grip 
strength 
1.18  (-1.29, 3.66)  
Neutral 
139 (4) 
(Akalin et al., 
2002, Baysal et 
al., 2006, 
Brininger et al., 
2007, Pinar et 
al., 2005)  
p = 0.35 3 low risk of bias 
Disability (DASH) -1.55 (-7.84, 4.75) 
Favours intervention 
153 (3) 
(Bialosky et al., 
2009b, Heebner 
and Roddey, 
2008, Horng et 
al., 2011) 
p = 0.63 2 low risk of bias 
Two point 
discrimination 
0.36 (-0.8, 0.08) 
Favours intervention 
173 (3) 
(Baysal et al., 
2006, Bardak et 
al., 2009, Akalin 
et al., 2002)  
p = 0.11 2 low risk of bias 
Phalen’s sign 0.81 (0.87, 1.86) 
Favours intervention 
229 (5) 
(Akalin et al., 
2002, Baysal et 
al., 2006, Bardak 
et al., 2009, 
Pinar et al., 
2005, Oskouei et 
al., 2014) 
p= 0.42 3 low risk of bias 
Legend: CTS – Carpal Tunnel Syndrome; CI – Confidence Interval; VAS – Visual Analogue Scale; 
DASH - Disability of arm, shoulder, hand symptom scale; No. – number. 
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Figure 2.2. Meta-analysis for pain in CTS 
 
 
Figure 2.3. Meta-analysis for disability in CTS 
 
2.3.5 Nerve related low back pain (N-LBP) 
The majority of studies were high risk of bias (see table 2.1). Five 
studies used a slump position as the NM (Ali et al., 2015, Cleland et al., 
2007a, Jain et al., 2012, Nagrale et al., 2012, Rezk-Allah et al., 2011). All the 
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studies using slump mobilisation had significant improvements in pain and 
disability.  
The meta-analyses found that NM had a significant effect for both pain 
(p=0.0001; effect 1.78; 95% CI -2.55 – -1.01) (Cleland et al., 2007a, Dwornik 
et al., 2009, Jain et al., 2012, Kaur and Sharma, 2011, Nagrale et al., 2012) 
(p=0.0001) and disability (p=0.0001; effect -9.26; 95% CI -14.5 – -4.01) 
(Cleland et al., 2007a, Jain et al., 2012, Kaur and Sharma, 2011, Nagrale et 
al., 2012) (p=0.0006) in participants with N-LBP.  
Three studies compared slump with exercises and lumbar mobilisation 
(Cleland et al., 2007a, Jain et al., 2012, Nagrale et al., 2012) and 1 compared 
it to stabilisation exercises (Ali et al., 2015). One study could not be included 
in the meta-analysis as it measured the H-reflex and compared slump with 
SLR (Rezk-Allah et al., 2011). 
The remaining studies used a variety of techniques. SLR mobilisation (Kaur 
and Sharma, 2011, Rezk-Allah et al., 2011, Ahmed et al., 2013) resulted in a 
significant improvement in pain and disability (p<0.05). SLR was compared to 
exercises in 2 studies (Ahmed et al., 2013, Kaur and Sharma, 2011). NM 
techniques which aimed at opening the intervertebral foramina (Mehta et al., 
2014) also reported improved pain (p=0.01) in the NM group compared to a 
group receiving ultrasound, exercises and lumbar mobilisation. Three studies 
compared two types of NM with each other (Patel, 2014, Rezk-Allah et al., 
2011, Waleed Salah El-din, 2015). One compared slump to bent leg raise 
(Patel, 2014) as described by Hall et al. (2006). Another compared slump to 
SLR (Rezk-Allah et al., 2011). The third study compared SLR and slump to 
lumbar mobilisation which included rotation with SLR (Waleed Salah El-din, 
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2015). All NM groups had an improvement in pain (p<0.09) but there were no 
statistically significant between-group differences (p>0.5). 
Four studies measured ROM in N-LBP (Dwornik et al., 2009, Kaur and 
Sharma, 2011, Mehta et al., 2014, Patel, 2014) with two reporting 
improvement in SLR in the NM group, (Patel, 2014, Kaur and Sharma, 2011) 
one an improvement in the slump (Mehta et al., 2014) and one non-significant 
change in Laseque’s sign (Dwornik et al., 2009). 
Five studies administered treatment over a period of three weeks (Ali et al., 
2015, Cleland et al., 2007a, Jain et al., 2012, Mehta et al., 2014, Nagrale et 
al., 2012) and two studies over a two-week period (Ahmed et al., 2013, 
Dwornik et al., 2009). One study had a one week intervention,(Patel, 2014) 
another four weeks (Rezk-Allah et al., 2011) and one study had a treatment 
period of six weeks (Waleed Salah El-din, 2015). 
Figure 2.4 and Figure 2.5 show the results of the meta-analyses and Table 
2.4 describes the studies.
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Table 2.4. Study descriptions for N-LBP 
Author 
Appraisal score 
Risk of bias 
Patient 
demographics 
Intervention Group 
(IG) 
Control Group (CG) Outcome Measures Result 
Ahmed et al. 
(2013) 
 
Appraisal 7 
 
Low risk of bias 
n=30 (14 male, 16 
female) 
 
Age range (years) 
45-67 
 
Mean age (years) 
IG  53.00 (±1.91) 
CG  52.60 (±1.60) 
 
Duration of 
symptoms (weeks) 
IG  4.87 (±1.50) 
CG  5.26 (±1.75) 
IG n=15 participants 
with sciatica 
 
Same treatment as 
control plus: 
SLR tibial and peroneal 
bias  
2 sets of 20 
mobilisation of each 
bias. 
3 treatments/week for 2 
weeks 
CG n=15 participants 
with sciatica 
 
Flexion and extension 
exercises(Elnaggar et 
al., 1991) 2-3 sets 
TENS 
Home exercises 
3 treatments/week for 2 
weeks  
Outcomes measured 
at baseline and end 
of treatment  
 
1) NPRS 
2) SF12 
No Baseline 
differences. 
Improvement in both 
measures in both 
groups, but 
significantly more and 
clinically relevant in 
the IG group 95% CI; 
2.85, 4.09) NRS CG  
4.93 ± 1.10 (95% CI 
(4.34, 5.55) Between 
groups difference 
favouring IG 1.46 
(14.6%) SF12 IG  
65.57 ± 12.00 95% CI 
(58.97, 72.17) SF12 
CG 54.53±7.34 95% 
CI (50.49, 58.57) 
Between groups 
difference favouring IG 
11.04 (11.04%)  
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Ali et al. (2015) 
 
Appraisal 6 
 
High risk of bias 
n=40 (10 male, 30 
female) 
 
Age range (years) 
20-60 
 
Mean age (years) 
IG 34.32 (±8.94)
  
CG 33.22 (±7.16) 
IG n=22 participants 
with chronic radicular 
LBP 
 
Same treatment as 
control plus: 
Slump slider 
mobilisation 
5 days/week for 3 
weeks 
 
CG n=18 participants 
with chronic radicular 
LBP 
 
Lumbar stabilisation 
exercises 
Shortwave diathermy 
5 days/week for 3 
weeks 
Outcomes measured 
at baseline and end 
of treatment  
 
1) MODI 
2) VAS – 5 point 
scale 
Both groups had a 
significant 
improvement in pain 
(VAS) 95% CI; 2.85, 
4.09) NRS CG  4.93 ± 
1.10 (95% CI (4.34, 
5.55). Between groups 
difference favouring IG 
1.46 (14.6%) 
SF12 IG  65.57 ± 
12.00 95% CI 
(58.9659, 72.1741) 
SF12 CG 54.53 ± 7.34 
95% CI (50.4905, 
58.5695)   
Between groups 
difference favouring IG 
11.04 (11.04%)Only 
the IG had a 
significant 
improvement in 
disability (MODI) (IG 
p=0.003; 2.91±0.69; 
CG p=0.163; 
1.49±0.32).  
Cleland et al. 
(2007a) 
n=30 (9 male, 21 
female) 
IG n=16 participants 
with LBP  
CG n=14 participants 
with LBP 
Outcomes measured 
at baseline and end 
No baseline 
differences between 
groups (p>0.05). 
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Appraisal 9 
 
Low risk of bias 
 
Age range (years) 
18-60 
 
Mean age (years) 
IG 40.0 (±12.2) 
CG 39.4 (±11.3)  
 
Duration of 
symptoms (weeks)  
IG 14.5 (±8.0) 
CG 18.5 (±12.5) 
 
 
Same treatment as 
control plus: 
Slumped stretching 
exercise (position held 
30 seconds, 5 
repetitions) 
Home exercise slump 
stretches (2 repetitions 
for 30 seconds) 
2 /week for 3 weeks 
 
5 min cycle warm up 
Lumbar spine 
mobilisation 
(PA mobilisations to 
hypo mobile lumbar 
segments, grade 3-4) 
Standardised exercise 
program (pelvic tilts, 
bridging, squats, 
quadruped alternate 
arm/leg activities; 2 
sets 10 repetitions 
each) 
 
2 /week for 3 weeks 
of treatment  
 
1) Body Diagram (for 
distribution of 
symptoms) 
2) NPRS 
3) MODI 
4) Fear avoidance 
beliefs questionnaire 
Participants who 
received slump 
stretching had 
significantly greater 
improvements in 
disability. Between 
group difference 
favouring IG 9.7 95% 
CI (5.4, 14.0) (9.7 
points on the MODI, 
p<0.001), pain (0.93 
points on the NPRS, 
p=0.001 2.91±0.69; 
CG p=0.163; 
1.49±0.32) and 
centralisation of 
symptom distribution 
(p<0.01).  
Dwornik et al. 
(2009) 
 
Appraisal 6 
 
High risk of bias 
n=97 (44 male, 53 
female) 
 
Age range (years) 
19-60 
 
Mean age IG and 
CG (years) 43 (±10)  
 
No other data 
IG n=42 participants 
with neurogenic LBP, 5 
did not complete 
treatment 
 
10 treatments over 2 
weeks. 
NM techniques 
according to 
Butler(Butler, 1991) of 
femoral, sciatic, tibial 
CG n=45 participants 
with neurogenic LBP, 2 
did not complete 
treatment 
 
10 treatments over 2 
weeks. 
10x TENS 10-15 min 
10x laser over painful 
area. 
Outcomes measured 
at baseline and end 
of treatment 
 
1) Resting muscle 
tone (quadriceps 
femoris, biceps 
femoris, Tibialis 
anterior, 
gastrocnemius) 
measured by EMG 
NM had significant 
effect on resting 
muscle tone compared 
to control. Significant 
improvement in clinical 
tests (Laseque 
p=0.0003 between 
group difference 2.7° 
(6%) favouring IG) and 
pain (p=0.00001 
difference 1.5 (15%) 
favouring IG)) and 
pain (p=0.00001). No 
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available 
 
 
nerves 
 
Techniques not 
described 
Movement exercises 
for intervertebral joints 
without axial loading 
2) ROM of Laseque 
sign and reverse 
Laseque sign 
measured with 
inclinometer 
3) Presence of 
Bragard sign and 
reverse Laseque 
sign 
4) VAS 
other values available. 
 
Drop out of 7 of 87 
participants. 
Jain et al. (2012) 
 
Appraisal 6 
 
High risk of bias 
n=30 (11 male, 19 
female) 
 
Age range (years) 
19-60 
 
Mean age (years) 
IG 34.26 (±5.66) 
CG 33 (±6.86)  
 
Duration of 
symptoms (weeks)  
IG 8.067 (±1.10) 
CG 8.266 (±1.16)  
IG n=15 participants 
with LBP, unilateral 
limb pain and positive 
slump  
 
All participants were 
treated for 9 sessions 
(3 days/ week for 1st 
week and 2 days/week 
for next 3 weeks) 
 
Same treatment as 
control plus: slump 
stretching from 2nd 
week 
 
CG n=15 participants 
with LBP unilateral limb 
pain and positive slump  
 
All participants were 
treated for 9 sessions 
(3 days/week for 1st 
week and 2 days/ week 
for next 3 weeks) 
 
PA mobilisation of 
lumbar spine, exercises 
 
Outcomes measured 
at baseline, 1, 2, 3, 4 
and 5 weeks 
 
1) VAS 
2) MODI 
For pain (VAS) 
significant differences 
were found at the end 
of 2nd, 3rd, 4th and 
5th week 
(p=0.0185,p=0.000, 
p=0.000 and p =0.000, 
respectively) between 
the 2 groups, in favour 
of the experimental 
group. 
MODI between the 
groups was non- 
significant differences 
at the end of 1st week 
(p=0.4375), 2nd week 
(p=0.4515), 3rd week 
(p=0.078) and 4th 
week (p=0.0865). No 
means or SD values 
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available 
Kaur and Sharma 
(2011) 
 
Appraisal 6 
 
High risk of bias 
n=27 
 
Age range (years) 
18-45  
 
No other data 
available 
IG n=12 participants 
with sub-acute 
Neurogenic LBP: pain 
in lower lumbar region 
with or without radiation 
to lower limb; without 
any neurological 
deficits and positive 
SLR.  
 
10 sessions over 2 
weeks 
Passive SLR 
CG n=15 participants 
with sub-acute 
Neurogenic LBP: pain 
in lower lumbar region 
with or without radiation 
to lower limb; without 
any neurological 
deficits and positive 
SLR.  
 
10 sessions over 2 
weeks 
Advice 
Exercise 
Outcomes measured 
at baseline and end 
of treatment 
 
1) VAS 
2) Hip flexion ROM  
3) Werneke overlay     
template 
4) MODI 
Between groups 
analysis of all the 
variables 
demonstrated a 
significant post-
intervention difference 
(p<0.05) in patient 
reported VAS scores, 
(mean change of 3 
(30%) favouring IG; IG 
2, 95% CI (0.74, 3.26) 
CG; 4, 95% CI (2.74, 
5.26)), hip flexion 
ROM (74.6° for IG and 
60° for the CG) hip 
flexion ROM and 
disability scores 
(MODI- IG -6 and CG -
2).  A statistically 
significant reduction in 
the area of reported 
symptoms for NM 
within the IG (50.3%) 
but not for the CG 
(25.1%).  
Mehta et al. (2014) 
 
Appraisal 5 
n=50 (22 male, 28 
female) 
Mean age (years) 
IG 45.58 (±6)  
IG n=25 participants 
with sub-acute LBP and 
a capsular pattern of 
restriction 
CG n=25 participants 
with sub-acute LBP 
and a capsular pattern 
of restriction 
Outcomes measured 
at baseline and end 
of treatment 
 
Both treatment 
techniques improved 
pain and disability but 
the NM group 
improved sooner than 
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High risk of bias 
CG 46 (±6.8) 
Gender: 
IG (12 males, 13 
females) 
CG (10 males and 
15 females)  
No other data 
available 
 
3 weeks treatment on 
alternate days and 
follow up on week 4 
Ultrasound 
Exercise 
NM from static opener 
progressing to dynamic 
end range closer 
30 mobilisations of 3 
sets with 30 sec. rest 
 
3 weeks treatment on 
alternate days and 
follow up on week 4 
Ultrasound 
Exercise 
Maitland joint 
mobilisation 
 
1) VAS 
2) ROM lumbar 
spine 
3) ROM Slump test 
4) MODI 
the other group. 
VAS p=0.0133(IG: 4.6 
CG: 6.3) p=0.0133 
Slump ROM (IG: 2.4 
CG 2.7 p=0.0038) At 4 
weeks post-treatment 
 
Nagrale et al. 
(2012) 
 
Appraisal 9 
 
Low risk of bias 
n=60 (19 male, 39 
female) 
 
Mean age (years) 
IG 38.2 (±3.47) 
CG 37.76 (±4.70) 
 
Symptom duration 
(weeks) 
IG 15.26 (±2.57) 
CG  14.76 (±1.79) 
IG n=30 participants 
with non radicular LBP 
with positive slump and 
SLR > 45° 
 
Same treatment as 
control plus:  
Slump stretching 5x 30 
second hold 
 
CG n=30 participants 
with non radicular LBP 
with positive slump and 
SLR > 45° 
 
3 weeks treatment 
PA mobilisation of 
lumbar spine 
Stabilisation exercises 
according to Childs et 
al(Childs et al., 2004) 
Outcomes measured 
at baseline, 1, 2, 3 
and 6 weeks. 
 
1) NPRS 
2) MODI 
3) Fear Avoidance 
Beliefs 
Questionnaire 
There were large 
within-group changes 
for all outcomes with 
p<0.01 and large 
between group (IG: 
28±3.93 CG: 
39.5±7.25) and 6 (IG: 
28.2±4.11 CG; 
44.1±6.40) for the 
MODI and weeks 1 
(IG: 5.4±0.93 CG: 
6.1±1.09), 2 (IG: 
3.6±0.77 CG: 
4.7±0.94), 3, (IG: 
2.1±0.54 CG: 
3.7±0.95) and 6 (IG: 
2.4±0.80 4.3±1.12) 
NPRS and FABQ at 
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p<0.01. Significant 
differences favouring 
the slump stretching 
group at p<0.01. 
Patel (2014) 
 
Appraisal 5 
 
High risk of bias 
n=50 
 
Age range (years) 
30-60 
 
No other data 
available 
Group A n=25 
participants with LBP 
and a positive SLR of 
more than 15° 
BLR(Hall et al., 2006) 
30 sec. x 3 
4 treatments for a week 
 
Group B n=25 
participants with LBP 
and a positive SLR of 
more than 15° 
Slump stretching 
exercise 30 sec. x 3 
4 treatments for a week 
 Outcomes measured 
at baseline and end 
of treatment 
 
1) VAS 
2) ROM of SLR 
Results of the study 
shows that both the 
techniques BLR and 
Slump are effective in 
reducing pain and 
alter the ROM 
(p≤0.05) p=0.003 pre 
test mean 67.6, post 
test mean 85), than 
the Group B  (p=0.07 
pre test mean 70.4 
post test mean 85.68 
of passive SLR. 
However group A 
showed greater 
improvement in pain 
and ROM of passive 
SLR (p=0.003), than 
the group B in 
participants with LBP. 
Rezk-Allah et al. 
(2011) 
 
Appraisal 6 
 
n=40 
 
Age range (years) 
35-50 
 
Group A n=20 Slump 
group. Positive findings 
of electromyography, 
prolonged latency of H-
reflex > 30 msec. 
Slump to full range – 
 
 
Outcomes measured 
at baseline and end 
of treatment 
 
1) VAS 
Significant reduction in 
pain and H-reflex 
latency (p<0.01) in 
comparison to pre-
treatment values, no 
significant difference 
in pain intensity 
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High risk of bias Mean age (years) 
Group A 43.95 
(±4.84)  
Group B 44.9 
(±4.55)  
 
No other data 
available 
held for 60 seconds x 5 
3 treatment/week for 4 
weeks  
 
Group B n=20 SLR 
group. Positive findings 
of electromyography, 
prolonged latency of H-
reflex > 30 msec. 
SLR to onset of 
symptoms or 
resistance- held for 60 
seconds x 5 3 
treatments/week for 4 
weeks  
2) H-reflex latency 
 
(Group A: t=13.85, 
p=0.0001 Group B: 
t=14.25, p=0.0001) 
and H-reflex latency 
(t=2.92, p=0.0058)  
between groups post-
treatment. NM 
significantly improved 
symptoms and 
decreased nerve root 
compression.  
Waleed Salah El-
din(Waleed Salah 
El-din, 2015) 
 
Appraisal 6 
 
High risk of bias 
n=60 
 
Age range (years) 
30-50 
Mean age (years) 
IG 44.2 (±6.16) 
CG 42.93 (±5.73) 
 
Duration of 
symptoms (weeks)  
Pain for longer than 
IG n=30 participants 
with chronic radicular 
LBP 
MRI compromise of 
nerve 
SLR and Slump 
mobilisation to onset of 
symptoms 
3 treatments/week for 6 
weeks 
 
CG n=30 
NOTE – used rot SLR 
(Maitland) in 
Comparison Group 
described as 
mobilisation group 
Outcomes measured 
at baseline and end 
of treatment 
 
1) VAS 
2) Oswestry 
Disability Index 
3) MRI compromise 
of nerve  
 
Manipulation and NM 
The lumbar 
manipulation (with 
SLR) techniques were 
more effective than 
NM techniques on leg 
pain (P=0.006), Group 
A: 3.03±1.88 Group B: 
1.83±1.31 p=0.006), 
MODI (Group A: 
23.9±4.9 Group B: 
18.4±6.87 p=0.001), 
and degree of nerve 
root compression 
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Legend: IG – Intervention group; CG – Control group; SLR – Straight leg raise; BLR – Bent leg raise; TENS – Transcutaneous Electro-nerve stimulation; 
NPRS – Numeric pain rating scale; SF – Short form; LBP – Low back pain; MODI – Modified Oswestry Disability Index; EMG – Electro-myogram; VAS – 
Visual analogue scale; ROM – Range of motion.
3 months 
 
No other data 
available 
Posterior-anterior 
mobilisation 3-4 
repetitions (Maitland) 
Lumbar rotation with 
SLR 3-4 repetitions 
(P=0.037). 
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Figure 2.4. Meta-analysis for pain in nerve-related low back pain (N-LBP) 
 
Figure 2.5. Meta-analysis for disability in N-LBP 
 
2.3.6 Nerve-related neck and arm pain (N-NAP) 
Five of the 10 studies had a low risk of bias (Table 2.1) (Allison et al., 2002, 
Coppieters et al., 2003b, Langevin et al., 2015, Nee et al., 2012b, Ragonese, 
2009). Outcome measures included pain, McGill Pain Questionnaire, Neck 
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Disability Index, Global Rating of Change, Patient Specific Functional Scale, 
Cervico-brachial Pain Questionnaire; DASH and Northwick Park 
Questionnaire; active ROM; shoulder girdle elevation force and ROM during 
neurodynamic testing.  
Pain (VAS and NPRS) was the only outcome measure on which meta-
analysis could be performed. Participants who received cervical lateral glides 
had a significantly better outcome for pain than the control groups (p=0.0003; 
effect 1.89; 95%CI -3.14, -0.64) (Figure 2.6). 
Two studies used only one intervention,(Coppieters et al., 2003b, Marks et al., 
2011) two had 10 sessions of treatment (Kumar, 2010, Nar, 2014) and one 
had five sessions over a seven day period (Gupta and Sharma, 2012). Three 
studies mention only the length of treatment (four weeks, (Langevin et al., 
2015) eight weeks (Allison et al., 2002) and six months (Anwar et al., 2015)). 
One study had four treatments over a period of two weeks (Nee et al., 2012b). 
Another study administered three treatments per week over three weeks 
(Ragonese, 2009).  
Four studies evaluated cervical lateral glide techniques (Allison et al., 2002, 
Coppieters et al., 2003b, Nee et al., 2012b, Ragonese, 2009) and all reported 
a significant improvement in pain for the groups receiving NM (meta-analysis: 
p<0.001) (Figure 2.4). Cervical lateral glide was compared to mobilisation of 
the gleno-humeral joint and thoracic spine, (Allison et al., 2002) ultrasound, 
(Coppieters et al., 2003a, Coppieters et al., 2003b) exercise and a 
combination of NM and exercise (Ragonese, 2009) and advice only (Nee et 
al., 2012b). These studies all had a low risk of bias. Another study with a low 
risk of bias (Langevin et al., 2015) used mobilisation techniques aimed at 
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opening the cervical foramina (including cervical lateral glide) and compared it 
to cervical spine mobilisation (Langevin et al., 2015). Both groups had 
significant improvement in disability and pain (p<0.05) but there were no 
between group differences.  
Four studies used nerve mobilisation exercises (Gupta and Sharma, 2012, 
Marks et al., 2011, Nar, 2014, Kumar, 2010). One found cervical spine 
mobilisation more effective than NM to improve ROM of the cervical spine 
(p<0.05) and the ROM during neurodynamic testing (p=0.01) (Marks et al., 
2011). The use of a tensioning technique (Nar, 2014) resulted in significant 
improvements in pain (p<0.001) in the NM group compared to interferential 
therapy, traction and exercises. Median nerve sliders (Gupta and Sharma, 
2012) improved pain in the NM group compared to exercise and ergonomic 
advice (p<0.05).  When comparing tensioning techniques for the radial nerve 
to McKenzie exercises (Kumar, 2010) it was found that the McKenzie exercise 
group had better outcomes in pain (p<0.001). The above studies all had a 
high risk of bias. One study did not specify the kind of NM used in 
combination with cervical spine mobilisation and exercises and compared it to 
cervical spine mobilisation and exercises only (Anwar et al., 2015). The 
addition of NM resulted in improvement in disability (p<0.05). 
The effect of NM on disability could not be explored by meta-analysis as 
different outcome measures were used. One low risk of bias study (Nee et al., 
2012b) reported better outcomes (number needed to treat) for the Neck 
Disability Index and the Patient Specific Functional Scale in the NM group 
compared to advice to stay active. Two high risk of bias studies reported 
better outcomes (p<0.05) on the Neck Disability Index in the groups receiving 
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NM compared to groups receiving mobilisation and exercise (Anwar et al., 
2015, Gupta and Sharma, 2012). One study did not report the outcomes for 
the Neck Disability Index (Nar, 2014). One other study also measured the 
Neck Disability Index (Langevin et al., 2015) but found that the NM group 
improved to the same extent as the comparison group. One low risk of bias 
study found that NM resulted in no adverse effects (Nee et al., 2012b).  
There were 5 studies in N-NAP that assessed ROM (Coppieters et al., 2003a, 
Gupta and Sharma, 2012, Kumar, 2010, Marks et al., 2011, Ragonese, 2009). 
Two studies reported an improvement in ULNDT1 elbow extension range in 
the NM groups (Coppieters et al., 2003a, Gupta and Sharma, 2012). In 
another study there was no significant difference between groups (Ragonese, 
2009) and the last study measured neck ROM and found improved extension 
and rotation towards the painful side in the group receiving joint mobilisation 
(Marks et al., 2011). Table 2.5 contains the study descriptions and Figure 2.6 
shows the forest plot for the meta-analyses on pain in N-NAP. 
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Table 2.5. Study descriptions N-NAP 
Author 
Appraisal score 
Risk of bias 
Patient demographics Intervention Group (IG) Control Group (CG) Outcome Result 
Allison et al. (2002) 
 
Appraisal 9 
 
Low risk of bias 
 n=30  (20  females, 10  
males) 
 
Age range 18-75 years 
 
Median duration of 
symptoms (months) 
IG 12  
CG 12 
Articular Treatment 72 
 
 
IG n=17 participants with 
cervico-brachial pain 
Cervical lateral glide, 
shoulder girdle oscillation, 
muscle re-education, home 
mobilisation. 
 
Duration of treatment 8 
weeks. 
 
 
CG n=10 participants with 
cervico-brachial pain 
Received no intervention 
for the initial 8 weeks 
(At the end of the study 
they were given neural 
treatment as a cross over 
protocol.) 
Articular treatment n=9 
patients with cervico-
brachial pain. Gleno-
humeral joint mobilisation, 
thoracic mobilisation and 
home exercise. 
 
Duration of treatment 8 
weeks. 
Outcomes 
measured at 
baseline, 4 weeks 
into treatment and 
post treatment. 
 
1) McGill pain 
questionnaire. 
2) Northwick Park 
questionnaire 
3) Pain (VAS) 
 
Both manual therapies 
combined with home 
exercises are effective in 
improving pain intensity, 
pain quality scores and 
functional disability 
levels. A group 
difference was observed 
for the VAS scores at 8 
weeks with the NM 
having a significantly 
lower score (p<0.001 
relative % change 66 
favouring NM). 
Anwar et al. (2015) 
 
Appraisal 5  
 
High risk of bias 
n=40 
 
Age and duration of 
symptoms not available  
 
IG n=20 participants with 
cervical radiculopathy  
Moist heat 
Mobilisation and isometric 
exercises 
Neural mobilisation 
CG n=20 participants with 
cervical radiculopathy 
Moist heat 
Mobilisation and isometric 
exercises 
 
Outcomes 
measured at 
baseline and end of 
treatment  
 
1) VAS 
2) NDI 
Addition of 
neurodynamics to a 
multimodal program 
resulted in a significant 
improvement in disability 
(p<0.05). p<0.05; 1.53 
+/- 0.52). No other 
values available 
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(technique not mentioned) 
 
Treated over a period of 6 
months 
Treated over a period of 6 
months 
(Coppieters et al., 
2003a, Coppieters 
et al., 2003b) 
 
Appraisal 8 
 
Low risk of bias 
n=20 (16 females, 4 
males)  
 
Age range 35- 65 years 
 
Mean age (years) 
IG 49.1 (±14.1) 
CG 46.6 (±12.1) 
 
Mean duration of 
symptoms (months) 
IG 2.7 
CG 3.2 
IG n=10 participants with 
brachial or cervico-brachial 
neurogenic pain 
 
 
Received NM treatment 
(contra-lateral glide of 
cervical segment) 
 
 
One intervention and 
immediate follow-up 
CG n=10 participants with 
brachial or cervico-
brachial neurogenic pain  
 
Received Ultrasound 
dose of 0.5 W/cm², 5mins 
sonation time, 20% size of 
head 5cm², frequency 
1MHz.  
 
One intervention and 
immediate follow up 
Outcomes 
measured at 
baseline and end of 
treatment 
 
1) Elbow extension 
ROM during NTPT1 
2) Pain (NPRS) 
neck and arm. 
3) Symptom 
distribution. 
Significant differences in 
treatment effects 
between 2 groups could 
be observed for all 
outcome measures 
(p≤0.306). For the 
mobilization group the 
increase in elbow 
extension from 137.3º to 
156.7º, the 43% 
decrease in area of 
symptom distribution and 
decrease in pain from 
7.3 to 5.8 were 
significant (p0.0003). 
For ultrasound group, 
there were no significant 
differences. 
Gupta and Sharma 
(2012) 
 
Appraisal 5 
 
High risk of bias 
n=34 initial 37 (16 
females, 18 males) 
 
Age range 18 – 40  
 
Median age 29.5 
 
IG n=16 participants with 
cervico-brachial pain n=2 
discontinued 
 
Median slider applied 3 x 10 
repetitions 
 
5 treatments over 7 days 
CG n=18 participants with 
cervico- brachial pain n=1 
discontinued 
 
Exercise (isometric), 
posture, advice to move 
regularly.  
 
Frequency not clear 
Outcomes 
measured at 
baseline and end of 
7 days  
1) NDI 
2) Cervico-brachial 
pain questionnaire 
3) VAS 
4) Pain free elbow 
Both groups showed 
statistically significant 
improvement in pain 
intensity, (0.95; Z=4.94, 
elbow extension ROM 
(12.50°; Z=5.02), NDI 
and CBSQ (both 
decrease of 5 in IG 
compared to CG 
decrease of 2 for the 
NDI and 1 for CBSQ 
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No other data available extension 
 
(p<0.05). However, 
experimental group 
receiving NM showed 
better improvement 
compared to 
conventional group.  
Kumar (2010) 
 
Appraisal 5 
 
High risk of bias 
n=30 (20 females, 10 
males) 
 
Age range (years) 25 to 
68  
 
No other data available 
Group B n=10 participants 
with cervical radiculopathy  
 
Active or passive through 
range and end range 
oscillation in ULNDT 2a 
position moving distal 
component 
Shortwave 
Traction  
 
10 treatments over 10 days 
Group A n=10 participants 
with cervical radiculopathy  
McKenzie exercises 
Shortwave 
Traction 
Group C with cervical 
radiculopathy n = 10 
Shortwave 
Traction 
 
10 treatments over 10 
days 
Outcomes 
measured at 1
st
, 5
th
 
and 10
th
 day 
 
1) VAS 
2) Pain recovery 
percentage 
3) ROM 
Pain reduction in first 5 
days was most in 
patients treated with 
McKenzie method and 
best symptom relief 
achieved (p=0.0001 
(Group A: t =10.24, 
p=0.0001, Group B: 
t=5.106, p=0.001 and 
group C:t=14.596, 
p=0.0001). Conventional 
method gave more relief 
between 5th and 10th 
day of treatment, Range 
of motion recovery was 
even in all groups. NM 
shows poor 
improvement possibly 
because of provocation 
to the nerve roots. 
Langevin et al. 
(2015) 
 
Appraisal 9 
 
Low risk of bias 
n=36 (male 12, female 
24) 
 
Mean age (years) 
IG 42.8 (±10.4) 
CG 47.8 (±11.3) 
IG n=18 participants with 
cervical radiculopathy 
 
Stabilisation and mobility 
exercises 
Cervical mobilisation 
techniques aimed at opening 
CG n=18 participants with 
cervical radiculopathy 
 
Cervical and thoracic 
mobilisations, as well as 
stabilisation and mobility 
exercises. 
Outcomes 
measured at 
baseline, 4 weeks 
and 8 weeks post 
treatment 
 
1) NDI 
Both groups showed 
statistically and clinically 
significant improvement 
from baseline to week 4 
and to week 8 in NDI 
(F
2,68
=0.84, p=0.44) 
QuickDASH (F2,62=0.36, 
p= 0.70), and NPRS 
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Symptom duration 
(weeks) 
IG 5.4  (±3.2) 
CG 5.7 (±3.7) 
the intervertebral foramina 
e.g. lateral glide and flexion 
rotation away from pain. 
 
Treatment period of 4 weeks 
 
 
Treatment period of 4 
weeks 
2) DASH 
3) NPRS 
Cervico-thoracic 
mobility 
(F2,68=1.87, p=0.16) 
scores (p<0.05).  
Manual therapy and 
exercises are effective in 
reducing pain and 
functional limitations 
related to cervical 
radiculopathy. NM 
yielded no significant  (p 
≥ 0.14) additional 
benefits. 
Marks et al. (2011) 
 
Appraisal 6 
 
High risk of bias 
n=20 (male 4, female 
16) 
 
Mean age (years) 
CG 53.7 (±9) 
IG 52.6 (±12.5) 
 
Symptoms duration 
(weeks) 
CG 215 (±214.2)  
IG 323 (±404.1) 
IG n=10 participants with 
cervico-brachial pain 
 
Nerve tensioner depending 
on most painful test 
 
Once for 15 minutes 
CG n=10 participants with 
cervico-brachial pain 
 
Cervical spine 
mobilisation and first rib  
 
Once for 15 minute 
Outcomes 
measured at 
baseline, post 
treatment and 1 
week follow up 
 
1) VAS neck and 
arm 
2) Active ROM 
F/E/LF/Rot 
3) ULNDT  
Significant decrease in 
neck pain in both groups 
post-test. (CG – 1.18; IG 
– 1.2). Significant 
improvement in CG for 
cervical extension and 
lateral flexion towards 
painful side. Significant 
improvement in range 
favouring CG (p=0.015) 
(CG: 5.2±7.2 IG: 
1.2±7.7).  
Nar (2014) 
 
Appraisal 6 
 
High risk of bias 
n=30 (males 9, female 
21) 
 
Mean age (years) 
IG  43.93(±7.05) 
IG n=15 participants with 
cervical radiculopathy 
Interferential therapy 
Traction 
Exercise 
CG n=15 participants with 
cervical radiculopathy 
Interferential therapy 
Traction 
Exercise 
Measured pre and 
post treatment 
 
1) VAS 
2) NDI 
NM along with 
conventional treatment is 
more effective than 
conventional treatment 
alone. VAS (IG: 
2.06+1.33 CG: 
3.53+1.12) p=0.01. 
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CG 45.06 (±7.46) 
 
Gender: 
IG (11 females, 4 males) 
CG (10 females and 5 
males) 
Advice 
NM using ULNDT1 
 
10 treatment 6 days per 
week 
Advice 
 
10 treatments 6 days per 
week 
 
 
Nee et al. (2012b) 
 
Appraisal 7 
 
Low risk of bias 
n=60 (38 females, 22 
males) 
 
Mean age = 47 (±9) 
 
Mean group age (years) 
IG 47(±8) 
CG 48(±9) 
 
Mean duration of 
Symptoms (weeks) 26 
(±12- 77)  
IG 32 
CG 18 
 
Gender: 
IG (14 males, 26 
females) 
CG (8 male, 12 female) 
IG n=40 participants with N-
NAP pain 
 
Advice to stay active 
Brief education 
Cervical lateral glide 
Nerve sliding exercises 
 
4 treatments over 2 weeks 
 
CG n=20 participants with 
N-NAP pain 
 
Advice to stay active 
Outcomes 
measured at 
baseline and 3-4 
weeks after 
treatment 
 
1) Global Rating of 
Change 
2) Neck Pain 
(NPRS) 
3) Arm Pain 
(NPRS) 
4) Patient Specific 
Functional Scale 
5) NDI 
Numbers needed to treat 
favoured the intervention 
group for NDI (IG: 
8.9±5.4 CG: 11.2±5), 
neck pain (IG: 2.6±2.4 
CG: 4.2±2.2), arm pain 
(IG: 2.4±2.1 CG: 4±1.9) 
and PSFS (IG: 2.0±2.1 
CG: 0.4±1). NM provides 
clinically relevant 
improvement with no 
evidence of harm.  Risk 
difference for global 
rating of change 
between groups -38 
(95%CI -16-60) 
favouring the IG 
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Legend: IG – Intervention group; CG – Control group; VAS – Visual analogue scale; N-NAP – Nerve-related Neck and Arm Pain; NPRS – Numeric pain 
rating scale; NDI – Neck disability index; ROM – Range of motion; DASH – Disability of the arm, shoulder, hand symptom scale; ULNDT – Upper limb 
neurodynamic test; NM – Neural mobilisation.
Ragonese (2009) 
 
Appraisal 7 
 
Unclear risk of bias 
n=30  
 
No other demographic 
data available 
IG 1 n=10 with cervical 
radiculopathy 
 
Cervical lateral glide grade 3-
4 
ULNDT sliders progressing 
to tensioners 
Thoracic mobilisation  
3 times/week for 3 weeks 
 
IG 2 n=10 with cervical 
radiculopathy 
Treatments as above plus 
strengthening of deep neck 
flexors, lower and middle 
trapezius and serratus 
anterior. 
3 times /week for 3 weeks 
CG n=10 with cervical 
radiculopathy 
 
Strengthening of deep 
neck flexors, lower and 
middle trapezius and 
serratus anterior 
 
 
Outcomes 
measured at 
baseline, end week 
1, week 2, week 3 
and end of 
treatment 
 
NPRS 
NDI 
Neck rotation ROM 
All groups improved 
significantly in terms of 
pain, (IG 1: 2.4 ± 1.1 IG 
2: 0.9 ± 1.2 CG: 1.6 ± 
1.5)(p<0.01), disability  
(IG 1: 17.2 ± 10.3 IG 2: 
7.8 ± 5.5 CG: 10.2 ± 7.1) 
and ROM (IG 1: 74.3 ± 
3.58 IG 2: 71.4 ± 3.67 
CG: 74.4 ± 4.12) 
p<0.05). For pain and 
disability the group 
receiving NM and 
exercise did significantly 
better than the other 2 
groups (p<0.01)  
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Figure 2.6. Meta-analysis for pain in N-NAP. 
 
2.3.7 Lateral Epicondylalgia  
Three studies used NM for the treatment of lateral epicondylalgia (Dabholkar 
et al., 2013, Drechsler et al., 1997, Vincenzino et al., 1996). One study had a 
low risk of bias (Vincenzino et al., 1996) and the other two had a high risk of 
bias (Dabholkar et al., 2013, Drechsler et al., 1997). 
One study administered treatment for four days per week over four weeks 
(Dabholkar et al., 2013) and another did two treatments per week over six 
weeks (Drechsler et al., 1997). The other study did one intervention over a 
three day period (Vincenzino et al., 1996). 
A low risk of bias study used cervical lateral glides as the intervention 
(Vincenzino et al., 1996) with significant improvements in pressure pain 
threshold, pain free grip strength, neurodynamic test ROM and pain scores 
compared to the placebo and control groups (p<0.05). Two studies 
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(Dabholkar et al., 2013, Drechsler et al., 1997) with a high risk of bias 
compared NM and radial head mobilisation to exercise (Dabholkar et al., 
2013) and friction massage and exercise (Drechsler et al., 1997). One study 
(Drechsler et al., 1997) concluded that significant improvements (p<0.05) in 
elbow and neurodynamic test ROM were due to radial head mobilisation. The 
other study (Dabholkar et al., 2013) reported improved grip strength 
(p<0.001), pressure pain threshold (p=0.031) and Patient Rated Tennis Elbow 
Evaluation Questionnaire (p=0.027) in the group receiving NM.  
Two studies (Drechsler et al., 1997, Vincenzino et al., 1996) on lateral 
epicondylalgia measured ROM of the ULNDT 2b  and both found improved 
ROM in the groups receiving NM. Due to difference in outcomes measures 
and techniques used, meta-analysis could not be performed. Table 2.6 
describes these studies. 
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Table 2.6. Study descriptions lateral epicondylalgia 
Author 
Appraisal Score 
Risk of Bias 
Patient demographics Intervention Group (IG) Control Group (CG) Outcome Result 
Dabholkar et al. 
(2013) 
 
Appraisal 4 
 
High risk of bias 
n=40  
 
No other data available 
IG n=20 participants with 
lateral epicondylalgia 
 
Exercise program 
Radial head mobilisation 
NM aimed at radial nerve into 
tension without provoking 
symptoms 
Treatment 6 to 7 repetition 
once a day  
4x/week for 4 weeks 
CG n=20 participants with 
lateral epicondylalgia 
 
Exercise program 
Treatment 6 to 7 repetition 
once a day  
4x/week for 4 weeks 
Outcomes 
measured at 
baseline and post 
treatment  
 
1) VAS 
2) Pain Free Grip 
Strength 
3) Pain Pressure 
Threshold 
4) Patient Rated 
Tennis Elbow 
Evaluation 
Questionnaire 
Both groups improved 
significantly in al 
outcomes but the 
Mulligan mobilization 
with movement of radial 
head and NM showed 
more improvement than 
the exercise group in 
grip strength (p<0.0001 
30.16 +/- 7.33), pressure 
pain threshold (p=0.031; 
4.7 +/- 1.8) and Patient 
Rated Tennis Elbow 
Evaluation 
Questionnaire (p=0.027; 
22.75 +/- 5.35).  
Drechsler et al. 
(1997) 
 
Appraisal 6 
 
High risk of bias 
 n=18 (10 females, 8 
males) 
 
Age range (years) 30-57  
 
Mean age (years) 46 
Mean age of groups 
(years)  
IG 46.4 
IG n=8 participants with 
lateral epicondylalgia 
 
Neural tension group  
ULTT 2b with  
1) Graded flexion and or 
shoulder abduction 
2) Anterior-posterior 
mobilisations of radial head if 
radial head mobility was 
CG n=10 participants with 
lateral epicondylalgia  
 
Standard treatment group 
2 times a week for 6-8 
weeks 
1) Ultrasound over common 
extensor tendon 
2) Transverse friction to 
Outcomes 
measured at 
baseline, post 
treatment and 3 
month follow up 
 
1 Self report 
questionnaire  
2 Grip strength  
3 Isometric 
testing 
Subjects who received 
radial head mobilisations 
improved over time 
(p<0.05). 
 
Results from IG were 
linked to radial head 
treatment and isolated 
effects could not be 
determined.  There were 
no long-term positive 
  60 
Legends: IG – Intervention Group; CG- Control Group; VAS – Visual Analogue Scale; ULNDT – Upper limb neurodynamic test 
CG 45.5 
 
judged hypo mobile 
 
Home exercise plan to mimic 
ULTT2b 10 reps a day 
increasing but not exceeding 
2 sets a day. 
2x week for 6-8 weeks 
tendon (1 min per session) 
3) Stretch and strengthen 
wrist extensors 5-10 reps 30 
seconds. Dumbbells 
gradually increasing to 3 
sets 15 reps 
4) Home exercise program 
stretch and strengthen 
extension of 
3
rd
 finger 
4 ULNDT2b  
5 Radial head 
mobility  
6 Elbow 
extension ROM 
during ULNDT. 
results in the standard 
treatment group. (p<0.05 
F4  71) 
 
Vincenzino et al. 
(1996) 
 
Appraisal 7 
 
Low risk of bias 
 n=15 with  lateral 
epicondylalgia  (8 
females, 7 males) 
 
Age range 22.5 - 66 
years 
 
Mean age (years) 44(±2)  
 
Duration of symptoms 
(months) 8(±2)  
 
Range of duration 
(months) 2 - 36  
 
IG   
Contralateral glide C5/6 
grade 3 with affected arm in 
a predetermined position 
 
 
All treatment were applied in 
3 sets of 30 seconds with 60 
second rest periods 
 
Subjects received 1 of the 3 
treatment conditions for 3 
days in a random order. 
 
CG 
Arm rested on abdomen with 
no manual contact 
 
Placebo group  
Manual contact was applied 
as in the treatment group 
with patients arm rested on 
abdomen but no glide was 
applied 
Outcomes 
measured at 
baseline 
(immediately 
before) and after 
treatment 
 
1) ULNDT2b 
(measuring 
degrees of 
abduction) 
2) Pain free grip 
strength (hand held 
dynamometer) 
3) Pressure pain 
threshold 
4) Pain via VAS 
(over 24 hours) 
5) Function VAS 
(over 24hours) 
The treatment group 
produced significant 
improvements in 
pressure pain threshold 
pain free grip strength, 
neurodynamics and pain 
scores relative to the 
placebo and control 
groups (p< 0.05). 
(Mean 45 kPa for IG), 
pain free grip strength 
(mean 33.2N for IG), 
neurodynamics (7° for 
IG) and pain scores (1.7 
cm) 
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2.3.8 Other conditions  
Four studies were identified that used NM for other conditions including tarsal 
tunnel syndrome and plantar heel pain (Kavlak and Uygur, 2011, Saban et al., 
2014), cubital tunnel syndrome (Svernlov et al., 2009) and post-lumbar 
surgery (Scrimshaw and Maher, 2001). Three studies were low risk of bias 
studies (Kavlak and Uygur, 2011, Saban et al., 2014, Scrimshaw and Maher, 
2001) and one had a high risk of bias (Svernlov et al., 2009). 
Mobilisation using SLR, deep calf massage and exercises compared to 
ultrasound and exercise resulted in a significant improvement in pain 
(p=0.034) in plantar heel pain (Saban et al., 2014). Using SLR with tibial 
nerve bias compared to exercises and supportive inserts improved Tinel’s 
sign and two-point discrimination (p<0.05) in tarsal tunnel syndrome (Kavlak 
and Uygur, 2011). Other outcomes such as disability, muscle strength, 
pressure pain threshold and thermal pain threshold were not significantly 
different between the NM groups and usual care groups (Kavlak and Uygur, 
2011, Saban et al., 2014). 
Patients with post-lumbar surgery received SLR and usual care compared to 
usual care only. However a SLR NM did not have any added benefit to usual 
care in post lumbar surgery (Scrimshaw and Maher, 2001). Lastly nerve-
tensioning exercises (Svernlov et al., 2009) did not result in improved pain 
and disability (p>0.05) when compared to a control group and a group that 
received an elbow brace for patients with cubital tunnel syndrome. Table 2.7 
describes the studies. 
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Table 2.7 Study descriptions other conditions. 
Author Patient 
demographics 
Intervention Group (IG) Control Group (CG) Outcome Measures Result 
Kavlak and Uygur 
(2011) 
 
Appraisal 8 
 
Low risk of bias 
n=28 
 
Mean age (years) 
IG 40.71 (±12.84) 
CG 43.64 (±14.72) 
 
Duration of symptoms 
(years) 
IG 3.40 (±-5.06) 
CG 2.54 (±2.43) 
IG n=14 participants with 
tarsal tunnel syndrome  
 
Strengthening and 
stretching exercise plus 
NM of the tibial nerve in 
slump for 6 weeks. Follow 
up every 10 days to check 
compliance 
CG n=14 participants with 
tarsal tunnel syndrome 
 
Strengthening and 
stretching exercises for 6 
weeks. Follow up every 
10 days to check 
compliance 
Outcomes measured at 
baseline and at 6 weeks 
 
1) VAS 
2) ROM of talar and 
sub-talar joints 
3) Strength of muscles 
innervated by tibial 
nerve 
4) Two-point 
discrimination 
5) Light touch 
Tinel’s 
Conservative treatment 
of tarsal tunnel 
syndrome is effective in 
increasing ROM and 
muscle strength and 
alleviating pain;(CG 
78.6% still positive 
compared to 100% in 
the IG) the addition of 
NM to this treatment did 
not enhance the 
treatment effects about 
these parameters. 
However, the decrease 
in Tinel’s sign and 2-
point discrimination (IG 
1.46 ± 0.30 and CG  
1.39 ± 0.44) values 
imply that sensory 
parameters may benefit 
from NM. 
Saban et al. (2014) 
 
Appraisal 9 
 
Low risk of bias 
n=69 (male 30, female 
39) 
 
Mean age (years) 
IG 54(±12) 
CG 52 (±13) 
IG n=33 participants with 
plantar heel pain 
syndrome 
Deep calf massage 
Stretching exercises as 
for SLR 
CG n=36 participants with 
plantar heel pain 
syndrome 
 
Stretching exercises 3 
times per day with 5 
repetitions for each 
Outcomes measured at 
baseline and 4 to 6 
weeks post-treatment 
 
1) Foot and ankle 
computerized adaptive 
test of Lower Extremity  
The overall group-by-
time interaction was 
statistically significant (p 
= 0.034) for Functional 
Scale points, with a 
change of (mean (CI) 
15 (9-21) for IG and 6 
(1-11) for the CG 
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Duration of pain at 
admission (weeks) 
IG 19 (±19)  
CG 25 (±21)  
Ultrasound 
SLR exercises with belt 
3 times per day with 5 
repetitions for each 
stretch, using intermittent 
stretching of 20 s followed 
by 10 s of rest 
stretch, using intermittent 
stretching of 20 s followed 
by 10 s of rest. 
Ultrasound 
2) Functional Scale respectively. Both 
treatment protocols 
resulted in an overall 
improvement 95%CI for 
within group changes 
on functional scale IG 
9-21 and CG 1-11). 
Both treatment 
protocols resulted in an 
overall improvement; 
however, IG treatment 
was significantly more 
effective in treating heel 
pain than CG treatment. 
Scrimshaw and 
Maher (2001) 
 
Appraisal 8 
 
Low risk of bias 
 n=81 (30 females, 51 
males) 
 
Mean age (years) 
IG 55 (±17) 
CG 59 (±16) 
 
Duration of symptoms 
IG <6 weeks 2 
>6 weeks 19 
>6 months 14 
CG <6 weeks 8 
>6 weeks 14 
>6 months 24 
IG n=35 participants 
undergoing lumbar 
discectomy (n=9), fusion 
(n=6) or laminectomy 
(n=20) 
 
Same as control plus 
neural mobilization (SLR) 
added. 
  
Exercises were 
encouraged for up to 6 
weeks post discharge 
CG n=46 participants 
undergoing lumbar 
discectomy (n=7), fusion 
(n=9) or laminectomy 
(n=30) 
 
Standard post operative 
care (exercises for lower 
limb and trunk) 
 
Exercises were 
encouraged for up to 6 
weeks post discharge 
Outcomes measured at 
baseline, 6 weeks, 6 
months and 12 months. 
1) Global perceived 
effect  
2) VAS  
3) McGill pain 
questionnaire  
4) Quebec disability 
scale. 
5) SLR 
6) Time taken to return 
to work 
All patients received the 
treatment as allocated 
with 12-month follow up 
data available for 94% 
of those randomized. 
There were no 
statistically significant or 
clinically significant 
benefits provided by the 
neural mobilizations 
treatment for any 
outcome. 
Svernlov et al. 
(2009) 
 
n=70 
 
Mean group age 
Group B n=23 participants 
cubital tunnel syndrome 
Excluded from analysis n 
Group A n=26 
participants cubital tunnel 
syndrome 
Excluded from analysis 
Outcomes measured at 
baseline and at 6 
months 
57 patients were 
followed for 6 months. 
51 (89.5%) were 
improved at the follow-
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Legend: IG – Intervention group; CG – Control group; VAS– Visual analogue scale; ROM – Range of motion; SLR – Straight leg raise; M – Male; F – Female; 
SD – Standard Deviation
Appraisal 5 
 
High risk of bias 
(years) 
Group A 43 (range 18–
72 / ±13.2)  
Group B 44 (range 26–
67 / ±10.1)  
Group C 44 (range 
17–72 / ±14.8) 
 
Duration of symptoms 
(months) 
Group A 13.5 (range 
3–72 / ±15.7)  
Group B 10.5 (range 
3–42 / ±9.6)  
Group C 9.5 (range 3–
24 / ±5.8) 
Gender: 
Group A (9 females, 
12 males) 
Group B (8 females, 7 
males) 
Group C (10 females, 
5 males) 
= 8 – final n = 15 with  
 
Nerve gliding/tensioning 
exercises(Byron, 1995) 6 
exercises maintained for 
30seconds x 3 with 1-
minute rest twice a day. 
Increased to 3 x /day if 
not aggravated. 
Exercise sheet given to 
patients.  
n=5 – final n=21  
 
Elbow brace that prevents 
more than 45° flexion for 
3 months at night 
 
Group C n=21 included 
excluded from analysis 
n=6 – final n=15 
 
Information on condition 
1) Canadian  
2) Occupational 
Performance Measure 
3) Grip strength 
4) Adduction strength 
5th digit 
5) VAS 
 
up. There were no 
significant differences 
between the groups in 
any of the recorded 
variables. 
Night splints and nerve 
gliding exercises did not 
add favorably to 
treatment outcomes. 
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2.3.9 Outcomes measures 
Pain intensity was reported in all but 6 studies (Akalin et al., 2002, Bardak et 
al., 2009, Brininger et al., 2007, Heebner and Roddey, 2008, Saban et al., 
2014, Drechsler et al., 1997). Disability and function was not consistently 
measured and the outcome measures varied greatly between studies. Only 
one study reported quality of life measures (Horng et al., 2011) and one study 
reported that adverse events were investigated (Nee et al., 2012b). 
Neurophysiological effects were reported in six studies (Bialosky et al., 2009b, 
Dwornik et al., 2009, Kavlak and Uygur, 2011, Oskouei et al., 2014, Rezk-
Allah et al., 2011, Schmid et al., 2012) 
2.3.10 Neurophysiological parameters 
Secondary outcomes measures reported in a number of studies were 
neurophysiological parameters. In CTS positive neurophysiological effects 
such as a decreased intra-neural oedema, decreased temporal summation 
and median nerve latency were found in the groups that received NM 
(Bialosky et al., 2009b, Oskouei et al., 2014, Schmid et al., 2012). Two 
studies on N-LBP also found positive effects. The H-reflex latency was 
improved from pre-treatment compared to post treatment in a study 
comparing slump and SLR (Rezk-Allah et al., 2011) and a decrease in nerve 
compression (measured by magnetic resonance imaging) was reported in 
another study (Waleed Salah El-din, 2015). Lastly, a decrease was found in 
sensory parameters in a study on tarsal tunnel syndrome in Tinel’s sign, light 
touch and 2-point discrimination values (Kavlak and Uygur, 2011). 
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2.4 Discussion 
NM is effective in reducing pain and disability in certain neuro-
musculoskeletal conditions when compared to usual care. Conditions where 
NM can be recommended (JBI grades of evidence) are N-LBP, N-NAP, tarsal 
tunnel syndrome and plantar heel pain. Currently there is no evidence for the 
use of NM for CTS, post-lumbar surgery and cubital tunnel syndrome. 
2.4.1 Carpal Tunnel Syndrome 
NM for CTS did not show significant effects for the clinical outcomes 
assessed. This finding is supported by a recent review on the effect of nerve 
gliding exercises for CTS (Ballestero-Pérez et al., 2016). The majority of 
studies had a low risk of bias, which should strengthen the confidence in the 
findings from a research methodological point of view. However, several 
studies gave patients home exercises with only one intervention before follow-
up. One study had three interventions and a follow-up at 11 months (Bardak 
et al., 2009). Although these studies can inform clinicians about these types of 
treatment schemes, some clinicians favour a more progressive exercise 
regime with closer monitoring and follow-up (Coppieters and Alshami, 2007, 
Schmid et al., 2012). Perhaps as a consequence, some studies had high 
patient dropout rates (Brininger et al., 2007, Horng et al., 2011). Furthermore, 
many studies (Akalin et al., 2002, Bardak et al., 2009, Baysal et al., 2006, 
Brininger et al., 2007, Heebner and Roddey, 2008, Horng et al., 2011, Pinar et 
al., 2005) evaluated tensioning techniques. Given the decrease in blood 
circulation in the median nerve in CTS (Bland, 2005) along with increased 
neural mechano-sensitivity in response to local inflammation (Dilley et al., 
2005, Fernandez-de-las-Penas et al., 2009), increasing the tension in the 
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nerve may further diminish circulation and aggravate symptoms. More studies 
are required that evaluate the effects of more modern NM concepts 
(Coppieters and Alshami, 2007), including ‘sliding techniques’, before 
conclusions can be reached regarding the effect of NM for CTS (and other 
conditions). Sliding techniques resulted in a reduction in intraneural oedema 
in CTS and improvement in pain and function (Schmid et al., 2012). 
2.4.2 Nerve–related low back pain 
Evidence for effective management of patients with N-LBP is scarce (Lee et 
al., 2013, Rubinstein et al., 2011). Furthermore, N-LBP is also a risk factor for 
chronicity (Grotle et al., 2007) and therefore effective management is 
important. People with N-LBP distal to the buttocks with a positive slump test 
and pain for longer than three months had a significant and clinically relevant 
(Farrar et al., 2001) improvement in pain and disability (Cleland et al., 2007a, 
Jain et al., 2012, Nagrale et al., 2012). Using other forms of NM such as SLR 
(Kaur and Sharma, 2011) techniques aimed at opening the foramina (Mehta 
et al., 2014) bent leg raise (Patel, 2014) and mobilisation of other nerves 
(Dwornik et al., 2009) also resulted in improved pain and disability. A recent 
review on lower quadrant NM for healthy and low back pain populations also 
found that NM improved pain and disability (Neto et al., 2017). The findings of 
the review support the findings of a previous study (Schafer et al., 2011) that 
suggest that patient outcomes can be improved when treatment is targeted at 
subgroups of patients with N-LBP. Therefore, NM exercises, incorporating the 
slump and SLR tests, can be recommended for N-LBP. 
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2.4.3 Nerve-related neck and arm pain 
As the evidence for non-surgical management of N-NAP is scarce, (Bono et 
al., 2011, Boyles et al., 2011, Salt et al., 2011) it is recommended that 
treatment be aimed at specific subgroups (Salt et al., 2011). Using cervical 
lateral glide techniques for people with N-NAP had a positive effect on pain, 
with a clinically meaningful effect size (Abbott and Schmitt, 2014, Cleland et 
al., 2008).  
The effect of NM on disability in N-NAP also seems positive (Gupta and 
Sharma, 2012, Nee et al., 2012b, Anwar et al., 2015, Ragonese, 2009). 
However, as this was not measured consistently, no firm conclusions can be 
made. Measuring function in these patients is important, as they are more 
disabled than patients with non-specific neck pain (Daffner et al., 2003). 
Future studies should investigate function and disability using common 
outcomes measures such as the NDI or Patient Specific Functional Scale.  
2.4.4 Lateral Epicondylagia 
A recent review on physical therapy for lateral epicondylalgia concluded that 
the intervention groups all improved significantly compared to control groups 
regardless of type of intervention (Weber et al., 2015). However, the studies 
on NM were not included in that review. In a study with low risk of bias the use 
of cervical lateral glides improved pain in epicondylalgia (Vincenzino et al., 
1996). Due to the low quality of the other studies (Dabholkar et al., 2013, 
Drechsler et al., 1997), differences in techniques used and conflicting 
outcomes it is not possible to make recommendations on the use of NM for 
lateral epicondylalgia. 
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2.4.5 Other conditions 
Two studies support the use of SLR for patients with plantar heel pain and 
tarsal tunnel syndrome (Kavlak and Uygur, 2011, Saban et al., 2014). This is 
in accordance with other studies that illustrated that SLR transmits movement 
to the tibial nerve (Coppieters et al., 2006) and can have an effect on the pain 
and movement of a patient with sub-calcaneal heel pain (Meyer et al., 2002). 
As these studies are low risk of bias the use of NM for these conditions can 
be recommended. 
Two studies (Scrimshaw and Maher, 2001, Svernlov et al., 2009) found no 
added benefit when using NM in addition to usual care for post-lumbar 
surgery and cubital tunnel syndrome. There is insufficient evidence for the use 
of NM in these conditions and more studies are needed before NM can be 
considered for these conditions. 
2.4.6 Outcomes measures 
 In studies evaluating CTS and N-LBP, similar outcomes measures 
were used and therefore a meta-analysis could be performed. Unfortunately, 
this was not the case for most other conditions. Pain was measured in most 
studies, however the method of assessment was not consistent across 
studies. Future studies should consider a core set of clinical outcome 
measures to establish the effectiveness of NM on neuro-musculoskeletal 
conditions. 
2.4.7 Neural mobilisation techniques 
Two NM techniques consistently produced good results in conditions 
considered difficult to treat (Luijsterburg et al., 2007, Salt et al., 2011). Slump 
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mobilisations improved pain and disability in N-LBP (Cleland et al., 2007a, 
Jain et al., 2012, Nagrale et al., 2012, Patel, 2014). Cervical lateral glides 
improved pain in N-NAP and epicondylalgia (Allison et al., 2002, Coppieters et 
al., 2003b, Nee et al., 2012b, Vincenzino et al., 1996). 
Our findings showed that tensioning techniques improved pain and disability 
in the treatment of chronic nerve-related conditions, such as N-LBP (Cleland 
et al., 2007a) and plantar heel pain (Saban et al., 2014, Kavlak and Uygur, 
2011). More recently, sliding techniques are often advocated as they expose 
the nervous system to less strain (Coppieters and Alshami, 2007), which 
might be more advantageous when nerve mechano-sensitivity is still 
increased (Coppieters and Butler, 2008). Therefore the choice of technique 
should be based on sound clinical reasoning (Eva, 2005, Nee and Butler, 
2006). Unfortunately, the reasoning process behind the choice of techniques 
is absent or unclear in many studies.  
The terminology can also be confusing. Some studies explicitly state 
whether  ‘sliding techniques’ or ‘tensioning techniques’ were used (Ali et al., 
2015, Gupta and Sharma, 2012, Marks et al., 2011), but other studies use the 
more generic term ‘nerve gliding exercises’. In order not to confuse generic 
‘gliding’ exercises with specific ‘sliding’ exercises, we recommend abandoning 
the term ‘nerve gliding exercises’ and use NM or neurodynamic techniques to 
refer to techniques that aim to mobilise the nerve or its surrounding structures. 
The need for consistent use of terminology is evident.  
2.4.8 Neurophysiological effects 
An improvement in neurophysiological parameters was found in a number of 
studies such as a decrease in intra-neural oedema (Schmid et al., 2012). A 
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decrease in intraneural oedema is supported by two studies on unembalmed 
cadavers, which demonstrated the ability of NM to disperse intraneural fluid 
(Brown et al., 2011, Gilbert et al., 2015). As ischemia of the median nerve 
contributes to the symptoms of CTS, (Han et al., 2009) a decrease in 
intraneural oedema would be important in the management of CTS. Sensory 
parameters may also benefit from NM (Kavlak and Uygur, 2011). One of the 
aims of NM is to restore neurophysiological homeostasis of the targeted nerve 
and the findings of the review support that NM has this effect. 
Although not included in this review a study by (Sterling et al., 2010) found 
that the cervical lateral glide decreased spinal hyper excitability. Furthermore 
it has been shown that NM has the ability to modulate the expression of 
endogenous opioids (Santos et al., 2014).  
2.4.9 Risk of bias across and within studies 
This review was limited to the inclusion of randomised clinical trials. We 
included all randomised clinical trials regardless of quality in an endeavour to 
include all conditions treated and all techniques used. High risk of bias was 
mostly due to lack of blinding of participants, assessors and group allocation. 
Nineteen studies had a low risk of bias. Only two other language studies were 
identified and not included (Bahrami et al., 2006, Leonelli et al., 2013). 
Potential publication bias could not be assessed further using Funnel plots as 
less than 10 trials were included in the meta-analyses (Anzures-Cabrera and 
Higgins, 2010). 
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2.5 Strengths and limitations 
This study included an additional 20 articles, which were not included 
in the most comprehensive review so far (Su et al., 2016). The increase in 
studies on CTS, N-LBP and N-NAP, and the performance of meta-analyses 
where possible, provided a better overview of the clinical effectiveness of NM. 
However, there is still a paucity of information on many relevant conditions, 
such as cubital tunnel syndrome and post-lumbar surgery.  
Analysing results for the various conditions such as CTS and N-LBP 
separately, made it possible to evaluate the effect of NM on these conditions. 
Meta-analyses could be performed for a number of outcomes and this gives a 
clearer picture of the effect of NM in regard to certain outcomes. Two 
systematic reviews could not make any firm recommendations regarding the 
effect of NM (Ellis and Hing, 2008, Medina McKeon and Yancosek, 2008), 
however, a more recent review on nerve-gliding exercises for CTS 
(Ballestero-Pérez et al., 2016) came to the same conclusion as the current 
review in that nerve-gliding exercises does not have an effect on most clinical 
outcomes in CTS. Another review concentrated on the effect of NM on the 
lower quadrant in patients and healthy individuals (Neto et al., 2017) and 
similar to the current review found NM to have a positive effect on pain and 
disability in N-LBP.  Su et al. (2016) did not find that NM had a positive effect 
in chronic musculo-skeletal conditions. It must be borne in mind that their 
review pooled results of different conditions together and only considered 
chronic conditions, which is different to the study population of this review. 
Although authors were contacted where possible, all the information that was 
needed was not always available and some authors could not be reached. 
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The majority of studies had a small number of study participants and therefore 
results are not necessarily generalizable. 
 
2.6 Recommendations 
The JBI grades of evidence (The Joanna Briggs Institute Levels of Evidence 
and Grades of Recommendation Working Party, 2014) were used for making 
recommendations (Appendix 3). 
 Cervical lateral glide mobilisation improves pain in nerve-related neck 
and arm pain (Level A).  
 Slump and SLR mobilisation improves pain and disability in nerve-
related low back pain (Level A). 
 NM has positive neurophysiological outcomes in CTS (Upper limb 
neurodynamic test 1) and N-LBP (Slump and SLR) (Level A). 
 NM does not have an effect on most of the clinical outcome measures 
in CTS (Level A). 
 NM improves pain in tarsal tunnel syndrome and plantar heel pain 
(single low risk of bias study evidence). 
2.6.1 Implications 
The findings of this review may help inform clinicians with regard to the 
management of chronic N-LBP, N-NAP and plantar heel pain. 
Sound clinical reasoning remains essential when treating nerve-related 
conditions with NM. 
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2.6.2 Caution 
 Due to the limited evidence and often, small study samples conclusions 
may change over time.  
 
2.7 Conclusion 
The slump and SLR mobilisation and cervical lateral glide have been shown 
to improve pain and function in patient groups that are often resistant to 
treatment, such as chronic N-LBP and N-NAP and plantar heel pain. The 
findings of this review may help inform guidelines on the management of CTS, 
and low back and neck pain. 
There were nine studies on N-NAP of which only four had a low risk of bias. 
Most of the studies had a low number of study participants (60 participants in 
the biggest study). Function was not measured consistently and none of the 
studies on N-NAP evaluated the effect of NM on quality of life. Furthermore, 
none of the studies used mobilisation along the course of the nerve to treat N-
NAP. The review supports the need for more studies with a bigger study 
population on N-NAP. 
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3 Chapter Three - Prevalence of neck and 
radiating arm pain among patients treated 
in private practices in Pretoria, South 
Africa 
 
To answer the first research question, a survey of patients attending private 
physiotherapy practices in Pretoria, South Africa was conducted. This chapter 
will describe the method, results and discuss the study. 
 
3.1 Introduction 
Neck pain is a common musculoskeletal problem with a point prevalence of 
4.9% (Hoy et al., 2014) and a lifetime prevalence ranging between 14.2% and 
71% (Fejer et al., 2006). However, there is very little information on the 
prevalence of neck pain in South Africa. 
Low back and neck pain are the conditions that contribute most to years lived 
with disability (Vos et al., 2016). Globally the disability adjusted life years of 
neck pain was 23.9 million in 1990 and increased to 33.6 million in 2010; an 
increase of 41% (Hoy et al., 2014). The prevalence of neck pain in the sub-
Saharan Southern Africa region is outranked only by Western Europe, North 
America and East Asia (Vos et al., 2012, Hoy et al., 2014). However, in 
estimating the burden of disease in 2000 for South Africa (SA), 
musculoskeletal disorders ranked 20th (Bradshaw et al., 2003). A more recent 
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fact sheet on health statistics, ranked musculoskeletal diseases as 16th in SA 
(World Health Organization, 2010). The latest available information (World 
Health Organization, 2012) ranks musculoskeletal disorders as 12th in terms 
of burden of disease. There is, therefore, a big discrepancy in ranking of 
musculoskeletal diseases in SA compared to the global burden of disease 
studies (Hoy et al., 2014, Vos et al., 2012, Vos et al., 2016). According to Rice 
et al. (2016) there is little information available for Sub-Saharan Southern 
Africa in terms of the global burden of pain. A systematic review on low back 
pain in Africa concluded that the prevalence of low back pain is similar to that 
of the global burden of disease (Woolf and Pfleger, 2003). It is also becoming 
a more common problem in SA (Louw et al., 2007). No such information could 
be found for neck pain and considering the high prevalence and associated 
levels of disability globally; the importance of more information on neck pain in 
SA is evident. 
In 2015 nearly a quarter of households (23,5%) had at least one member who 
belonged to a medical aid (Statistics South Africa, 2015). In metropolitan 
areas such as Pretoria the number is higher where 26.4% of people have 
access to medical aids (Statistics South Africa, 2015). Studying this group of 
people in private practice is therefore of interest and given the specific nature 
of the condition that was being looked at, it was decided that the information 
would be available in the private sector. A follow up study in the public sector 
could be done, bearing in mind that patients are not often able to attend for a 
course of treatment. 
Radiating arm pain is commonly associated with neck pain with more than 
65% of the neck pain population presenting with neck and radiating arm pain 
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(Daffner et al., 2003, van Hulst et al., 2016). These patients are more disabled 
than patients with only neck pain and are more likely to utilise healthcare 
(Daffner et al., 2003, Huisstede et al., 2008). 
There are only a few studies on the prevalence of neck pain in the SA 
population (Brink et al., 2009, Mafanya and Rhoda, 2011, Smith et al., 2009), 
and most were done on an adolescent population. In a study of risk factors for 
neck pain amongst 181 adolescents, the prevalence of neck pain was 53.7% 
(Mafanya and Rhoda, 2011). Smith et al. (2009) reported a 20% prevalence of 
neck pain in adolescent computer users (n=1073). Similarly a 26% reported 
neck pain was documented in a study on the sitting posture of SA 
adolescents, (Brink et al., 2009). A study on the prevalence of 
musculoskeletal disorders of office workers in a private hospital in SA (Zungu 
and Ndaba, 2009) found a prevalence of 76% of musculoskeletal complaints, 
with low back pain the most common complaint followed by neck pain.    No 
studies could be found on the prevalence of neck pain in private 
physiotherapy practices in South Africa. 
 
Therefore the aims of this study were to: 
 determine the prevalence of patients with neck pain and radiating arm 
pain in private physiotherapy practices in Pretoria. 
 document the areas of pain and associated symptoms in patients with 
neck pain and radiating arm pain. 
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3.2 Methods 
3.2.1 Materials and setting  
Convenience sampling was undertaken by approaching physiotherapists 
attending North Gauteng Orthopaedic Manipulative Physiotherapy Group 
meetings (n=70 physiotherapists). The meetings were held between March 
2012 and July 2012. This group of physiotherapists was selected as they 
have a special interest in treatment of musculoskeletal disorders. Six 
practices (9% of this physiotherapy population) gave consent to have their 
records surveyed. 
3.2.2 Design 
A retrospective survey of physiotherapy patient records dated 1 January 2011 
to 31 December 2011 was conducted. The prevalence of patients with neck 
pain in relation to other musculoskeletal complaints was calculated and 
expressed as a percentage.  
3.2.3 Procedure 
All records of patients with neck pain were analysed by the researcher to 
obtain a common set of data. This included: age, gender, area/s of pain, 
associated symptoms and whether pain was due to injury or of insidious 
onset. Data were directly entered into an Excel spread sheet using coding. 
Specific care was taken to ensure that none of the data could be linked back 
to identify individuals. This was done by selecting patient records in random 
order, whilst ensuring that all records were surveyed. Participating practice 
owners identified patient records for the year 2011 and practices were 
numbered to ensure that information could not be linked to a specific practice. 
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The age, gender and body chart was the only information accessed, and the 
researcher was the only person with access to the data.  
Symptoms recorded included the following: headache, dizziness, pins and 
needles, feeling of weakness, other sensations, more than one symptom and 
pain in other area/s. Based on body charts, areas of pain were coded as neck 
pain only, pain in the shoulder, shoulder and upper arm, shoulder to elbow, 
lower arm, hand, neck and arm up to wrist, neck and arm including hand.   
3.2.4 Data analysis 
Descriptive statistics were used to analyse the data. Age was expressed as a 
mean and standard deviation. Percentages were calculated for the proportion 
of neck pain relative to other musculoskeletal complaints, areas of pain and 
associated symptoms. The researcher was the only person with access to the 
data (for confidentiality purposes) and did all the analysis using Microsoft 
Excel (2011). 
3.2.5 Ethical approval 
Approval for the study was obtained from the Human Research Ethics 
Committee of the University of the Witwatersrand (Ethical clearance number 
M111002). As it was a retrospective survey, using patient records only, 
patient permission was waived. All participating practice owners received 
information letters describing the study and gave written consent for their 
records to be surveyed (Appendices 3.1 and 3.2). 
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3.3 Results 
Records in six practices were analysed. Four of the six practices were sole 
owner practices. One of the practices was in an industrial set-up treating 
workers from factories. Two practices were general practices and the 
remaining three concentrated on musculoskeletal problems.  
The total number of records reporting on musculoskeletal complaints was 
n=1337. The non-specific neck pain or neck and arm pain population 
comprised 46.1% (n=616) of the records and n=720 (53.9%) were other 
musculoskeletal complaints. The neck/arm pain population consisted of 
63.1% (n=389) females and 36.9% (n=227) males. The mean age of the 
neck/arm pain population was 44.5 (± 15.2) years. Pain was due to injury in 
21.4% (n=132) of the records and was of insidious onset in the rest of the 
sample. 
3.3.1 Area of symptoms 
Two hundred and ninety five (47.8 %) of the neck/arm pain population had 
only neck pain; the remaining 52.2% (n=363) had neck and radiating arm 
pain. The area most commonly associated with neck pain was the shoulder 
(n=127, 20.6%) followed by symptoms in the arm including the hand (n=80, 
13%). Symptoms in the shoulder and upper arm (n= 48, 7%) and symptoms in 
the arm up to the wrist (n=44, 7.1%) were also common. Only 2 (0.3%) 
records reported symptoms in the neck and lower arm and n=26 (4.2%) 
reported symptoms in the neck and hand. Table 3.1 illustrates the occurrence 
of pain in the different areas and practices. 
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Table 3.1. Distribution of neck and radiating arm pain according to body area 
and physiotherapy practices 
Area of 
pain 
Practice 
1 
n =  215 
(%) 
Practice 
2 
n = 52 
(%) 
Practice 
3 
n = 168 
(%) 
Practice 
4 
n = 72 
(%) 
Practice 
5 
n = 88 
(%) 
Practice 
6 
n = 21 
(%) 
Neck only 84 (39.1) 39 (75) 97 (57.7) 31 (43.1) 40 (45.4) 5 (23.8) 
Neck and 
shoulder 
31 (14.4) 10 (19.2) 19 (11.3) 19 (26.4) 23 (26.1) 4 (19.1) 
Neck, 
shoulder 
and 
upper 
arm 
4 (1.9) 2 (3.8) 14 (8.3) 7 (9.7) 4 (4.4) 0  
Neck up 
to elbow 
12 (5.6) 0 7 (4.2) 2 (2.9) 7 (7.9) 3 (14.3) 
Neck & 
lower arm 
2 (0.9) 0 0 0  0 0 
Neck & 
arm up to 
wrist 
24 (11.2) 1 (1.9) 11 (6.5) 3 (4.2) 3 (3.4) 2 (9.5) 
Neck and 
hand 
13 (6.5) 0 3 (1.8) 6 (3.6) 4 (4.4) 0 
Neck & 
arm 
including 
hand 
38 (17.7) 0 17 (10.1) 4 (23.8) 8 (9.1) 7 (33.3) 
 
The prevalence of areas of symptoms varied among the practices with the 
arm and hand symptoms being more prevalent in one of the practices than 
shoulder pain. Another practice did not have any records reporting pain up to 
the elbow, lower arm, hand and only one with pain in hand and arm. The 
areas of pain per practice is illustrated in Figure 3.1 
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Figure 3.1 Distribution of body areas of radiating arm pain per practice  
 
3.3.2 Symptoms associated with neck and radiating arm 
pain 
The symptom most commonly reported with neck/and radiating arm pain was 
headache (n=156, 25.4%) followed by pain in another area such as the lower 
back (n=139, 22.6%), and pins and needles were described in n=69 (11.2%) 
of the records. There were also some less common sensations (n=67, 
10.7%). Of these the most common was numbness (n=26, 4.2%) and burning 
(n=13, 2.1%). There were five (0.8%) records that reported a “lame feeling” 
and three (0.5%) each of the following – ache, cold, stiffness and shooting 
pain. Sensations of swelling, heaviness and pounding were described in two 
(0.3%) records each. Only one record described tenderness. There were 169 
(27.4%) records that did not report any associated symptoms. The areas of 
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onwards) were similar. Figure 3.2 illustrates the areas of pain for the two 
groups. 
Associated lumbar pain was reported in 78 (12.6%) of the neck pain 
population and thoracic pain in 46 (7.5%) cases.  Thoracic and lumbar pain 
was associated with neck pain by n=21 (3.4%) of the population and leg pain 
by n=10 (1.6%) of the population. The results for associated symptoms in the 
2015 clinical trial group (see Chapter 4 onwards) were similar except for more 
patients reporting headache (n=40, 29.2%) and dizziness (n=4, 2.9%) than in 
the 2011 retrospective survey group. Figure 3.3 shows the associated 
symptoms. 
 
 
Figure 3.2 Areas of pain for 2011 retrospective survey and the clinical trial 
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Figure 3.3 Symptoms associated with neck and radiating arm pain 
 
3.4 Discussion 
The aim of this study was to establish the prevalence of neck pain in private 
physiotherapy practices, in Pretoria South Africa. Neck pain or neck and arm 
pain comprised 46.1% of all musculoskeletal complaints seen in these 
physiotherapy private practices. This finding is similar to a national survey of 
general practitioner practices in the Netherlands (Bot et al., 2005), which 
concluded that neck pain is prevalent and commonly seen. A more recent 
population- based study in Sweden also found bothersome neck pain to be a 
common complaint (Skillgate et al., 2012). Huisstede et al. (2008) report that 
physiotherapists saw 54.5% of persons with complaints of arm neck and 
shoulder pain who used health-care. In their study, these health-care users 
had more continuous, severe pain and interference with daily activities than 
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The prevalence of neck pain varies between 20% and 53% in studies on 
South African adolescents (Brink et al., 2009, Mafanya and Rhoda, 2011, 
Smith et al., 2009, Zungu and Ndaba, 2009). This wide range is similar to the 
findings of a systematic review on the prevalence of neck pain in which the 
lifetime prevalence of neck pain ranged between 14.2% and 71% (Fejer et al., 
2006). The prevalence in this study is 46.1% of all musculoskeletal complaints 
seen in private physiotherapy practices. No studies on the prevalence of neck 
pain in the physiotherapy private practices in SA could be found in a literature 
search. However, the results of this study are similar to the SA studies on 
adolescents. This high prevalence of neck pain seen in private practice has 
important implications in terms of management, especially in light of the fact 
that neck pain contributes significantly to disability worldwide (Hoy et al., 
2014). 
In this study 52.2% of the population had neck and radiating arm pain, which 
is similar to the findings of other studies (Daffner et al., 2003, Huisstede et al., 
2008, van Hulst et al., 2016). Leaver et al. (2013b) also found an extremely 
high prevalence of upper limb pain (80%) in a population with new onset of 
non-specific neck pain. The high prevalence of neck pain in physiotherapy 
practices found in this study is disquieting as health-care users, i.e. patients 
who seek physiotherapy treatment, tend to have more pain and are more 
disabled (Huisstede et al., 2008).  
One of the factors associated with poor recovery of neck pain is pain in other 
areas (Croft et al., 2001, Viikari-Juntura et al., 2001). More than 25% of the 
population in this study had pain in other areas associated with their neck 
pain. Once pain has become chronic, effective management becomes more 
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challenging with uncertain outcomes (Valat, 2005). Furthermore, more than 
50% of the study population had radiating arm pain and there is limited 
evidence for the effective management of neck and radiating arm pain (Childs 
et al., 2008, Gross et al., 2009, Salt et al., 2011). This highlights the 
importance of accurate information on the prevalence of neck pain in SA. As 
neck pain comprises more than 46% of the musculoskeletal population seen 
in the private practices surveyed, physiotherapists should have knowledge of 
the optimum management strategies for neck/and arm pain.  
Considering the global impact of neck pain (Hoy et al., 2014, Vos et al., 2012) 
and the high incidence of neck pain found in this study there is a clear need 
for epidemiological studies on the prevalence of musculoskeletal complaints 
in SA. Identifying prognostic factors assists in predicting outcomes (Carroll et 
al., 2008) and assists in the planning of effective management strategies to 
address these problems at an early stage. There is a need for more studies 
on the prevention of neck pain and effective management strategies.  Even 
though prevention is important, there is limited evidence for effective 
preventative strategies. There is some support for the use of exercise and 
education in the prevention of neck pain (Hurwitz et al., 2008, Linton and van 
Tulder, 2001).  
Neck pain is most prevalent in middle age (Bot et al., 2005, Hoy et al., 2014, 
Huisstede et al., 2008, Skillgate et al., 2012), which is similar to the findings of 
this study (44+/- 15.2). As people age, the prevalence will most likely increase 
(Hoy et al., 2014). Management of an ageing population will therefore become 
increasingly important. 
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Neck pain is more prevalent in females than males (Bot et al., 2005, Cote et 
al., 2004, Huisstede et al., 2008, Skillgate et al., 2012) as was the case in this 
study.  Skillgate et al. (2012) found in their study that females were more likely 
to have neck pain than males and that they were less likely to recover from 
pain. Being female is one of the non-modifiable risk factors for developing 
neck pain (Hogg-Johnson et al., 2008). Data from two population based 
surveys in the Netherlands confirm that women consistently have a higher 
prevalence of musculoskeletal pain irrespective of anatomic site (Wijnhoven 
et al., 2006). They cite three possible reasons for this 1) women are more 
willing to report pain than men 2) biological and physiological differences 
between the sexes 3) women are more exposed to risk factors than men 
(Wijnhoven et al., 2006). 
As is the case in this study, shoulder pain is commonly associated with neck 
pain (Bot et al., 2005, McLean et al., 2011). In a study of new onset neck pain 
(Leaver et al., 2013b), neck pain was also commonly associated with 
headache (64%), low back pain (39%), dizziness (31%) and nausea (23%). 
The prevalence of headache (26.1%) and low back pain (12.6%) is 
considerably lower in this study than the study by Leaver et al. (2013b). Here 
dizziness is only mentioned once and there is no mention of nausea. The 
small number of practices surveyed and the fact that I could only report on 
recorded symptoms may in part explain the differences in findings. 
Furthermore, pain and areas of pain were recorded meticulously in the 
practices surveyed, but symptom description was often vague. Therefore the 
recorded symptoms (such as dizziness and nausea) may not be accurate. 
The study by Leaver et al. (2013b) reports on patients seeking manual 
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therapy for a new episode of neck pain and therefore may represent a skewed 
population which could further explain the difference in findings. Dizziness 
and nausea are commonly in co-existence with neck pain and headache 
(Malmström et al., 2007, Reid et al., 2015). The high percentage of patients 
reporting dizziness and nausea in the study by Leaver et al. (2013b) seems to 
be more in line with other studies than the findings here. The low reporting of 
dizziness and nausea in this study should therefore be interpreted with care. 
Finding practices willing to participate in this study was very challenging. 
According to M’kumbuzi et al. (2004) record keeping of physiotherapists in SA 
is compromised. They collected data from six state hospitals, five private 
physiotherapy practices and two community physiotherapy services to 
evaluate record retrieval. Although the retrieval of records was significantly 
higher in private practice (87.4%) than in public hospitals (34.7%), some 
records were incomplete (M’kumbuzi et al., 2004). They stated that it seemed 
that practices were more concerned with rendering physiotherapy services 
than keeping a record of the service. Other reasons given for poor record-
keeping were being too busy and not having considered the consequences of 
not having good records (M’kumbuzi et al., 2004). Another study retrieved 100 
randomly selected records in a hospital and also found that physiotherapy 
records were incomplete (Philips et al., 2006). There are, however, no recent 
studies on recordkeeping amongst South African physiotherapists and there is 
therefore no current evidence to support that record keeping is still 
compromised in physiotherapy practice. Good record keeping helps to 
maintain the quality of practice (Martin and Moriarty, 2012) and as first line 
practitioners in SA we have a responsibility to our profession and patients to 
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maintain a high quality of care. With the rise in malpractice claims in SA 
(Malherbe, 2013, Pepper and Slabbert, 2011), record keeping has vital legal 
implications (Glasper, 2011). The reluctance of physiotherapists to make their 
records available is therefore of concern.   
 
3.5 Strengths and limitations 
No other studies could be identified on the prevalence of neck pain in private 
practice in SA. Furthermore no studies could be identified which describe 
sensations associated with neck pain such as paraesthesia, numbness, and 
burning to mention a few. Only one study was identified that reported on 
associated symptoms of neck pain and radiating pain (Leaver et al 2013) in 
an acute neck pain population. 
A requirement for establishing prevalence of a condition is to have a randomly 
selected, representative sample of the population. This was a sample of 
convenience with a very low number of practices surveyed and a low number 
of patient records. The findings of this study should therefore be interpreted 
with caution although most findings are similar to other publications. Some of 
the records were incomplete with regards to associated symptoms. 
Furthermore the study could only report on symptoms as recorded by the 
physiotherapist and this could potentially create a false impression.  
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3.6 Recommendations 
There is a need for bigger population based studies on the prevalence of neck 
pain in SA. Prevention and effective management of neck pain is important to 
avoid the consequences of chronic pain and its related disability.  
 
3.7 Conclusion 
The prevalence of neck pain in private physiotherapy practices in Pretoria, SA 
is high with radiating arm pain and pain in other areas being commonly 
associated with neck pain. Furthermore, other symptoms such as headache 
and paraesthesia are also frequently present. Neck pain is multi-faceted and 
this has implications for its management. Future studies with a bigger, 
representative population sample are needed to establish the prevalence of 
neck pain in SA.  
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4 Chapter Four – Outcomes measures 
 
This chapter will discuss the different outcomes measures used in the 
randomised clinical trial. 
 
4.1 Outcomes measures – research question two 
What is the effect of NM on the pain, function and quality of life of patients 
with acute cervico-brachial pain? 
4.1.1 Numerical Pain Rating Scale 
The Numeric Pain Rating Scale (NPRS) (Appendix 4.1) is an 11-point scale 
where patients are asked to rate their pain as 0 representing “no pain” and 10 
“worst pain possible”. In a study comparing three pain measures (Bolton and 
Wilkinson, 1998) the NPRS was the most responsive pain measure with an 
effect size of 0.86 (Bolton and Wilkinson, 1998). The validity of the NPRS in 
an acute setting was established by Bijur et al. (2003) and is strongly 
correlated with the visual analogue scale (r= 0.94, 95% CI  0.93 – 0.95) (Bijur 
et al., 2003). A reduction of 1.3 points in mechanical neck pain (Cleland et al., 
2008), is considered clinically meaningful. Reliability of the NPRS was 
established as good (r = 0.72 to 0.78) (Good et al., 2001). The NPRS is as 
sensitive to change as the visual analogue scale which is currently considered 
the “gold standard” (Holdgate et al., 2003). 
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4.1.2 The Patient Specific Functional Scale 
The Patient Specific Functional Scale (PSFS) (Appendix 4.2) is a self-report 
measure to rate activity limitation and function. Patients are asked to 
nominate three to five activities that are difficult to perform and rate them on 
an 11 point scale where 0 equals “unable to perform activity” and 10 
represents “able to perform activity as before”. In this study patients were 
asked to nominate three activities. The scale was initially developed for 
patients with back pain and validated for patients with neck pain by Westaway 
et al. (1998). The scale has excellent reliability (r = 0.92) and validity (r=0.73 - 
0.83) when compared to the Neck Disability Index and r=0.52 - 0.62 
compared with the prognosis rating (Westaway et al., 1998). Cleland et al. 
(2006) compared the Neck Disability Index and the PSFS in patients with 
cervical radiculopathy and found that the PSFS was more responsive than the 
Neck Disability Index in this population (Cleland et al., 2006). In their study the 
reliability was good with an interclass coefficient (ICC) of 0.82. The minimally 
clinically important change for the PSFS was 2.0 (Cleland et al., 2006). 
Hefford et al. (2012) found the PSFS to be a valid, reliable and responsive 
measure of function for patients with upper extremity problems. 
4.1.3 EuroQuol 5 Instrument 
The EuroQuol 5 Instrument (EQ5D) (Appendix 4.3) is a quality of life 
measurement and was used to rate the quality of life of study participants. It 
has two sections: the first part consists of five domains namely mobility, self-
care, usual activities, pain/discomfort and anxiety/depression. Each section is 
rated by three descriptions from “I have no problem” to “I am unable”. The 
second section of the questionnaire has a 20cm Visual Analogue Scale with 
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“best imaginable health state” at the one end and “worst imaginable health 
state” at the other end and marked 0 - 100. The construct validity was 
established by measuring it against the SF-12 and positive correlations were 
found (r=0.41). It has excellent reliability (ICC 0.82) (Coons et al., 2000). In 
another study, the test–retest reliability ranged between 69.8 and 99.7% for 
the EQ5D dimensions and Kappa coefficients were 0.67. Correlation 
coefficients with other measures of self-rated health indicated validity (r = 
0.56) (Ravens-Sieberer et al., 2010). 
 In a study of patients receiving knee arthroscopy, the psychometric properties 
of three quality of life measures were compared and the authors recommend 
the use of the EQ5D in this acute musculoskeletal population (Goodwin et al., 
2011). The quality of life using the EQ5D was measured in patients with 
cervical radiculopathy and whiplash associated disorder and health related 
quality of life was worse in these populations compared to a healthy group 
(Peolsson et al., 2014).  
4.1.4 Global Rating of Change Scale 
Patients were asked to complete the Global Rating of Change Scale (GROC) 
(Appendix 4.4) at six weeks after treatment had commenced. This scale 
measures the patient’s impression of improvement after an intervention. 
According to a Cochrane review, there are eight different scales to measure 
change, in use. In this study an 11 point Likert scale was used with -5 
representing very much worse, 0 is unchanged and +5 is fully recovered 
(Kamper et al., 2009).  The test-retest reliability has an ICC of 0.9. The scale 
has significant correlation with importance of change (r=0.72) and magnitude 
of change (r=0.91) on the Roland Morris, Oswestry, Pain Rating Scale and 
  94 
the EQ5D (Kamper et al., 2009). The GROC is often used in studies on neck 
and arm pain to establish patient’s perception of change (Cleland et al., 
2007b, Nee et al., 2012b, Walker et al., 2008). 
4.1.5 Upper Limb Neurodynamic Test 1 
The Upper Limb Neurodynamic Test 1 (ULNDT1) is described as the straight 
leg raise test of the arm (Butler, 2000). The upper limb nerves are elongated 
and moved in their nerve bed (Coppieters et al., 2009) as was verified in an 
“in vivo” study. The test consists of different components of movement: patient 
supine, neck in neutral, shoulder abduction to ± 110°, extended wrist and 
fingers, forearm supination, shoulder lateral rotation and the amount of elbow 
extension is then measured (Butler, 2000).  The reliability of measuring onset 
of pain and sub-maximal pain in a clinical setting in patients with cervico-
brachial pain was established as excellent by Coppieters et al. (2002) (ICC ≥ 
0.98; SEM ≤ 3.4°). The ULNDT1 is a valid test to identify peripheral 
neuropathy (Nee et al., 2012a). It is also a test that is used in a cluster of tests 
to diagnose cervical radiculopathy and has a specificity (negative likelihood 
ratio) of 0.90 (95% CI 0.82–0.98) (Wainner et al., 2003). 
 
4.2 Outcomes Measures – research question three 
Does the presence of high catastrophising scores and neuropathic pain have 
an influence on treatment outcome? Two questionnaires were used to 
establish which patients had neuropathic pain and which patients were 
catastrophisers.  
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4.2.1 Neuropathic Pain Diagnostic Questionnaire 
The Neuropathic Pain Diagnostic Questionnaire (DN4) (Appendix 4.5) 
(Bouhassira et al., 2005) consists of two sections namely an interview and 
examination. The interview has two questions, the first about the 
characteristics of the pain (e.g. burning) and the second about associated 
symptoms (such as pins and needles) to which the answer is either yes or no. 
In the examination, tests for hypoesthesia to touch and prick in the painful 
area as well as whether or not brushing aggravates the pain, are done. Each 
positive answer scores a point with a total score of 10. A patient with a score 
of 4/10 or more can be diagnosed with neuropathic pain (Bouhassira et al., 
2005). The sensitivity of the test at the cut off of four is 82.9 and the specificity 
is 89.9. The inter-rater reliability has Kappa values of between 0.70 and 0.96 
(Bouhassira et al., 2005). Recently the DN4 was compared to three other 
neuropathic pain questionnaires (ID Pain, the painDETECT questionnaire and 
the Leeds Assessment of Neuropathic Signs and Symptoms) (Gudala et al., 
2017) to assess the ability of the questionnaires to detect neuropathic pain in 
patients with chronic low back pain. Receivers Operating Characteristic 
(ROC) curves were used to assess the diagnostic accuracy of the 
questionnaires. The DN4 had an area under the curve of (AUC) ＞  0.8 
indicating excellent discrimination in this population (Gudala et al., 2017). This 
tool is recommended for use to identify patients with neuropathic pain by the 
“South African Management of Neuropathic Pain Guidelines” (Chetty et al., 
2012). 
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4.2.2 Pain Catastrophising Scale 
The Pain Catastrophising Scale (PCS) (Appendix 4.6) is a questionnaire that 
establishes the levels of catastrophic thinking present in patients. The 
questionnaire has three components: magnification, rumination and 
helplessness. Participants are asked to reflect on past painful experiences 
and to indicate the degree to which they experience each of 13 thoughts or 
feelings when experiencing pain. It is scored on a 5-point scale from 0 “not at 
all” to 4 “all the time” with a maximum score of 52. A score above 24 classifies 
the patient as a catastrophiser (Sullivan et al., 1995). The internal consistency 
of the three subscales are Cronbach’s α of Rumination α = 0.85, Magnification 
α = 0.75 and Helplessness α = 0.85 (Osman et al., 2000). The criterion 
reliability as tested by Osman et al. (2000)  could correctly identify  77.1% of 
the cases. This also confirms the findings of (Sullivan et al., 1995) that the 
three dimensions represent a single construct. It can be evaluated as an 
interval level scale (Walton et al., 2013b). 
 
4.3 Demographic information – research question 
four 
What is the influence of demographic factors such as age, gender, headache, 
dizziness, paraesthesia, injury, previous pain, exercise and education on pain, 
function and quality of life in patients with cervico-brachial pain? 
Participants were asked to complete a demographic questionnaire (Appendix 
4.7) that included age, gender, duration of symptoms, previous neck pain, 
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injury or insidious onset, education, occupation, exercise, presence of 
headache or dizziness and an indication of the area of pain on a body chart.  
The demographic questionnaire was compiled and then distributed to four 
manual therapists with an interest in neck pain. Feedback was incorporated 
into the questionnaire and after the third round of feedback consensus was 
obtained from all therapists. 
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5 Chapter Five – Method: randomised 
clinical trial 
 
This chapter will discuss the method employed for the randomised clinical 
trial. The primary outcomes of interest were pain, function and quality of life. 
Secondary outcomes assessed were the effect of the presence of neuropathic 
pain and pain catastrophising on treatment outcomes. The primary outcome 
point was at six weeks. 
 
5.1 Study design 
A randomised clinical trial (RCT) was used to answer the aims of the study. 
There were no changes to the methods of the clinical trial after the trial 
design. Trial registration Number: PACTR201303000500157 
The RCT comprised of two groups, a control group and an experimental 
group. The control group received “usual care” (UC) as identified by a review 
of the literature. The intervention group (IG) received NM in addition to the 
UC.  
5.1.1.1 The aims of the study were to establish the effect of NM 
on the: 
 pain of patients with cervico-brachial pain.  
 function of patients with cervico-brachial pain.  
 quality of life of patients with cervico-brachial pain.  
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5.1.1.2 To compare: 
  the effect of NM added to UC (IG) on the above factors with a 
control group that received UC only. 
 the number of treatment sessions between the NM group (IG) and 
UC group. 
 the effect of NM added to UC (IG) on the elbow range of movement 
of the upper limb neurodynamic test compared to UC. 
5.1.1.3 To determine: 
 the influence of neuropathic pain on treatment outcomes in patients 
with cervico-brachial pain.  
 the between group differences in terms of pain, function and quality 
of life in patients with neuropathic pain. 
 the effect of high catastrophising scores on treatment outcomes in 
patients with cervico-brachial pain. 
 the effect of age, gender, headache, hours sitting, previous neck 
pain/arm pain, education, exercise, paraesthesia and dizziness on 
treatment outcomes. 
 
5.2 Participant selection procedure 
Patients were screened for inclusion into the study from March 2012 to 
November 2015. Patients were recruited from private physiotherapy practices, 
whose owners had agreed to take part in the study. These practices are 
situated in the Pretoria region, Gauteng, South Africa. Patients were referred 
to private practices by general practitioners or were self-referred.  Patients 
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presenting with cervico-brachial pain were screened for eligibility and invited 
to take part in the study (Figure 5.1).  
5.2.1 Inclusion criteria 
 Patients over the age of 18, with cervico-brachial pain as defined by 
Hall and Elvey (Hall and Elvey, 1999). To be included patients had to 
present with at least five of the following characteristics: 
o antalgic posture 
o active movement dysfunction of the cervical spine 
o passive movement dysfunction of the cervical spine which is 
associated with active movement dysfunction.  
o adverse responses to neurodynamic tests which related 
specifically and anatomically to the active and passive 
movement dysfunction.  
o mechanical allodynia in response to palpation of specific nerve 
trunks. 
o evidence from the physical examination and patient history of a 
local cause of the neurogenic pain (Hall and Elvey, 1999).  
 Patients must have had a positive upper limb neurodynamic test 1 
(ULNDT1). The ULNDT1 was considered positive if the patient’s pain 
was reproduced or partially reproduced by the test and changed by 
structural differentiation (Nee et al., 2012a).  
 Patients with pain from recent onset (one day) up to 12 weeks, 
recurrent or first incident. 
  101 
 Patients with bilateral arm pain were included if they complied with the 
other inclusion criteria. These patients received NM for both arms if 
they were part of the IG. 
5.2.2 Exclusion criteria 
 Absence of a positive neurodynamic test. 
 Previous surgery or recent fractures of the cervical spine. 
 Serious neurological signs such as signs of spinal cord pressure or 
involvement of more than two nerve roots. (These patients were 
excluded based on neurological examination). 
 Conditions with long tract signs. (Long tract signs are neurological 
signs such as clonus, muscle spasticity, or bladder involvement that 
usually indicate a lesion in the middle or upper parts of the spinal cord 
or in the brain (Mosby, 2009).) 
 Pathological diseases such as rheumatoid arthritis, neurological 
diseases, stroke, cerebral palsy, carcinoma or other red flags.  
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Figure 5.1. Screening and allocation of patients
Patient presents to practice 
Screening for eligibility  
 Musculoskeletal evaluation to determine if patients comply 
with criteria for cervico-brachial pain as set by Hall & Elvey 
(1999). 
 Upper limb neurodynamic test 1 must be positive 
If eligible: 
 Neurological examination 
 Physical examination of DN4 test 
 Complete questionnaires 
Randomisation (2:1) and treatment allocation by blinded research 
assistant after full examination was completed 
Intervention Group Usual Care 
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5.3 Sample size 
Primarily this study set out to assess whether, 6 weeks after onset of 
treatment the Numerical Pain Rating Scale (NPRS) score in the intervention 
group was reduced compared to the UC group. The sample size calculation is 
reported for the NPRS, which require the largest sample size. A sample size 
of 60:26 i.e. a total sample of 86 patients had an 85% power to detect a 
clinically relevant increase of 2 for the change from baseline at six weeks in 
the NPRS score. A standard deviation of 2.05 was assumed as derived from 
the effect size reported by Bolton and Wilkinson (1998). The standard 
deviation was furthermore inflated by √2 since change from baseline was of 
interest. A dropout rate of 15 – 20% was assumed. One-sided testing was 
done at a 0.05 level of significance (nQuery advisor 7). 
 
5.4 Interventions 
The American Physical Therapy Association Guidelines (Childs et al., 2008) 
as well as the Australian Guidelines (TRACsa, 2008) both recommend the 
use of a multimodal intervention comprising of gentle exercise, advice to stay 
active and cervical mobilisation / manipulation. The UC was done according to 
these guidelines. No specific mobilisation/ manipulation technique has been 
shown to be superior to another (Gross et al., 2010, Miller et al., 2010). 
Therefore, as most physiotherapists in South Africa have been Maitland 
trained, the patients received Maitland mobilisation (Hengeveldt et al., 2005) 
of the cervical and thoracic spine. The UC consisted of posterior/anterior and 
unilateral posterior/anterior mobilisation of the cervical and thoracic spine, 
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exercises and advice to stay active. Exercises included postural correction, 
deep neck flexor training according to Falla et al. (2007) and strengthening 
and mobilising exercises progressing to the use of yellow Theraband ™ as 
described by Gross et al. (2009). All study patients received advice to stay 
active (Childs et al., 2008). The number of treatments was determined by the 
treating physiotherapist and was recorded. Patients in the UC group did not 
receive any NM. 
The IG received NM in addition to UC. The NM used in this study were done 
as described by Butler (2000), a gentle soft tissue mobilisation of the neural 
container/ interface “along the tract” (Butler, 2000) pp. 380,) of the nerve – 
directly where the nerve is palpable and indirectly where it lies deeper. The 
treatment concentrated on areas where the nerve was mechano-sensitive to 
palpation and was done from the hand or elbow (depending on patient’s area 
of pain) and followed up along the arm, first rib, scalene and into the neck. 
Mobilisation was first done in a position where the nerve is relaxed, not to 
provoke any of the patient’s symptoms. Palpation was done in such a way as 
to only provoke minimal symptoms and disappear as soon as it was stopped. 
The basic principles of neural mobilisations were used to progress treatment; 
that is to commence treatment in the acute phase with the nerve in a neutral, 
non-tension position and to progress into a more tensioned position as pain 
and irritability improved (Butler, 2000, Nee et al., 2011).  
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5.5 Outcome measures 
The primary outcomes were pain (Numeric Pain Rating Scale – NPRS), 
function (Patient Specific Functional Scale – PSFS) and quality of life 
(EuroQual Instrument – EQ5D). These self-report outcomes were followed up 
at three weeks, six weeks, six months and 12 months. The other two 
measures (Diagnostic Neuropathic pain questionnaire – DN4 and Pain 
Catastrophising Scale – PCS) were administered at baseline, six months and 
12 months. Outcomes measures were discussed in chapter 4. Follow-up of 
the primary outcomes was done telephonically at three weeks and six weeks. 
The Global Rating of Change was completed at six weeks. At six months and 
12 months patients were asked to return to the practices for measurement of 
the ULNDT1 and the physical examination of the DN4. All other 
questionnaires were also completed at six months and 12 months. (See Table 
5.1) 
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Table 5.1. Outcomes measures and timeline of measurements 
Measure  Baseline 3 weeks 6 weeks 6 months 12 months 
NPRS ✔ ✔ ✔ ✔ ✔ 
PSFS ✔ ✔ ✔ ✔ ✔ 
EQ5D ✔ ✔ ✔ ✔ ✔ 
DN4 ✔   ✔ ✔ 
PCS ✔   ✔ ✔ 
GROC   ✔   
ULNDT1 ✔   ✔ ✔ 
Demographics ✔     
Neural 
conduction 
✔     
Legend: NPRS – Numerical Pain Rating Scale; PSFS – Patient Specific Functional Scale; 
EQ5D – EuroQual Instrument; DN4 – Diagnostic Neuropathic Questionnaire; PCS – Pain 
Catastrophising Scale; GROC – Global Rating of Change; ULNDT1 – Upper Limb 
Neurodynamic Test 1. 
 
5.6 Randomisation and group allocation 
Block randomisation with a 2:1 ratio in blocks of 6 was done (Dumville et al., 
2006, Shen and Lu, 2006). An unequal randomisation is ideal for smaller 
randomised controlled trials and multicentre trials (Moher et al., 2009).  
Randomisation was done using a computer random number generator 
(Schulz and Grimes, 2002).  
Two research assistants were used in the study. Research assistant one was 
a qualified physiotherapist blinded to patient group allocation. She conducted 
all the follow-up measurements. Research assistant two was an 
administrative person, naïve to the study content and at another location than 
treating practices. She had the list with randomisation and was responsible for 
informing physiotherapists of patient number and treatment allocation. 
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The treating physiotherapists screened patients for eligibility and did a full 
clinical evaluation, which included neurological testing, the physical 
examination of the DN4 and the ULNDT1. They also administered the 
baseline set of questionnaires.  
Treatment (group) allocation was given to participating physiotherapists after 
all baseline measurements were done thus ensuring concealed allocation. An 
independent research assistant (two), naïve to study content, was contacted 
by telephone by the treating physiotherapists. She gave the treating 
physiotherapist a sequential patient number as well as the treatment 
allocation (intervention or usual care).  
The physiotherapists involved in the study, then received an envelope with the 
consent form (Appendix 5.1), patient information leaflet (Appendix 5.2), 
treatment recording sheet (Appendix 5.3) and all questionnaires. This 
included the NPRS, PSFS, EQ5D, DN4, PCS and the demographic 
information. The research assistant (one) doing follow up measurements 
(qualified physiotherapist) was blinded to group allocation. Treatment 
recording sheets were only collected at the end of the data collection period.  
The treatment sheets were used to assess whether treatment allocation was 
followed and to establish the number of treatment sessions. 
 
5.7 Ethical Considerations 
Written consent (Appendix 5.1) to take part in the study was obtained from all 
study participants and they received an information sheet (Appendix 5.2) 
explaining the study. Written consent was obtained from treating 
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physiotherapists. Ethical approval for the study was obtained from the Human 
Research Ethics Committee of the University of the Witwatersrand, 
Johannesburg, South Africa (Appendix 5.4) 
 
5.8 Procedure 
5.8.1 Familiarisation of physiotherapists 
Four physiotherapists in private practice (including the researcher) were the 
treating physiotherapists. All the treating physiotherapists had a post-graduate 
qualification in orthopaedic manual therapy with knowledge of NM. The 
average age of treating physiotherapists was 37.5 (range 31- 53) and the time 
qualified as manual therapists was seven years except for one therapist who 
had been qualified as a manual therapist for 30 years.  
All participating physiotherapists took part in a training workshop run by the 
researcher. The training workshop consisted of: training of the application of 
neural mobilisation along the tract of the nerve, protocol for treatment groups, 
administration of the outcomes measures, baseline measures as well as 
patient screening; that is inclusion and exclusion criteria. The NM technique 
was practised on models and the models rated the technique from “feels the 
same”, “feels similar”, “does not feel at all the same”. After two rounds of 
practising the technique on different models, all physiotherapists performed 
the technique in the same way. The range of ULNDT1 was measured using a 
standard goniometer to measure the range of elbow extension (Sterling et al., 
2002). Measurement of the elbow range for the ULNDT1 was demonstrated 
and all therapists had time to practise before inter-rater reliability on non-
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injured participants was established with an ICC of 0.67 and a reliability 
coefficient of 1.2. 
The inter- and intra-rater reliability of the researcher and research assistant 
was established for the ULNDT1. The inter-class correlation coefficient was 
good at 0.85, (95%CI 0.66-1.06). The intra-class correlation coefficient for 
researcher 1:  0.85, (95%CI 0.64 -1.06) and for researcher 2: 0.70 (95%CI 
0.31- 1.09), which was acceptable. 
 
5.9 Initial assessment 
Patients presenting at participating physiotherapy practices with neck and 
shoulder/arm pain were screened for inclusion into the study by treating 
physiotherapists. Suitable candidates received a full musculoskeletal 
examination to confirm that they complied with the criteria for cervico-brachial 
pain as described above (Hall and Elvey, 1999). They completed all the 
questionnaires as discussed after it was established that they complied with 
the inclusion criteria.  
The physical examination included the ULNDT1. The test was done as 
described above (Butler, 2000). The examination section of the DN4, that is; 
testing for hypoesthesia to touch, and prick and pain caused by brushing was 
done at baseline, six months and 12 months. Neural conduction tests of 
sensation, muscle power and reflexes were done according to Petty and 
Moore (1998). (See Table 5.1 for timelines of measures) 
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5.10  Statistical Considerations 
Primarily this study set out to assess whether, six weeks after onset of 
treatment the NPRS score in the intervention group reduced compared to the 
UC group.  
5.10.1 Data Analysis 
The data summary employed descriptive statistics, namely for continuous 
variables means, standard deviations and 95% confidence intervals and is 
reported by study group  (intervention & usual care) for the NPRS, PSFS and 
EQ-5D. Categorical data such a catastrophising (yes & no) and neuropathic 
pain (yes & no) were summarised using frequencies, percentages that were 
displayed in cross tables.  
The two treatment groups were compared with respect to the change from 
baseline at six weeks in the NPRS, PSFS and EQ-5D scores using an 
analysis of covariance (ANCOVA) with baseline scores, catastrophising (yes 
& no) and neuropathic pain (yes & no) as covariates.  For the total 
assessment period of 12 months the interaction between visits and treatment 
were assessed with respect to NPRS, PSFS and EQ-5D scores in a linear 
mixed model analysis. Effect sizes are expressed as Cohen’s d for the NPRS. 
To establish the effect of demographic factors on the outcomes measures 
(NPRS, PSFS and EQ5D), the individual level based mixed effects models 
and also population level based Generalized Estimating Equations (GEE) 
models were utilised. GEE based analysis was used for each variable of 
gender, pain before, accident, education, sit/day, exercise, headache, dizzy, 
paraesthesia and area. 
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For all data description and analyses an intention-to-treat analysis was 
performed, where data were missing multiple imputation procedures were 
used. Statistical testing was done at the 0.05 level of significance. 
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6 Chapter six – Results of the randomised 
clinical trial 
 
This chapter will describe the results of the study. Results will be presented as 
per the objectives of the study. 
 
6.1 Demographic and Clinical Profile of 
Participants 
Participants for the study were recruited from February 2012 to October 2014. 
Data collection was completed in November of 2015. There were 60 patients 
in the Intervention Group (IG) and the Usual Care (UC) group consisted of 26 
patients. Figure 6.1 illustrates the recruitment of patients and their follow up.  
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Figure 6.1 Flow diagram of participant recruitment and follow-up.
All analysed with intention to treat analyses 
Excluded n = 31 
Pain for longer than 3 months n = 12 
Did not want to take part in the study n = 5 
Not positive ULNDT1 n = 4 
Previous surgery n = 4 
Not fluent in English n = 2 
Wanted different treatment n = 2 
Cervical spine fracture n = 1 
Rheumatoid Arthritis n = 1 
Included n = 86  
Full assessment and randomisation 
Randomised 2:1 
Consent, questionnaires 
Assessed for inclusion n= 117 
Intervention group n = 60 
- Cervical and thoracic mobilisation 
- Exercises 
- Advice about condition and to stay active 
- Mobilisation along the course of the nerve 
 
Usual Care group n = 26 
- Cervical and thoracic mobilisation 
- Exercises 
- Advice about condition and to stay active 
 
6 weeks n = 59 (1 (1.67%) could not be reached) 6 weeks n = 26 
 
6 months n = 53 (7 (11.67) could not be reached of 
which 2 had relocated) 
    
6 months n = 23 (3 (12%) could not be reached) 
12 months n = 53 (7 (11.67%) could not be reached)  12 months n = 25 (1 (4%) could not be reached) 
3 weeks n = 59 (1 (1.67%) could not be reached) 
 
3 weeks n = 25 (1 (4%) could not be reached) 
 
Received allocated treatment n = 59 
Wanted needling in addition to intervention n = 1 
All analysed in allocated group 
Received allocated treatment n = 25 
Preferred to have the intervention n = 1 
All analysed in allocated group 
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The demographic and clinical information for the study sample is illustrated in Tables 6.1a and 6.1b below.   
 
Table 6.1a. Demographic information for continuous data 
 Intervention Group n = 60 Usual Care n = 26  
 Mean (Standard deviation) Mean (Standard deviation) p value 
Age 46.47 (14.09) 48.61 (13.64) 0.51 
Duration of pain (days) 30.19 (27.39) 23.46 (22.90) 0.28 
Hours sitting per day   6.72 (2.96)   7.23 (2.97) 0.46 
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Table 6.1b. Demographic and clinical information for categorical data 
Demographic Intervention group  
n = 60 (%) 
Usual Care 
n = 26 (%) 
p value 
Had pain before 49 (81.67) 21 (80.77) 0.92 
Pain due to injury/ accident 20 (33.33) 8   (30.77) 0.82 
Regular exercise 39 (65) 13 (50) 0.19 
Headache 35 (58.53) 15 (57.69) 0.96 
Dizziness 17 (28.33)   4 (15.38) 0.20 
Paraesthesia 32 (53.33) 14 (53.85) 0.96 
Education < 12 years 0 0  
Education 12 years 12 (20) 6 (23.1) 0.75 
Education College/ 
University 
48 (80) 20 (76.92) 0.75 
 
 
   
The study participants comprised of more females than males (75% to 25%). This distribution was also mirrored in the study groups 
with 75% females in the IG and 76.9% females in the UC group. There were no significant differences in any of the baseline 
measures (p>0.05). A large proportion of patients had previous neck pain (IG 49 (81.67%) and UC 21 (80.77%) p = 0.92). The most 
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common symptom associated with neck and arm pain was headache (IG 35 (58.53) and UC 15 (57.69%), p = 0.96) followed by 
pins and needles (IG 32 (53.33) and UC 14 (53.85%), p = 0.97). 
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Table 6.2 illustrates the distribution of pain for the different upper limb areas  
Table 6.2.  The distribution of pain for the different upper limb areas  
Intervention Group (n=60)  
                                               n (%) 
Usual Care Group (n=26)  
 n (%)                     p = 0.83   
Shoulder 19 (31.67) 9 (34.62) NS 
Shoulder and upper arm   7 (11.67) 3 (11.54) NS 
Upper arm and elbow   8 (19.23) 5 (13.33) NS 
Lower arm    4 (6.67)  1 (3.85) NS 
Arm up to wrist   5 (8.33)  4 (15.38) NS 
Hand     4 (6.67)  1 (3.85) NS 
Arm and hand 13 (21.67) 3 (11.54) NS 
 
The body area most commonly reported to be painful was the shoulder (IG 19 
(31.67%) and the UC 9 (34.62%). There were no significant differences 
between the groups for the distribution of pain (p = 0.831) 
The distribution of the study sample by occupation is illustrated in Table 6.3 
below. 
 
Table 6.3.  The distribution of the study sample by occupation  
Occupation Intervention Group 
n = 60(%) 
Usual Care 
n = 26 (%) 
p value 
Sedentary  36 (60)  17 (65.4) 0.64 
House wife   7 (11.7)   1 (3.8) 0.25 
Allied Health   4 (6.7)    4 (15.4) 0.20 
Miscellaneous  13 (21.7)   4 (15.4) 0.50 
 
The occupations of patients were grouped together in common themes. The 
majority of patients had sedentary occupations (IG 36 (60%) and UC 17 
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(65.4%)). There were no significant differences between the groups (p>0.05). 
Table 6.4 illustrates the Upper Limb Neurodynamic Test  (ULNDT1) 
demographics 
  
Table 6.4. Positive Upper Limb Neurodynamic Test Responses: Left, right and 
bilateral. 
Upper limb 
neurodynamic test 
Intervention Group 
n = 60(%) 
Usual Care    
n = 26 (%) 
p value 
Left 29 (48.33)  13 (50) 0.89 
Right 23 (38.33) 12 (46.15) 0.25 
Bilateral   8 (13.33)   1 (3.8) 0.19 
 
In the IG there were more patients with bilateral positive ULNDT1 compared 
to the UC (IG 13.33% compared to 3.8% in the UC) but the difference was not 
significant. The distribution of the neurological findings for the study 
participants is shown in Table 6.5.  
 
Table 6.5. The distribution of the neurological findings. 
Neurological 
Findings 
Intervention Group 
n = 60(%) 
Usual Care 
n = 26 (%) 
p value 
No changes 12 (21.66)   7 (29.92) 0.57 
Myotome 28 (46.66) 11 (42.31) 0.71 
Sensation 38 (63.33) 16 (61.54) 0.87 
Reflexes 18 (30)   8 (30.77) 0.94 
2 changed 22 (36.66)   9 (34.66) 0.86 
3 changed   8 (13.33)   4 (15.38) 0.80 
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Only about a quarter of patients had no neurological changes (IG 21.7%; UC 
26.9%). Sensory changes were the most common neurological changes 
found (IG n=38 (63.3%) and for the UC n= 16 (61.5%)). 
 
6.2 The effect of NM on pain 
The Numerical Pain Rating Scale (NPRS) was used to measure pain. Figure 
6.2 shows the changes in the NPRS over the study period.   
 
Figure 6.2. Difference in measurements of the NPRS between groups 
 
The IG had significantly less pain at 6 months compared to the UC (p=0.03: 
IG 95% CI 1.01 – 2.06; UC 95% CI 1.70 – 3.59). At all other time points there 
was not a significant difference between groups (baseline p=0.67: IG 95% CI 
6.45 – 7.29; UC 95% CI 6.57 – 7.23; 3 weeks p=0.50: IG 95% CI 2.84 – 3.91; 
UC 95% CI 2.67 – 4.82; 6 weeks p=0.34: IG 95% CI  2.29 – 3.61; UC 95% CI 
2.51 – 4.54; 12 months p= 0.05: IG 95% CI 0.81 – 1.87; UC 95% CI 1.32 – 
3.59). At 6 weeks n=13 (15.1%) of the IG had no pain and n=2 (7.6%) of the 
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UC had no pain. At 6 months n=23 (26.7%) of the IG had no pain and n=7 
(26.9%) of the UC had no pain. At 12 months n=30 (50%) of the IG was pain 
free (p=0.32) whereas only n=10 (38.46%) of the UC was pain free. There 
was a significant difference for the whole group in the NPRS at all 
measurement points compared to baseline (p = 0.0001)  
Most of the demographic factors did not have any significant effect (p>0.05) 
on the NPRS except for paraesthesia, which had a negative effect on pain 
(p=0.0116; CI 0.16 – 1.26). (See Appendix 6.1) 
 
Table 6.6 illustrates the effect sizes of change of the NPRS for the two groups 
at different time points.
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Table 6.6. Effect sizes at different time points for the NPRS between the two groups 
 
IG   n=26 Cohen’s d Effect size r   95% C I  PS UC   n=60   Cohen’s d   Effect size r 95% CI    PS  
0 – 1  1.85*** 0.68  -2.46 – -1.24    90 1.56***  0.61    -2.46 – -0.68   86 
1 – 2  0.2  0.10  -0.62 – -0.47    56 0.13  0.05  -0.9 – -0.64   53 
2 – 3   0.63**  0.29  -1.15 – -0.11    66 0.36*   0.15  -1.14 – -0.04   58 
3 – 4   0.07  0.05  -0.62 – 0.47    53 0.14  0.05  -0.91 – -0.62   53 
0 – 3   2.99*** 0.83  -3.73 -  -2.26    98 2.39***  0.76  -3.33 – -1.34   94 
0 – 4   3.03*** 0.83 -3.78 – -2.29   98 2.39***  0.76  -3.40 – -1.39   94 
Legend: CI – Confidence Interval; PS – Probability of superiority (PS gives the percentage of occasions when a randomly sampled member of the distribution 
with the higher mean will have a higher score than a randomly sampled member of the other distribution(Fritz et al., 2012)); 0-1 baseline to 3 weeks; 1-2 3 
weeks to 6 weeks; 2-3 6 weeks to 6 months; 3-4 6 months to 12 months; 0-3 baseline to 6 months; 0 – 4 baseline to 12 months Effect sizes using Cohen’s d 
*Small (d – 0.2) **Medium (d – 0.5) ***Large (d – 0.8)
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From baseline to three weeks both groups showed a large effect (Cohens d 
IG=1.89; UC=1.56) with both groups having around 3 points less pain on an 
11-point scale. A large effect size was found in the IG from baseline to six 
months (Cohen’s d=2.99) where patients had on average 5.3 points less pain 
on an 11-point scale. A large effect was also seen in the UC for the same time 
frame (Cohen’s d=2.39), with the UC having an average of 4.3 points less 
pain on an 11-point scale. At six weeks to six months the IG had an 
intermediate effect and the UC a small effect. 
 
6.3 The effect of NM on function 
The Patient Specific Functional Scale (PSFS) was used to measure function. 
Figure 6.3 shows the outcomes for the two groups.  
 
 
Figure 6.3. Difference in measurements of the PSFS scores between groups 
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There were no significant differences between groups in their PSFS scores at 
any time points (baseline p=0.65: IG 95% CI 11.90 – 15.27; UC 95% CI 11.73 
– 16.80; 3 weeks p=0.86: IG 95% CI 19.17 – 22.68; UC 95% CI 17.82 – 
23.69; 6 weeks p=0.82: IG 95% CI 20.83 – 24.68; UC 95%CI 19.47 – 25.18; 6 
months p=93: IG 95% CI 24.18 – 26.95; UC 95% CI 23.21 – 27.32; 12 months 
p=0.92: IG 95% CI 24.92 – 27.85; UC 95% CI 24.88 – 28.56). At 12 months 
follow-up only n=17 (28.33%) of the IG and n=3 (30.76%) of the UC had 
regained full function. Both groups improved significantly over time 
(p=0.0001). (See Appendix 6.1) 
 
Table 6.7 illustrate the demographics that had an influence on function. 
 
Table 6.7 Demographics that had an influence on function as measured by 
the PSFS 
Demographics Fixed effect = p 95% Conf. Interval 
Accident 0.02* -3.59 – -0.36 
Gradual onset 0.03*  0.18 – 3.36 
Paraesthesia 0.001* -3.58 – -0 .92 
Legend: Conf: confidence; * significant <0.05 
 
The demographics that had an effect on function were, whether symptoms 
were due to an accident/injury (p=0.02; 95%CI -3.59 – 0.36) and these 
patients did not do as well as those with a gradual onset (p=0.03; 95%CI 0.18 
– 3.36). Paraesthesia also had a significant effect on function as measured by 
the PSFS (p =0.001; 95%CI -3.58 – -0.92).  
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6.4  The effect of NM on quality of life 
6.4.1 Health state of the EQ5D 
The EuroQual 5D instrument (EQ5D) was used to measure quality of life. 
 
Figure 6.4 illustrates the changes over time between groups.  
 
Figure 6.4. Difference in measurements of the health state of the EQ5D 
between groups. 
 
There were no significant differences in terms of the health state between 
groups at any time point (Baseline p=0.99: IG 95% CI 67.36 – 77.50; UC 95% 
CI 65.94 – 78.83; 3 weeks p=0.45: IG 95% CI 77.81 – 83.53; UC 95% CI 
73.10 – 85.26; 6 weeks p=0.70: IG 95% CI 81.20 - 86.91; UC 95% CI 78.17 – 
87.75; 6 months p=0.37: IG 95% CI 82.45 – 88.12; UC 95% CI 79.41 – 88.03; 
12 months p=0.20: IG 95% CI 83.26 – 89.04; UC 95% CI 77.79 – 88.59). 
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Both groups improved significantly over time (p=0.0001) but there were no 
between group differences (Baseline p=0.99; 3 weeks p=0.45; 6 weeks 
p=0.70; 6 months p=0.37; 12 months p=0.20). (Appendix 6.1). The 
demographics that had a significant effect on the health state are illustrated in 
Table 6.9. 
 
Table 6.8. Demographics that had a significant effect on the Health State of 
the EQ5D. 
Demographics Fixed effect = p 95% Conf. Interval 
Area of pain   
Shoulder 0.0001* -15.53 –  -6 .86 
Upper arm 0.004* -9.74 –  -1.85 
Arm up to hand 0.005* -10.94 –  -1.94 
Hand 0.0001* -15.65 –  -4.59 
Whole arm including hand 0.01* -8.70 –  -1.20 
Hours sitting per day 0.02* 24.95 – 2.28 
Headache 0.03* -5.76 –  -0.24 
Dizziness 0.0001* -9.33 –  -3.11 
Paraesthesia 0.001* -9.39 –  -4.08 
Legend: Conf. – confidence; *significance <0.05 
 
A number of demographic variables had an effect on the health state (see 
Table 6.8). The area of pain and the presence of paraesthesia and dizziness 
resulted in a significantly poorer quality of life (p=0.0001). Other 
demographics that had a significantly negative influence on health state were 
longer hours sitting per day (p=0.02) and the presence of headache (p=0.03).  
  126 
 
6.4.2 Domains of the EQ5D 
The five domains that the EQ5D measures are mobility, self-care, usual 
activities, pain and anxiety and depression. Between groups comparison of 
the percentage of patients presenting with restriction in the different domains 
of the EQ5D at baseline and 12-month follow-up is illustrated in Figure 6.5. 
 
 
Legend: A&D – Anxiety and depression 
Figure 6.5. Between group comparison of restrictions in the different domains 
of the EQ5D at baseline and 12 month follow-up. 
 
At baseline there were no significant differences in any of the domains 
(p>0.05). (Appendix 6.1 pp. 29-36) 
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6.4.2.1 Mobility 
At baseline 15% of the IG and 12.5% of the UC had moderate problems with 
mobility. There was no significant difference between groups at any time 
points (p>0.05). The percentage of patients who had problems with mobility 
did not change much over the study period (12 months IG 12.5%; UC 8.3%).  
6.4.2.2 Self-care 
At baseline 23.12% of the IG and 23.07% of the UC reported moderate 
difficulty with self-care. At 12 months this had decreased to 3.77% (n=2) in the 
IG and 4.16% (n=1) in the UC. There were no significant differences between 
the groups at any time points (p>0.05).  
6.4.2.3 Usual activities 
There were 60% (n=36) in the IG and 53.85% (n=14) of the UC with some 
problems with usual activities. At baseline 1.89% (n=1) of the IG and 4.16% 
(N=1) of the UC stated that they could not perform their usual activities at all. 
At 12 months 11.32% (n=6) of the IG and 20.8% (n=5) of the UC still had 
some problems with usual activities. There were no significant differences 
between the groups at any time points (p>0.05). 
6.4.2.4 Pain 
At baseline 33.33% (n=20) of the IG and 23.07% (n=6) of the UC reported 
extreme pain. At 12 months 3.77% (n=2) of the IG and 4.16% (n=1) of the UC 
still reported extreme pain. At 12 months only 28.33% (n=17) still reported 
moderate pain in the IG whereas 45.8% (n=11) of the UC still had moderate 
pain. However, this was a non-significant difference (p=0.13). There were no 
significant differences between the groups at any of the time points (p>0.05) 
  128 
6.4.2.5 Anxiety and depression 
At baseline 38.33% (n=23) of the IG and 38.46% (n=10) of the UC had 
moderate anxiety and depression. This had decreased to 15% (n=9) in the IG 
and 12.5% (n=3) in the UC at 12 months. There were no significant 
differences between groups at any time points (p>0.05). 
 
6.5 Patient’s’ perspective of change in their 
condition  
The global rating of change questionnaire was administered at six weeks to 
measure the patient’s’ perspective of change in their condition. Figure 6.6 
illustrates the findings. 
Figure 6.6. Distribution of the Global Rating of Change between groups at 6 
weeks. 
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There were no significant differences between the two groups at 6 weeks in 
terms of their perception of change in their condition (p=0.36). The majority of 
responses in the IG and UC were between +3 (better) and +5 (completely 
recovered). There was one patient that was at -1 and one at -2 (slightly 
worse) in the IG. Two in the UC were -2 (slightly worse) and one was  -4 
(worse). (Appendix 6.1) 
 
6.6 Number of treatments 
Figure 6.7 illustrates the distribution of treatments between the groups. 
 
Figure 6.7 Distribution of the number of treatments between groups. 
 
There were no significant differences between groups with regards to the 
number of treatments they received (p=0.10; IG 3.92± 1.78; UC 4.69± 2.34). 
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The mean number of treatments was 4.2± 1.98 (Appendix 6.1 pp. 15). 
However, in the IG there were four patients (6.6%) who needed seven to nine 
treatments compared to six patients (23.08%) in the UC. This is a significant 
difference (p=0.03) favouring the IG (Appendix 6.1 pp. 35). All four patients in 
the IG were classified as having neuropathic pain whereas two of the six 
patients in the UC were classified as having neuropathic pain. Two of each 
group were catastrophisers.  
 
6.7 Neuropathic pain 
The Neuropathic Pain Diagnostic Questionnaire (DN4) was used to identify 
patients with neuropathic pain. A total of 45 patients (52.32% of the whole 
group) i.e. UC (n=13) and IG (n=32) were identified with neuropathic pain at 
baseline (p=0.78). Eleven patients in the whole group could still be classified 
as having neuropathic pain at 12 months. There were no differences between 
the groups at 6 months (IG n=9; UC n=4; p=0.96) or 12 months (IG n= 7; UC 
n=4; p=0.63) in terms of number of patients identified with neuropathic pain.  
  
6.7.1 Neuropathic pain and pain 
Table 6.9 illustrates the findings for patients with neuropathic pain and the 
NPRS.  
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Table 6.9.  Between group comparison of the number of patients with neuropathic pain and their NPRS scores. 
Intervention Group   n      mean  95% Conf. Interval  Usual Care n      mean 95% Conf. Interval     p 
Baseline  32     7.09  6.50 - 7.68     13    7.11 6.62 - 7.61  0.95   
6 months  9     2.91     1.74 - 4.08     4      5.5  3.45 - 7.55     0.01* 
12 months  7     2.93  0.85 - 5.00     4     3.75     -0.01   7.51  0.58 
Legend: *significant p<0.05; Conf. – confidence. 
 
The patients with neuropathic pain were comparable at baseline with respect to NPRS (p=0.95). There were no significant 
differences between groups at three weeks and six weeks (p>0.05). At six months patients with neuropathic pain had significantly 
less pain in the IG (p=0.01) compared to the UC. This was a large effect with the IG having on average 2.59, on an 11-point scale, 
less pain than the UC group (d = -1.77 95% CI -1.77 - -0.41). At 12 months there was no longer a significant difference between 
groups (0.58).  
 
The between group differences for patients with neuropathic pain compared to those without neuropathic pain in terms of the NPRS 
is illustrated in Table 6.10 
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Table 6.10. DN4 positive (neuropathic pain) compared to DN4 negative (not neuropathic pain) with regards to NPRS 
Positive     n        Mean     Std. Dev.   (95% Conf. Interval)     Negative   n     Mean   Std. Dev.     (95% Conf. Interval) p 
Baseline      45    7.10     1.44         6.66 – 7.53   41     6.72       1.54    6.23 – 7.20    0.24         
6 months     13    3.71     1.87        2.57 – 4.84   62     1.44       2.02     0.93 – 1.96    0.0001* 
12 months   11    3.23            2.21        1.74 – 4.71              65     1.38       2.14     0.88 – 1.91    0.01* 
Legend: *significant p<0.05; Conf. – confidence. 
 
Patients with neuropathic pain compared to those not classified with neuropathic pain, were comparable at baseline (p=0.95). 
However, at 6 months and at 12 months patients with neuropathic pain had significantly more pain than those without (6 months: 
p=0.0001: mean pain for neuropathic pain was 3.71 compared to 1.54 for the non-neuropathic pain) (12 months: p=0.01: mean pain 
for neuropathic pain 3.23 compared to 1.38 for the non-neuropathic pain).  
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6.7.2 Neuropathic pain and function 
Table 6.11 illustrates the differences between groups of patients with neuropathic pain in terms of the PSFS  
 
Table 6.11. Between group comparison of the number of patients with neuropathic pain and their PSFS scores 
Intervention Group   n      mean  95% Conf. Interval  Usual Care n      mean 95% Conf. Interval  p 
 
Baseline  32       14.5     12.18 – 16.82    13     13.92    10.08 – 17.76  0.79 
6 months  9 24.11   21.30 – 26.92    4 23.25    14.12 – 32.38  0.75 
12 months  7 23.86  19.41 – 28.31    4 24    17.25 – 30.75  0.69 
Legend: *significant p<0.05; Conf. – confidence. 
 
Groups with neuropathic pain were comparable at baseline with respect to function (0.79). Although both groups improved 
significantly (p=0.0001) over time there were no significant between group differences at any time points (p>0.05).  
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Table 6.12 illustrates the findings for patients with neuropathic pain compared to those without neuropathic pain and the PSFS. 
 
Table 6.12. DN4 positive (neuropathic pain) compared to DN4 negative (not neuropathic pain) in terms of the PSFS 
Positive     n        Mean     Std. Dev.   (95% Conf. Interval)      Negative   n     Mean   Std. Dev.   (95% Conf. Interval)    p 
Baseline 45    14.33    6.34    12.43 – 16.24    41    13.20    6.53    11.13 – 15.26   0.41 
6 months 13    23.85   4.16     21.33 – 26.36  62    26.21     5.36    24.85 – 27.57   0.14 
12 months 11    23.91   4.39     20.96 – 26.86   65    27.15     4.85    25.95 – 28.36   0.04* 
LEGEND: * significance<0.05; Conf. – confidence. 
 
At baseline and 6 months patients with neuropathic pain and patients without neuropathic pain were the same in terms of function 
(p>0.05). However at 12 months patients with neuropathic pain were more limited in terms of function (PSFS score 23.9) compared 
to patients without neuropathic pain (PSFS score 27.15) (p= 0.04) 
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6.7.3 Neuropathic pain and health state of the EQ5D 
The differences between groups for patients with neuropathic pain in terms of their health state is shown in Table 6.13 
 
Table 6.13. Between group comparison of patients with neuropathic pain and their health state as measured by the EQ5D 
Intervention Group   n      mean  95% Conf. Interval  Usual Care n      mean 95% Conf. Interval  p 
Baseline  32 71  63.57 – 78.43    13 68.92  59.55 - 78.29  0.75 
6 months  9     83.11  72.17 – 94.05 4 79.50  54.97 - 104.03 0.69 
12 months  7 77.57  65.72 – 89.42 4 83.75  66.11 - 101.39 0.44 
LEGEND: * significance<0.05; Conf. – confidence. 
 
There were no significant differences in the health state as measured by the EQ5D in the groups with neuropathic pain at baseline 
(p = 0.75).  Although health state improved, there were no significant between group differences at any time points (p>0.05).  
 
The differences in terms of the health state for patients with neuropathic pain compared to patients not classified with neuropathic 
pain are shown in Table 6.14. 
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Table 6.14 DN4 positive (neuropathic pain) compared to DN4 negative (not neuropathic pain) with regards to health state of the 
EQ5D 
Positive     n        Mean     Std. Dev.   (95% Conf. Interval)    Negative    n     Mean   Std. Dev.   (95% Conf. Interval) p 
Baseline     45        70.4    19.12      64.65 – 76.15   41    74.63   17.78     69.02 – 80.24 0.29 
6 months    13        82    14.05       73.51 – 90.49   62    85.61   10.46     82.96 – 88.27 0.29 
12 months  11       79.82     12.05       71.72 – 87.91   65    86.11   11.11     83.35 – 88.86 0.09 
LEGEND: * significance<0.05; Conf. – confidence. 
 
There were no significant differences between patients with neuropathic pain compared to patients without neuropathic pain at any 
time point in terms of the health state of the EQ5D (p>0.05)
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6.8 Pain Catastrophising 
The two groups were comparable with regards to pain catastrophising at 
baseline (p=0.30). There were n=23 (26.74%) of patients identified as 
catastrophisers in the whole group.  At 12 months only n=7 (8.14%) of the 
whole group could still be classified as catastrophisers. As treatment was not 
aimed at changing catastrophising, comparisons between treatment groups 
are not reported. 
 
6.8.1 Pain Catastrophising and pain 
Table 6.15 shows the findings of patients classified as catastrophisers 
compared to those who were not catastrophisers in terms of pain as 
measured by the NPRS.  
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Table 6.15 PCS positive (catastrophisers) compared to PCS negative (non-catastrophisers) in terms of the NPRS 
Positive     n        Mean     Std. Dev.   (95% Conf. Interval)      Negative   n     Mean   Std. Dev.   (95% Conf. Interval)     p 
 
Baseline 23    7.35 1.05         6.90 – 7.81      61    6.80      1.60    6.39 – 7.21     0.13 
6 months 4      4.25 3.86        -1.90 – 10.40      70    1.70      2.00    1.22 – 2.17     0.02* 
12 months 7     3.56     2.67   1.10 – 6.02      68    1.47      2.12     0.96 – 1.99    0.02* 
LEGEND: * significance<0.05; Conf. – confidence. 
 
Patients, who could be classified as catastrophisers, were comparable to those that were not catastrophisers at baseline in terms of 
pain as measured by the NPRS (p=0.13). However, at 6 months (p=0.02) and 12 months (p=0.02) pain catastrophisers reported 
significantly more pain than patients who were not classified as catastrophisers. At 6 months there was a 2.56 difference on an 11-
point scale and at 12 months still more than a 2 points difference between the catastrophisers and non-catastrophisers.  
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6.8.2 Pain catastrophising and function 
Catastrophisers compared to non-catastrophisers in terms of the PSFS is illustrated in Table 6.16 
 
Table 6.16 PCS positive (catastrophisers) compared to PCS negative (non-catastrophisers) in terms of PSFS 
Positive     n        Mean     Std. Dev.   (95% Conf. Interval)      Negative   n     Mean   Std. Dev.   (95% Conf. Interval)    p 
Baseline      23      12.35 6.37       9.59 – 15.10   61    14.34       6.40     12.70 – 15.98   0.21 
6 months 4       24.25 4.5               17.09 – 31.41    70    25.83       5.30     24.56 – 27.09   0.56   
12 months 7      25.14 5.49       20.06 – 30.22   68    26.79   4.87    25.62 – 27.97   0.40 
LEGEND: * significance<0.05; Conf. – confidence. 
 
There were no significant differences at any time points between catastrophisers and non- catastrophisers in terms of function as 
measured by the PSFS (P>0.05). 
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6.8.3 Pain catastrophising and health state of the EQ5D 
Catastrophisers compared to non-catastrophisers in terms of the health state of the EQ5D is illustrated in table 6.17.  
 
Table 6.17. PCS positive (catastrophisers) compared to PCS negative (non-catastrophisers) in terms of health state of the EQ5D  
Positive     n        Mean     Std. Dev.   (95% Conf. Interval)        Negative  n     Mean   Std. Dev.   (95% Conf. Interval)    p 
Baseline    23       61.96   22.94     52.04 – 71.87   61    75.79    15.12       71.91 – 79.66 0.002* 
6 months    4        87     8.72       73.13 – 100.87   70    85.01    11.32       82.31 – 87.71 0.73 
12 months  7        84.86 8.86       76.66 – 93.05   68    85.09 11.69       82.25 – 87.92      0.96 
 LEGEND: * significance<0.05; Conf. – confidence. 
  
At baseline the pain catastrophisers had a significantly lower health state than the non-catastrophisers (p=0.002). At 6 months 
(p=0.73) and 12 months (p=0.96) there were no significant differences between the groups. The demographics that had a 
significantly negative effect on catastrophising were longer duration of pain (p=0.04; 95% CI 0.01 – 0.11) and the presence of 
paraesthesia (p=0.01; 95% CI 0.74 – 5.96). (Appendix 6.1) 
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6.9 Outcomes of the ULNDT1 
The measurement of the ULNDT1 at the elbow is shown in Table 6.18 
 
Table 6.18 ULNDT1 measurements at the elbow at different time points  
Intervention Group     n = 60 Usual Care            n = 26 
ULNDT left n Mean SD n Mean SD p value 
Baseline 36 110° 29.81 12 96° 46.63 0.23 
6 months 32 134° 28.81 12 80° 31.43 0.0001* 
12 months 24 145° 26.81 11 120° 34.85 0.03* 
ULNDT right        
Baseline 32 98° 26.20 13 80° 31.63 0.06 
6 months 25 136° 28.14 10 135° 29.46 0.93 
12 months 20 136° 24.14 8 90.5° 44.85 0.0001* 
Legend: SD – standard deviation; * - significance <0.05 
 
At baseline the ROM for the ULNDT1 was similar for both groups (p>0.2308). 
At the six-month follow-up there was a significant difference in the ROM on 
the left side favouring the IG (p=0.0001). At the 12-month follow-up the ROM 
improved significantly on the left and right side of the IG (p<0.05) compared to 
the UC. As a number of patients were not prepared to come in to the practice 
for measurements and were only followed up telephonically, the dropout for 
the ULNDT1 was therefore higher than for the self-report questionnaires. On 
the left side, at 12 months n=12 (33.3%) in the IG were lost to follow-up and 
n=1 (8.3%) lost in the UC. At 12 months on the right side the loss to follow-up 
was n=7 (37%) in the IG and n=5 (38%) in the UC (Appendix 6.1 illustrates 
the measurements pp. 10-11). 
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6.10 Summary 
All patients improved significantly in terms of primary outcomes namely pain, 
function and quality of life over the 12-month period. However, the IG had 
significantly less pain than the UC at six months (p=0.03 95% CI 0.9606 - 
2.0281) and this difference was more pronounced in patients with neuropathic 
pain (p=0.01). Therefore the null hypotheses 1a can be rejected and the 
alternative hypothesis accepted. There were no significant differences 
between groups in terms of function or quality of life. The findings support the 
null hypotheses 1b and 1c and the alternative hypotheses can be rejected. 
At six weeks there was no significant differences between groups with respect 
to perceived change although the majority felt better or were completely 
recovered. Both groups received four treatments on average.  
Secondary outcomes were the effect of neuropathic pain and pain 
catastrophising on cervico-brachial pain. Patients with neuropathic pain had 
significantly more pain at six (p=0.0001) and 12 months (p=0.01) compared to 
those without neuropathic pain. At 12 months, function was also negatively 
affected by neuropathic pain (p=0.04). Catastrophisers had significantly more 
pain at six (p=0.02) and 12 months (p=0.02) compared to non-
catastrophisers. There was no difference in their function, however at baseline 
they reported lower quality of life (p=0.002). 
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7 Chapter seven – Discussion of the 
randomised clinical trial 
 
In this chapter the results of the randomised clinical trial (RCT) will be 
discussed. This study examined the effect of neural mobilisation (NM) on 
pain, function and quality of life of patients with cervico-brachial pain. The 
primary outcomes were pain as measured by the Numerical Pain Rating 
Scale (NPRS), function as measured by the Patient Specific Functional Scale 
(PSFS) and quality of life as measured by the EuroQual Instrument (EQ5D). 
There were two groups of patients: the intervention group (IG) received 
cervical and thoracic spine mobilisation, exercise and advice to stay active 
with the addition of NM. The usual care group (UC) received the same 
treatment without NM. Furthermore, the influence of the presence of 
neuropathic pain and catastrophising on treatment outcomes was explored. 
Outcomes were assessed at three weeks, six weeks, six months and 12 
months with the primary outcome point at six weeks. 
 
7.1 A brief overview of results 
At six weeks there were no significant differences between groups in any of 
the outcome measures. However at six months the IG had significantly less 
pain (p=0.03) than the UC group. The improvement in pain was maintained at 
12 months follow-up, but the between group difference failed to reach 
significance (p=0.05). At 6 months follow up the patients with neuropathic pain 
in the IG also had significantly less pain (p=0.01) than the UC and 
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improvement was maintained at 12 months. This supports the alternative 
hypothesis 1a. There were no between group differences in terms of function 
and quality of life at any of the measurement time points and therefore the null 
hypotheses 1b and 1c can be accepted and the alternative hypotheses 
rejected. However, both groups improved significantly in terms of pain, 
function and quality of life from baseline to the 12 months follow-up.  
More than half of the study population had neuropathic pain (IG n=32; UC 
n=13) at baseline but this number had decreased to around 13% (UC 15% 
n=4; IG 11.7% n=7) at 12 months follow-up. Patients with neuropathic pain 
reported more pain and lower function than patients without neuropathic pain. 
Only about 28% of the total sample could be classified as catastrophisers and 
after 12 months follow-up this had decreased to 8%. This group reported a 
worse quality of life at baseline, and significantly more pain at follow-up than 
non-catastrophisers.  
7.2 Study population 
According to the Bone and Joint decade task force on neck pain (Guzman et 
al., 2009), the majority of the study sample could be classified with Grade III 
neck pain as they presented with neurological changes.  The remainder of the 
population had Grade II neck pain as all the patients had functional limitations. 
Considering the poor prognosis of acute idiopathic neck pain (level I 
evidence) and the associated disability (Hush et al., 2011), as well as limited 
evidence for the effective management of acute/sub-acute Grade II and III 
neck pain (Salt et al., 2011, Thoomes et al., 2013), favourable treatment 
outcomes, as was found in this study, can have important implications in 
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terms of preventing the transition of acute pain to chronic pain. 
More than half of the sample could be classified as having ‘probable 
neuropathic pain’ according to the updated classification of the International 
Association for the Study of Pain special interest group on neuropathic pain 
(Finnerup et al., 2016, Haanpää et al., 2011). They describe this as a history 
of a neurological lesion and a neuro-anatomically plausible area of symptoms 
and sensory changes. In an overview of 55,686 insurance claims for painful 
neuropathic disorders, back and neck pain with neuropathic involvement were 
the most common problems (Berger et al., 2004). Similarly Baron et al. (2016) 
found that a neuropathic pain component is common and under-recognised in 
patients with low back pain. The findings of this study would therefore support 
this in an acute/sub-acute neck pain population. However, the findings should 
be confirmed in a larger study population. The high prevalence of neuropathic 
pain in the study population has important implications on treatment outcomes 
as these patients are often resistant to treatment, have poorer health and a 
higher utilisation of heath care (Baron et al., 2016, Berger et al., 2004, Smart 
et al., 2012b). Therefore, the significant improvement in the IG of patients with 
neuropathic pain, at six months and of both groups in function and quality of 
life is very encouraging.  
The baseline pain scores of patients in this study are higher than in most of 
the studies on NM for cervico-brachial pain (Allison et al., 2002, Gupta and 
Sharma, 2012, Kumar, 2010, Langevin et al., 2015, Marks et al., Nee et al., 
2012b) where the studies had a pain score of four to five. Only three studies 
reported a high pain score similar to this study (Coppieters et al., 2003b, Nar, 
2014, Kumar, 2010). High pain scores at baseline have been shown to be a 
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predictor of poor outcomes (Miedema et al., 2016, Walton et al., 2013a). 
Healthcare users e.g. seeking physiotherapy treatment, report higher pain and 
disability (Huisstede et al., 2008) than those who do not use healthcare. The 
patients in this study all sought health care and that could possibly be part of 
the reason for the high levels of reported pain. Therefore, the overall 
improvement of both groups in this study is better than expected. This study 
population, which presented with many features that should result in poor 
treatment outcomes, improved significantly in terms of pain, function and 
quality of life and treatment effect was maintained at 12 months follow-up.  
 
7.3 Demographics 
At baseline, all patients were asked to complete an information sheet to 
gather information on demographics. Groups were similar at baseline. 
7.3.1 Age 
Neck pain is most prevalent in middle age (Bot et al., 2005, Hoy et al., 2014, 
Huisstede et al., 2008, Skillgate et al., 2012), which is similar to the findings of 
this study. The median age of patients was 46.5 years in the IG and 48.1 
years in the UC. This is also similar to the “Global burden of disease 2015” 
study that found the peak age to be around 44 years of age (Vos et al., 2016). 
Most of the other studies on cervico-brachial pain have a similar age range 
except for two studies, one where the median age was 29.5 years (Gupta and 
Sharma, 2012) and the other where the median age was 52 (±9) years (Marks 
et al., 2011). 
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7.3.2 Gender 
Neck pain is more prevalent in females (Hoy et al., 2014, Huisstede et al., 
2008, Wijnhoven et al., 2006). Women have also been shown to be more 
likely to develop neck pain and less likely to recover according to a study by 
Skillgate et al. (2012).  
The majority of patients were female with 75% in the IG and 76.9% in the UC. 
In the other studies on NM for cervico-brachial pain the distribution of females 
to males were similar ranging between 66% and 75%. One study had more 
males than females (Gupta and Sharma, 2012). The gender distribution of this 
study is therefore similar to the literature. 
7.3.3 Duration of symptoms 
A number of the studies on NM for cervico-brachial pain or cervical 
radiculopathy were done on a more chronic population (Allison et al., 2002, 
Marks et al., 2011, Nee et al., 2012b). Unfortunately, the majority of studies 
had no information on the duration of symptoms (Anwar et al., 2015, Gupta 
and Sharma, 2012, Kumar, 2010, Nar, 2014, Ragonese, 2009). Two studies 
included patients with a symptom duration of between five and a half weeks to 
just over three months (Coppieters et al., 2003b, Langevin et al., 2015). The 
mean duration of pain in the IG was 30.1 days and for the UC it was 23.5 
days. One of the exclusion criteria of this study was pain for longer than three 
months as the intention was to include only acute and sub-acute patients with 
cervico-brachial pain. There are fewer studies on acute neck pain compared 
to studies on chronic neck pain (Hush et al., 2011) & (PubMed search 29 
October 2016). There are even fewer studies on acute cervico-brachial pain 
(Salt et al., 2011). The management of patients in the acute phase is 
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extremely important in order to prevent the transition to chronic pain 
especially in light of the poor prognosis of neck pain (Hush et al., 2011). 
7.3.4  The presence of previous episodes of neck pain 
 One of the risk factors for chronicity is a history of neck pain (Bruls et al., 
2015, Walton et al., 2013a). In the IG 81.7% of patients had previous 
episodes of neck pain and in the UC 80.8%. This high incidence of previous 
pain means that these patients have a poor prognosis compared to first onset 
neck pain (Bruls et al., 2015, Walton et al., 2013a). This could in part explain 
why a high percentage of patients still reported some measure of pain at 12 
months follow-up. 
7.3.5 Pain due to accident or injury compared to gradual 
onset 
There is very weak evidence that the mechanism of injury plays a role in 
symptom presentation (Walton et al., 2009). However, whiplash associated 
disorders often have associated factors that impact on treatment outcomes 
(Anstey et al., 2016, Smith et al., 2016, Sterling and Pedler, 2009). In the IG 
33.3% of the population had pain they ascribed to injury or accident and 
30.8% in the UC had pain ascribed to injury or accident. In this study, function 
was negatively affected in those reporting an accident or injury as the cause 
of their pain compared to those with a gradual onset of symptoms. This is in 
line with studies that have shown that high disability in whiplash-associated 
disorder is associated with poor treatment outcomes (Peolsson et al., 2014, 
Smith et al., 2016). 
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7.3.6 Regular exercise 
Sixty-five per cent of the IG exercised regularly and 50% of the UC exercised 
regularly. This did not influence any of the treatment outcomes. This is similar 
to studies reported in the literature that found no association between 
exercise, pain and function in patients with neck pain (Hogg-Johnson et al., 
2008, Walton et al., 2009). In contrast, Palmlöf et al. (2016) found that leisure 
time physical activity has a protective effect in the development of neck pain.  
7.3.7 Education 
Some studies have shown lower education levels to be associated with poor 
prognosis (Hendriks et al., 2005, Walton et al., 2013a). In this study, all 
participants had a minimum of 12 years of education, and the majority of the 
study population (IG 80%; UC 76.9%) had college or university education. In 
this study none of the study population had an education of less than 12 
years. The majority of the study population (IG 80%; UC 76.9%) had college 
or university education. The remainder had 12 years’ education. This may 
account for the fact that education had no effect on any of the treatment 
outcomes. 
7.3.8 Occupation 
Patient occupation can have an influence on the development of neck pain 
(Cho et al., 2012, Hanvold et al., 2014, Viikari-Juntura et al., 2001). Sixty per 
cent of the IG and 65.4% of the UC had sedentary occupations. This has 
been associated with neck and shoulder complaints (Cho et al., 2012, 
Larsson et al., 2007). Ergonomic advice (van Vledder and Louw, 2015) as 
well as postural correction (Brink et al., 2015, Lluch et al., 2014) could assist 
patients with sedentary occupations to manage symptoms.   
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7.3.9 Hours sitting per day 
Longer hours spent sitting per day has been associated with poorer quality of 
life in older people (Meneguci et al., 2015). Furthermore, hours of computer 
exposure are associated with upper quadrant musculoskeletal complaints 
(Gerr et al., 2004, Smith et al., 2009). The average sitting time of the study 
population was around seven hours per day, which is an extremely long 
period and this could possibly have contributed to the onset of symptoms. 
Jensen (2003) recommended three to four hours of sitting to prevent onset of 
symptoms. In this study, longer hours seated was associated with poor quality 
of life and this is consistent with findings in the literature (Meneguci et al., 
2015, Rebar et al., 2014).  
7.3.10 The presence of headache and dizziness 
Headache is commonly associated with neck pain (Ashina et al., 2015, Leaver 
et al., 2013b) and is associated with poor treatment outcomes (De Pauw et 
al., 2015, Walton et al., 2013a). In the IG 58.5% and in the UG 57.8% of the 
study population had headaches associated with their cervico-brachial pain. 
Dizziness was less frequently present (IG 28.3%; UC 15.4%). Both headache 
and dizziness had negative effects on the quality of life in this study. 
Headache is consistently linked to poor quality of life (Diener, 2001, Lantéri-
Minet et al., 2010, Zimmer et al., 2014) as was the case in this study. 
Dizziness has also been found to have an impact on quality of life (Reid et al., 
2015). As headache and dizziness is frequently associated with cervico-
brachial pain it is important to assess for these symptoms. Mobilisation and 
exercise has been shown to be effective in treating these symptoms (Jull et 
al., 2002, Reid et al., 2015). The presence of these symptoms was not re-
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assessed and therefore it is not known whether this had an influence on the 
improvement in quality of life. 
7.3.11 Paraesthesia 
Paraesthesia is commonly associated with cervico-brachial pain (Hall and 
Elvey, 1999, Nee et al., 2012b). Paraesthesia reflects hyper-excitability or 
reduced inhibition of the nervous system (Schmid et al., 2013) and is thought 
to be due to neuro-inflammation or partial nerve injury (Djouhri et al., 2012, 
Schmid et al., 2013). Fifty three per cent of the study population presented 
with paraesthesia and this is the same percentage as in a study by Nee et al. 
(2012b). The presence of paraesthesia was the only demographic factor that 
had a negative effect on pain, function and quality of life. No studies could be 
found that evaluated the effect of paraesthesia on pain, function and quality of 
life. Considering the high prevalence of paraesthesia in this population and 
the impact it has, there is a need for further investigation into the effect of 
paraesthesia on different treatment outcomes as well as effective 
management strategies to improve paraesthesia. 
 
7.4 The effect of NM on pain 
The pain in both groups improved significantly from baseline to three weeks 
follow-up, and this improvement was also clinically important (more than three 
points on an 11 point scale) (Cleland et al., 2008, Farrar et al., 2001, Pool et 
al., 2007). This improvement can be expected taking natural recovery into 
consideration (Leaver et al., 2013a, Vasseljen et al., 2013). In their 
population-based study, Vasseljen et al. (2013) found the mean improvement 
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in new-onset neck pain was 0.9 on an 11-point scale, whereas the 
improvement in the IG was 3.5 and 3.3 in the UC at three weeks follow-up. 
This difference, which is higher than the expected rate of recovery, can 
probably be ascribed to treatment effect especially in light of the higher 
baseline pain than in the general population (Vasseljen et al., 2013). Both 
groups showed improvement at the six weeks follow-up although the 
improvement from three weeks to sig weeks was no longer clinically 
important. This is similar to the findings of previous studies that found a 
significant improvement in the first four weeks after onset of pain (Leaver et 
al., 2013a, Trott et al., 2014) in patients receiving manual therapy. At 6 
months there was a significant difference (p=0.03) between the groups and 
this can only be ascribed to the addition of NM to the treatment of the IG. The 
difference was more marked in patients with neuropathic pain (p=0.01). The 
IG had a mean improvement of 2.5 more than the UC on an 11-point scale. 
This is a very meaningful clinical difference as a change of 1.3 is considered 
meaningful in a neck pain population (Cleland et al., 2008). An increased rate 
of recovery can therefore be important and may prevent the transition to 
chronic pain. Chronic pain is described as pain lasting beyond normal healing 
time (Merskey and Bogduk, 2011) and is often associated with central 
sensitisation in musculoskeletal conditions (Nijs et al., 2010).  
Three trajectories of recovery have been identified (van Hulst et al., 2016, 
Walton et al., 2014) and around 60-65% of patients will have a modest rate of 
recovery. According to a systematic review, the prognosis of patients with 
acute neck pain is not as favourable as previously believed (Hush et al., 
2011). Improvement is expected within the first six and a half weeks; however, 
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neck pain severity remains high at 12-month follow-up.  In line with this 
finding, studies have found that improvement takes place in the first two 
months after which levels of pain and disability will remain the same up to 
twelve months (Hush et al., 2011, Maher, 2013, Vasseljen et al., 2013, Walton 
et al., 2014). In contrast to these findings the IG kept on improving from six 
weeks to six months at a moderate level (Cohen’s d=1.4) and the UC had a 
small improvement (Cohen’s d=0.87) from six weeks to six months. This is 
therefore, different from the natural course of neck pain (Hush et al., 2011, 
Vasseljen et al., 2013, Walton et al., 2014) at the 6-month follow-up. None of 
the studies on cervico-brachial pain (Basson et al., 2015b) or a review on the 
effectiveness of non-invasive treatment of cervico-brachial pain (Salt et al., 
2011) had follow-up measurements at six months, therefore they could not be 
compared to this study.  
At 12 months both groups had significant improvement in pain (p< 0.0001) 
compared to baseline, but the difference between groups failed to reach 
significance (p=0.05). The IG was compared to an effective management 
protocol and therefore the natural history is not known. However, literature 
would suggest a less favourable outcome (Hush et al., 2011, Maher, 2013, 
Vasseljen et al., 2013, Walton et al., 2014). At 12 months follow-up 50% of the 
IG (95% CI 0.81 – 1.87) had no pain, whereas more than 60% (95% CI 1.32 – 
3.41) of the UC still had pain. The use of a multi-dimensional pain measure 
such as the McGill Pain Questionnaire could possibly have shed more light on 
differences at the 12-month time point. A follow-up measurement of the 
Global Rating of Change (GROC) – which was only measured at the primary 
end point of six weeks – could also have added more information if it had 
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been measured at six months and 12 months. Although both groups improved 
significantly (effect size from baseline to 12 months, Cohen’s d IG 3.03 and 
UC 2.36), the presence of pain at six and 12 months is much higher than 
previously suggested (Côté et al., 2016, Leaver et al., 2013a, Walton et al., 
2014). A clinical practice guideline on management for neck pain (Côté et al., 
2016) recommends  “Clinicians should educate and reassure patients about 
the benign and self-limiting nature of the typical course of NAD grades I–III” 
(pp. 2001). In light of the findings of this study the outcome of grade II and III 
neck pain may not be as benign as it is believed to be and would agree with 
the findings of Hush et al. (2011) that the prognosis of acute neck pain is 
poor. Therefore adding neuroscience education instead of using only advice 
to stay active may be beneficial for patients with cervico-brachial pain. There 
is evidence that neuroscience education improves pain and disability in 
chronic musculo-skeletal conditions (Louw et al., 2011). 
Both treatment groups received cervical and thoracic joint mobilisation in 
combination with exercises and advice to stay active. This multimodal 
treatment approach is widely accepted as effective for the management of 
non-specific neck pain (Gross et al., 2009, Côté et al., 2016, Childs et al., 
2008, Hurwitz et al., 2008). There is, however, limited evidence for the 
management of cervico-brachial pain (Salt et al., 2011) and cervical 
radiculopathy (Boyles et al., 2011, Thoomes et al., 2013) and therefore most 
guidelines suggest a similar approach for cervico-brachial pain. The findings 
of this study support the recommendation that this is an effective treatment 
approach for patients with cervico-brachial pain as both groups improved 
significantly in terms of pain. In two systematic reviews both exercises (Gross 
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et al., 2016) and mobilisation (Gross et al., 2015) have been shown to have 
an effect on pain. The use of these two modalities as part of the treatment 
could explain the similar improvement in the two treatment groups.  
All patients were given the same exercises. At 12 months there was a 
tendency for the IG to have better pain outcomes but it failed to reach 
significance. The addition of nerve-sliding exercises to the IG group may have 
added to the treatment effect. 
7.4.1 Neural mobilisation 
The NM used in this study was “mobilisation along the tract of the nerve” 
(Butler, 2000) and the technique has been described as follows  “a gentle soft 
tissue mobilisation of the neural container/interface “ along the tract” of the 
nerve (Butler (2000) pp. 380) –  directly where the nerve is palpable and 
indirectly where it lies deeper. Butler (2000) proposes that this technique be 
used in acute and sub-acute pain. Only one case report could be identified 
that used a similar technique (Costello, 2009) which resulted in a decrease in 
pain and improved function. This technique is commonly used in clinical 
practice, but no other studies exist to support the use thereof. 
The aim of neural mobilisation is to restore the homeostasis in and around the 
nerves (Coppieters and Butler, 2008) by reducing inflammation, improving 
circulation and the ability of the nerve to adapt to the strain and excursions 
needed for movement (Topp and Boyd, 2006). A positive neurodynamic test 
was one of the inclusion criteria for this study. The upper limb neurodynamic 
test (median nerve bias) (ULNDT1) tests the mechano-sensitivity of the nerve 
(Coppieters et al., 2005, Schmid et al., 2013). Mechano-sensitivity has been 
shown to be due to disruption of axoplasmic flow of the nerve (Dilley and 
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Bove, 2008) and local inflammation of the nerve trunk (Dilley et al., 2005, 
Schmid et al., 2009). Neural mobilisation has been shown to reduce intra-
neural oedema in unembalmed cadavers (Brown et al., 2011, Gilbert et al., 
2015). Using NM for carpal tunnel syndrome also resulted in a decrease in 
intraneural oedema (Schmid et al., 2012).  Furthermore, NM decreases 
temporal summation (Bialosky et al., 2009b), central hyper excitability 
(Sterling et al., 2010), H-reflex latency (Rezk-Allah et al., 2011), nerve 
compression (Waleed Salah El-din, 2015) and improves median nerve latency 
(Oskouei et al., 2014). These studies used different types of NM techniques 
for instance nerve-gliding exercises, straight leg raise, slump mobilisation and 
ULNDT mobilisation. Therefore the findings cannot necessarily be 
extrapolated. It does seem, however, as if neurophysiological changes occur 
when the nervous system is targeted regardless of the technique used.  
Neurophysiological parameters were not measured in this study and it is 
therefore not possible to say if such changes are responsible for the treatment 
effect. Based on the existing evidence it is plausible that some of the effects 
can be ascribed to positive neurophysiological changes.  
Using the cervical lateral glide in patients with chronic whiplash associated 
disorder resulted in a decrease in spinal hyper-excitability (Sterling et al., 
2010). However, the effect of manual therapy techniques on central pain 
modulating systems is still unclear (Voogt et al., 2014), but it seems as if it 
may have a desensitising effect (Santos et al., 2014, Bialosky et al., 2009a). 
Greening et al. (2005) established a change in the transverse movement of 
the median nerve at the wrist in patients with non-specific arm pain. There are 
however, no changes in longitudinal sliding of the median nerve at the elbow 
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in patients with non-specific arm pain (Dilley et al., 2008). The mobilisation 
along the tract of the nerve used in this study could possibly have had a 
biomechanical effect on the nerve, surrounding tissue and the movement of 
the nerve (Topp and Boyd, 2006).  
Using NM in patients with nerve-related neck and arm pain, poorer treatment 
outcomes were associated with the presence of neuropathic pain (measured 
with the Leed’s Assessment of Neuropathic Signs and Symptoms), younger 
age and a decrease in elbow joint range with the ULNDT (Nee et al., 2013). 
The NM used in their study was cervical lateral glides and neural sliding 
exercises. Nee et al. (2013) reasoned that the patients with neuropathic pain 
and decreased elbow range with the ULNDT1 represented a group with a 
more sensitised nervous system and therefore the techniques were not as 
effective in this group of patients. Follow-up in this study was at five to six 
weeks.  At this point in this study there were no significant differences 
between the groups. It is thus possible that Nee et al. (2012b) may have seen 
a difference at six months in patients with neuropathic pain as was the case in 
this study. The patients with neuropathic pain were significantly better 
(p=0.01) in the IG compared to the UC at six months and although the 
difference at 12 months was not significant there was still almost a point 
difference between the two groups favouring the IG.   
Santos et al. (2015) found that NM relieves pain by modulating endogenous 
analgesia in rats with neuropathic pain. The rats also showed improvements 
in mobility and strength following NM. In another study they also found that 
NM resulted in a reduction of hyperalgesia and allodynia (Santos et al., 2012). 
The effect of NM on the group of patients with neuropathic pain in this study 
  158 
could possibly be due to similar changes. The fact that a significant difference 
between the groups was only visible at six months was unexpected. The 
length of time for these changes to be observed lends credibility to the 
argument of neurophysiological changes being responsible for the 
improvement in pain. 
Joint mobilisation / manipulation has also been shown to have a hypoalgesic 
treatment effect (Bialosky et al., 2009a, Bialosky et al., 2014, Voogt et al., 
2014). The combination of exercise and mobilisation has a medium and long-
term (one year follow-up) effect on pain in chronic non-specific/ mechanical 
neck pain (Miller et al., 2010, Walker et al., 2008). More recently a systematic 
review found moderate improvement at long-term follow-up with mobilisation 
in acute neck pain (Gross et al., 2015). Similarly exercise improves pain and 
function in short and long term follow-up (Gross et al., 2016). This could 
possibly explain the fact that there was no longer a significant difference 
between the groups at the 12-month follow-up. 
7.4.2 The influence of demographics 
The only demographic factor that had a significantly negative effect on pain 
was the presence of paraesthesia (p=0.01). The presence of paraesthesia 
was reported in 53.5% of the study population. The high prevalence of 
paraesthesia can be expected in this study sample with a high prevalence of 
neurological changes (75%). It has also been described as a symptom 
frequently present in nerve-related conditions such as cervico-brachial pain 
(Hall and Elvey, 1999, Moloney et al., 2011). Sensory profiles of patients with 
non-specific arm pain and cervical radiculopathy differ (Moloney et al., 2013). 
In non-specific arm pain there is widespread sensitivity to thermal and 
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pressure pain whilst in cervical radiculopathy thermal and vibratory 
hypoaesthesia together with localized cold and pressure pain sensitivity is 
present (Moloney et al., 2013). In this study population there has been no 
attempt to differentiate between the two groups, therefore both sensory 
profiles were probably present. In a study on the sensory profiles of patients 
with neuropathic pain, Freeman et al. (2014) found that there was a strong 
correlation between pain intensity and presence of paraesthesia in patients 
with HIV neuropathic pain and diabetic peripheral neuropathy. This could 
possibly explain the impact of paraesthesia on pain. The presence of 
paraesthesia was only established at baseline and no follow-up was done to 
establish whether paraesthesia was still present at 12 months. Considering 
the impact of the presence of paraesthesia on pain, it is important to take note 
of this during evaluation of a patient, and to reassess its presence after 
intervention.  
7.4.3 Summary 
In patients with cervico-brachial pain, NM added to usual care, consisting of 
cervical and thoracic mobilisation, exercise and advice to stay active, 
improved pain significantly more than the treatment without the addition of 
NM, at six-month follow-up; however, at 12 months follow-up the difference 
was no longer significant. This difference was more marked in patients with a 
neuropathic pain component. In light of the fact that neuropathic pain can 
contribute to central sensitisation and chronic pain states (Berger et al., 2011), 
early treatment for these patients is important. As stated before, neuropathic 
pain leads to higher pain, disability (Baron et al., 2016, Jensen et al., 2001, 
Smart et al., 2012a), poor treatment outcomes and higher cost (Schmidt et al., 
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2009).  
 
7.5  The effect of NM on function 
The impact that a condition has on an individual’s function is important to the 
patient, society and employers (Turner et al., 2004, Üstün et al., 2010). 
Functional limitation and disability contributes to the burden of disease (Hoy et 
al., 2014) and the impact of neck pain on an individual. There was no 
significant difference between groups at any of the follow-up measurements 
although both groups improved significantly over time in terms of function as 
measured by the PSFS. The improvement was maintained at the 12-month 
follow-up. The improvement was also clinically meaningful for this patient 
population (IG mean at baseline 4.46 and UC 4.75 compared to IG mean at 
12 months 8.79 and UC 8.9 i.e. a change of more than 4). Young et al. (2010) 
found the minimal clinically important difference of the PSFS to be 2.2. As is 
the case with pain, studies found that function would improve over the first six 
and a half weeks after onset of neck pain with no further improvement up to 
12 months (Hush et al., 2011). Contrary to this finding the patients in both 
groups kept on improving up to 12 months. However, at 12 months follow-up 
just over 30% (IG n=17; UC n=8) of patients had regained full function. The 
findings of this study therefore support the use of cervical and thoracic joint 
mobilisation in combination with exercises (Côté et al., 2016, Gross et al., 
2009) to improve function in patients with cervico-brachial pain. The addition 
of NM does not add anything to treatment outcome in terms of function. As 
has been discussed for pain, the study population prognosis in terms of full 
functional recovery is poor. Given this finding for pain and function, 
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recommendations about the benign nature of especially cervico-brachial pain, 
should be reconsidered. It may be important to inform patients that it is not 
unusual to still have some pain and functional limitations at 12 months after 
onset of pain.  
Similar to the findings of this study, Langevin et al. (2015) reported a 
significant improvement in disability using the Neck Disability Index (NDI) and 
the Disability of Arm, Shoulder and Hand (DASH) questionnaires in both 
groups receiving mobilisation, traction and exercise for patients with cervical 
radiculopathy, but there were no between group differences. They compared 
foraminal opening techniques to other mobilisation techniques of the neck.  
Four other studies, however, found significant improvement in the NDI in the 
groups receiving NM compared to mobilisation and exercise (Anwar et al., 
2015), interferential therapy, traction and exercise (Nar, 2014), exercise and 
advice to stay active (Gupta and Sharma, 2012) and NM and exercise 
compared to exercise only (Ragonese, 2009). Another study found that the 
“number needed to treat” favoured the group receiving NM compared to 
advice to stay active (Nee et al., 2012b).  
With the exception of a high risk of bias study by Anwar et al. (2015), the 
other studies did not have mobilisation as part of the treatment for the 
comparison group. Although NM did not contribute to improvement in function 
in this study, comparing the results from the other studies (Anwar et al., 2015, 
Gupta and Sharma, 2012, Nar, 2014, Nee et al., 2012b, Ragonese, 2009), it 
seems as if exercise alone is not enough to improve disability. In a systematic 
review with meta-analysis, Bertozzi et al. (2013) concluded that exercise 
improves pain in chronic non-specific neck pain, but does not have a 
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significant effect on disability. It seems as if the combination of mobilisation 
and exercise has a better effect on function than either alone. This is in line 
with guideline recommendation (Childs et al., 2008, Côté et al., 2016) and 
systematic reviews (Gross et al., 2016, Gross et al., 2015, Miller et al., 2010). 
Function and/or disability were evaluated in only six of the ten studies on NM 
for cervico-brachial pain and cervical radiculopathy (Anwar et al., 2015, Gupta 
and Sharma, 2012, Langevin et al., 2015, Nar, 2014, Nee et al., 2012b, 
Ragonese, 2009). As functional limitations play an important role in the 
presentation of this patient group, measurement of function should be an 
important aspect to assess in cervico-brachial pain. 
A review on exercise for neuropathic pain (Dobson et al., 2014) concluded 
that exercise improves nerve function, neuropathic pain, sensory  dysfunction 
and functional mobility. Another review also recommends exercise as safe 
and beneficial for neuropathic pain (Cooper et al., 2016). These findings may 
in part explain the fact that there were no differences between the IG and UC 
for patients with neuropathic pain as both groups received exercises as part of 
the treatment regime.  
Turner et al. (2004) found that in patients with low back pain, there were 
distinct groups, and that for the group with pain of seven to ten out of ten; a 
decrease of two points was necessary for improvement in disability compared 
to a decrease of one out of ten in the group with less pain. In Carpal Tunnel 
Syndrome the relationship was not as linear. It seems clear that a decrease in 
pain will lead to an improvement in function. It is therefore plausible that the 
significant decrease of pain from baseline to 12 months in both groups 
contributed to the improvement in function. Initially pain decreased more than 
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2 points which is necessary for improvement in function (Turner et al., 2004). 
At six months when there was a significant difference in pain between groups 
the median pain was below four and therefore a decrease of one point would 
be enough to lead to an improvement in function, further explaining the non-
significant between group difference at six months. 
Psychosocial factors have also been shown to have an effect on disability and 
function (Feleus et al., 2007, Lee et al., 2016, Peters et al., 2005, Vranceanu 
et al., 2009). In this study the only psychosocial aspect measured was pain 
catastrophising. The presence of catastrophising had no effect on function in 
this study population. This is similar to a systematic review by Lee et al. 
(2015) who found self-efficacy and psychological distress mediated the role 
between pain and disability, but not catastrophising. 
 
7.6 The effect of NM on quality of life 
Both groups improved significantly over time in terms of the health state of the 
EQ5D, but there were no between group differences at any time-points. The 
addition of NM to the treatment regime of the IG did not add to improved 
health related quality of life. Only one study on NM for carpal tunnel syndrome 
measured quality of life and the group receiving NM did not improve as much 
as the group receiving tendon gliding exercises, splinting and paraffin baths 
(Horng et al., 2011). None of the other studies on NM identified in the 
systematic review (Basson et al., 2015b) evaluated quality of life. 
Considering the high burden of disease of neck pain (Hoy et al., 2014), 
measuring the quality of life of patients with neck pain is important. Spinal 
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pain is associated with lower function and quality of life equal to that of other 
chronic diseases such as chronic obstructive pulmonary disease and 
rheumatoid arthritis (Fanuele et al., 2000). Furthermore, patients with neck 
and radiating arm pain have more pain and disability than those with only 
neck pain (Daffner et al., 2003). More than half of the study population had 
neuropathic pain and this is also associated with higher pain and disability 
and poor quality of life (Smart et al., 2012a, Smith et al., 2007, Sterling and 
Pedler, 2009). 
The EQ5D domains of pain, followed by usual activities and then anxiety and 
depression were most affected. This is similar to the findings of a population 
based sample of patients with musculoskeletal diseases (Picavet and 
Hoeymans, 2004). They concluded that people with musculoskeletal diseases 
have a significantly lower quality of life compared to the general population. In 
this study all domains improved over the 12-month period except for mobility, 
which remained about the same. This is not unexpected, as problems with 
mobility would probably not be directly related to the presence of cervico-
brachial pain.   
A number of demographic factors had an impact on the health state of the 
EQ5D. The area of pain was associated with a worse quality of life with the 
exception of pain in the lower arm. This could be due to less than 6% of 
patients having pain in this area. The finding that radiating pain is associated 
with poorer quality of life is similar to other studies that found neck and 
radiating pain to be associated with more pain, disability and poor quality of 
life (Daffner et al., 2003, Huisstede et al., 2008). 
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Dizziness is commonly associated with neck pain (Leaver et al., 2013b, Reid 
et al., 2015). The presence of dizziness in persons with neck pain may be due 
to a number of factors such as disturbed postural control, neck movement 
control, head and neck awareness and oculomotor disturbances (Kristjansson 
and Treleaven, 2009). In this study sample 24.4% reported dizziness 
associated with their cervico-brachial pain and it had a significantly negative 
effect on quality of life (p=0.0001). Reid et al. (2015) also found dizziness to 
have a substantial effect on the functional, emotional and physical wellbeing 
of patients. Complaints of dizziness should therefore be taken seriously as 
this has such a significant impact on quality of life. 
The presence of paraesthesia also had a significantly negative effect  
(p=0.001) on patient’s quality of life. Whilst this can be observed in clinical 
practice with anecdotal reports of interference with sleep and concentration, 
literature to support this could not be found. Future studies should assess for 
the presence of paraesthesia before and after treatment. 
Other factors that had a significant effect on quality of life were the number of 
hours sitting per day (p=0.02) and the presence of headache (p=0.03). Sixty 
per cent of the study population had sedentary occupations. However, 
occupation did not have a significant effect on pain, function or quality of life.  
Some studies have shown a relationship between hours of computer use and 
neck/shoulder/arm pain (Jensen, 2003, Smith et al., 2009, Waersted et al., 
2010) and found that longer hours sitting in front of a computer was 
associated with an increase in pain and especially hand and wrist symptoms. 
In a study on the effect of hours sitting in an older population, it was found that 
especially the physical domain (using the World Health Organisation Quality 
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of Life instrument) and social participation were affected adversely in those 
that sat for longer (Meneguci et al., 2015). Physical activity, on the other hand 
enhances all dimensions of quality of life (Gill et al., 2013). However, here 
regular exercise did not have a significant effect on quality of life. Therefore it 
seems as if sustained positions and posture have more of an impact on 
quality of life in cervico-brachial pain. This is supported by a study that found 
sitting posture, especially sitting with the neck flexed to be a risk factor for 
developing neck pain (Ariëns et al., 2001). 
The last factor that had a significant impact on quality of life was the presence 
of headache. Headache is commonly associated with neck pain (Ashina et al., 
2015, Leaver et al., 2013b, Smith et al., 2009) and 58% of this study sample 
complained of headache. The presence of headache has been shown to have 
a negative effect on function, emotions, concentration, close relationships and 
quality of life (Diener, 2001, Lantéri-Minet et al., 2010, Zimmer et al., 2014). 
The presence of headache in neck pain is also associated with poor treatment 
outcomes (Leaver et al., 2013b). The co-existence of musculoskeletal 
conditions is common and the presence of multiple musculoskeletal 
conditions results in a group whose quality of life is most adversely affected 
(Picavet and Hoeymans, 2004). 
There are multiple factors that should be taken into account in terms of quality 
of life when assessing patients. Although certain aspects cannot be modified 
by treatment interventions, others, such as dizziness and headache can often 
be successfully treated with the management strategy used in this study 
(Childs et al., 2008, Côté et al., 2016, Reid et al., 2015). However, the 
addition of NM did not contribute to improved quality of life when compared to 
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the UC. 
 
7.7 Patient’s perspective of change in their 
condition  
The perception of treatment effect was measured using the Global Rating of 
Change questionnaire at six weeks, as this was the primary treatment 
endpoint. It was expected that there would be a between group difference at 
this point. However, there were no significant differences between groups. 
This supports the findings that pain, function and quality of life had all 
improved significantly but that there were no between group differences at six 
weeks. The majority of participants reported an improvement of “better” to 
“completely recovered” (3-5 on a scale of -5 to 5). This is probably a reflection 
of the significant improvement observed in pain, function and quality of life in 
both groups.  
Only one study on NM for nerve-related neck and arm pain has measured the 
Global Rating of Change (Nee et al., 2012b). In their study the “number 
needed to treat” (NNT) favoured the NM group in comparison to advice to 
continue activities. Although there was not a significant difference between 
groups in this study, the IG was compared to an effective UC treatment. In a 
study on patient satisfaction with musculoskeletal care in Australia, patients 
specifically valued interpersonal aspects, advice on their condition and self-
management (Hush et al., 2012). Both groups had advice and received 
personal attention and treatment. This could have added to the perceived 
improvement in the condition of both groups. Both management strategies (IG 
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and UC) of patients with acute /sub-acute cervico-brachial pain resulted a 
perceived improvement at six weeks follow-up. 
 
7.8 Number of treatments 
The mean number of treatments given in both groups was four. In other 
studies on cervico-brachial pain and cervical radiculopathy the number of 
treatments varied greatly from only one treatment (Coppieters et al., 2003b, 
Marks et al., 2011) to treatment administered over a six-month period (Anwar 
et al., 2015). More commonly five to ten treatments were documented (Gupta 
and Sharma, 2012, Kumar, 2010, Langevin et al., 2015, Nar, 2014, 
Ragonese, 2009). Only one other study used four treatments (Nee et al., 
2012b) and the NNT favoured the NM group in terms of pain and disability 
when compared to advice to stay active.  
There were, however, significantly more patients in the UC group (p=0.03) 
that needed between seven and nine treatments compared to the IG. All the 
patients that needed more treatment in the IG had neuropathic pain at 
baseline. This can be expected as studies frequently report that these patients 
are poor responders to treatment (Berger et al., 2004, Smith et al., 2007, 
Sterling and Pedler, 2009) and cost of care is substantially higher than 
patients with nociceptive pain (Schmidt et al., 2009).  
Other factors also related to treatment outcomes are social class, 
catastrophising, anxiety and depression, severity of baseline neck pain and 
disability, presence of comorbid back pain, and older age (Hill et al., 2007). 
Patients in this study had a high level of pain and low functional capacity but 
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despite this, the majority of patients only needed four treatments. Of the 
patients that needed more treatments, two patients in each group were 
catastrophisers. It is therefore not possible to assess if catastrophising could 
account for the need for more treatment. Anxiety and depression were not 
evaluated in this study except for the anxiety/depression domain of the EQ5D. 
In the IG only one patient had extreme anxiety/depression and one had 
moderate anxiety/depression. In the UC only one patient had moderate 
anxiety/depression. It is therefore difficult to know whether anxiety/depression 
had an influence on the number of treatments needed.  
Patient expectations have been shown to influence treatment outcomes 
(Bishop et al., 2013, Hill et al., 2007). It is possible that patients in the UC did 
not expect as much benefit from treatment as those in the IG. However, it was 
explained to them that they were receiving evidence informed treatment. 
Using a sham treatment in the usual care group may have made the two 
groups more comparable as the IG had an extra intervention (NM) in 
comparison to the UC. Treatment expectations may not have been similar 
even though both groups had an active intervention. The fact that both groups 
improved significantly could account for the mean number of treatments to be 
equal in both groups.  
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7.9 The influence of neuropathic pain on pain, 
function and quality of life in patients with 
cervico-brachial pain 
Neuropathic pain is defined as “pain caused by a lesion or disease of the 
somatosensory nervous system” (International Association for the Study of 
Pain, 2011) (web page). Neuronal damage causes maladaptive changes in 
the nociceptive pathways such as altered gene expression and changes in ion 
channels (Zhou and Luo, 2015), neuro-immune interactions (Thacker et al., 
2007) and aberrant synaptic connectivity (Costigan et al., 2009).  Neuropathic 
pain is associated with cervico-brachial pain and cervical radiculopathy, 
especially in the presence of negative neurological symptoms such as loss of 
sensation, reflexes and muscle weakness (Hall and Elvey, 1999, Nee and 
Butler, 2006).  
Fifty two per cent of the study population presented with neuropathic pain at 
baseline as defined by the DN4 (Bouhassira et al., 2005). Other studies have 
found that the incidence of neuropathic pain in musculoskeletal conditions is 
under recognised (Freynhagen and Baron, 2009, Tampin et al., 2013a). The 
high percentage of patients with a predominantly neuropathic pain component 
could possibly be ascribed to the presence of referred pain of neural origin 
(Tampin et al., 2013a) and the high incidence of negative neurological 
changes found in the study population (78.3%). At 12 months the percentage 
of patients who still presented with neuropathic pain was 12.8%. This is higher 
than the prevalence of neuropathic pain in a nationwide survey (23712 
respondents), which reported a prevalence of 6.9% (Bouhassira et al., 2008). 
The high prevalence of neuropathic pain in this study population might in part 
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explain the findings of other studies that patients with nerve-related neck and 
arm pain are more disabled and have more pain than patients with only neck 
pain (Daffner et al., 2003, Sarquis et al., 2016).  
The number of patients that could be classified with neuropathic pain at 12 
months follow-up (n=11; 12.8%) was significantly less than at baseline (n=45; 
52.3%) (p<0.0001). It seems as if the IG treatment as well as the UC 
treatment was effective in reducing the number of patients with neuropathic 
pain. However, it is also possible that a neuropathic pain presentation in the 
acute/sub-acute population may resolve over time. As the presence of 
neuropathic pain is often the driver behind the development of chronic pain 
(Baron et al., 2016, Freynhagen and Baron, 2009, Moalem and Tracey, 2006), 
the fact that the number of patients with neuropathic pain decreased 
significantly can have an important impact on long-term treatment outcomes. 
A study on neuropathic pain in acute whiplash-associated disorder (Sterling 
and Pedler, 2009) found 34% of their study population presented with pain of 
predominantly neuropathic origin. As has been discussed before, these 
patients presented with a more complex pain presentation and higher 
disability. In a study on the incidence of neuropathic pain in an acute pain 
service (Hayes et al., 2002), the incidence was between 1-3%, however, 55% 
of these patients had on-going pain at 12 months follow-up despite aggressive 
multimodal treatment. Therefore identifying patients with neuropathic pain in 
the acute phase and treating them effectively is very important. The incidence 
of neuropathic pain in a group of patients with chronic cervical radiculopathy 
and non-specific neck and arm pain was 25.8% (Tampin et al., 2013b). At 
follow-up, the percentage patients in this study, who could still be classified as 
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having neuropathic pain was about half the number in the study by Tampin et 
al. (2013b). It therefore seems as if the treatment intervention in the acute 
phase (for both IG and UC), improves outcomes even for patients with 
neuropathic pain.  As neuropathic pain is a risk factor for the development of 
chronic pain (Doth et al., 2010), and early spontaneous afferent input has 
been shown to be a trigger for neuropathic pain (Xie et al., 2005), early and 
effective treatment is very important. 
At 12 months follow-up in this study, only two (both in the IG) of the seven 
patients with neuropathic pain were pain free and only three had regained full 
function. The presence of neuropathic pain therefore has negative 
implications in terms of pain-related treatment outcomes. These findings are 
similar to findings in chronic pain conditions with a predominantly neuropathic 
pain component (Baron et al., 2016, Berger et al., 2004, Lopez-de-Uralde-
Villanueva et al., 2015, Smart et al., 2012a).  
Surprisingly, there was not a significant difference between patients with 
neuropathic pain compared to those without neuropathic pain in terms of their 
health related quality of life. This is in contrast to other studies that have 
shown the presence of neuropathic pain to have a negative impact on quality 
of life (Doth et al., 2010, Smart et al., 2012a, Smith et al., 2007). It is possible 
that the impact of neuropathic pain in an acute and sub-acute population, on 
quality of life, is not as substantial as in a more chronic population. The 
significant decrease in pain in both groups from baseline to 12 months may 
have had a positive impact on the quality of life in patients (Cuesta-Vargas et 
al., 2013). Neuropathic pain is prevalent in patients with cervico-brachial pain. 
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As this is associated with higher levels of pain and disability, assessment for 
the presence of neuropathic pain is important.  
 
7.10 The influence of pain catastrophising on pain, 
function and quality of life in patients with 
cervico-brachial pain 
Pain catastrophising has emerged as one of the most powerful psychological 
predictors of pain-related outcomes (Park et al., 2016, Sullivan et al., 2001). 
The Pain Catastrophising Scale (PCS) was developed as an instrument to 
identify pain-related catastrophic thinking in clinical and non-clinical 
populations (Edwards et al., 2006, Sullivan et al., 1995). Catastrophising has 
been described as an excessively negative orientation towards any painful 
stimuli or health condition (Sullivan et al., 1995). It has been suggested as a 
multi-dimensional construct with three dimensions namely magnification, 
rumination and helplessness. Catastrophisers have been characterised as 
chronic worriers who experience higher levels of anxiety in a wide range of 
health related situations (Vasey and Borkovec, 1992). Pain catastrophising 
has been linked to high pain reports, disability, poor quality of life (Geelen et 
al., 2016, Sullivan et al., 1998) and poor treatment outcomes (Verhagen et al., 
2010). 
In this study 27% (n=23) patients could be classified as catastrophisers at 
baseline. At six months only 6% (n=5) were still catastrophisers and at 12 
months seven patients (8%) could still be classified as catastrophisers. Wirth 
et al. (2016) have shown that there is a significant improvement in 
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psychological parameters within the first month of acute/ sub-acute neck pain. 
They also found that those patients who did not show an improvement in the 
psychological parameters were more likely to report poor treatment outcomes 
(Wirth et al., 2016). Their findings are similar to this study. It seems to be 
natural for some patients to catastrophise when confronted by pain, however, 
as pain decreases the majority of patients will have a decrease in their pain 
catastrophising scores (Racine et al., 2016). It is therefore important not only 
to assess patients at the first consultation for the presence of pain 
catastrophising, but also to reassess at one-month follow-up. If pain 
catastrophising is still present once pain has decreased, other treatment 
options should be considered. 
Catastrophising has consistently been linked to poor pain related outcomes 
and high reports of pain (Karels et al., 2007, Rivest et al., 2010, Vranceanu et 
al., 2014). In this study, catastrophisers reported significantly more pain at six 
months (p=0.02) and 12 months (p=0.02) follow-up. The difference was more 
than two points on an 11-point scale which is also a clinically meaningful 
difference (Cleland et al., 2008). Furthermore, at 12 months follow-up only 
one of these patients was pain-free. Therefore the presence of 
catastrophising had a negative influence on pain related treatment outcomes 
(Catastrophisers: mean 3.56; 95% CI 1.10 – 6.02 compared to non-
catastrophisers: mean 1.47; 95% CI 0.96 – 1.99). This finding is supported by 
studies in the literature (Leung, 2012, Quartana et al., 2009).   
Racine et al. (2016) found a temporal relationship between pain and 
catastrophising, where a decrease in pain was related to a decrease in 
catastrophising scores. Therefore either targeting catastrophising could lead 
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to a decrease in pain report, or treating pain could lead to a decrease in 
catastrophising. In this study, treatment was not aimed at changing 
catastrophising, but rather at improving pain. Only eight per cent of the study 
population were still catastrophisers at 12 months follow-up and this seems to 
support the findings by Racine et al. (2016). The relationship between pain 
and catastrophising in a chronic population is multifaceted (Quartana et al., 
2009, Sullivan et al., 2001) and therefore targeting pain in a chronic 
population will probably not have the same outcomes. It therefore underlines 
the importance of treating pain effectively in the acute and sub-acute stage. 
There was no significant difference between catastrophisers and non-
catastrophisers in terms of function (p>0.05). This finding is contrary to other 
studies, which found that catastrophising negatively impacted on function 
(Arnow et al., 2011, Dimitriadis et al., 2015, Sullivan et al., 1998). It must be 
borne in mind that these observations were in a chronic population. However, 
Lee et al. (2015) found self-efficacy and psychological distress mediated the 
role between pain and disability, but not catastrophising. Only two of the 
seven patients who could still be classified as catastrophisers at 12 months, 
had regained full function. This seems to indicate that catastrophising had 
some influence on function. The small number of patients at six months (n=5) 
and 12 months (n=7) could have had an influence on the statistical analyses 
as a larger study is needed to identify differences (Hackshaw, 2008). 
Therefore the findings should be interpreted with caution; Catastrophisers: 
mean 25.14; 95% CI 20.06 – 30.22 compared to non-catastrophisers: mean 
26.75: 25.62 – 27.97. Catastrophising has also been associated with bed rest 
and immobility, which may interfere with healing mechanisms (O’Sullivan, 
  176 
2005, Verbunt et al., 2008). Whilst it may not be able to transform a 
catastrophiser to a non-catastrophiser, the frequency of catastrophising 
thoughts experienced may be reduced by strategies such as engagement in 
physical activity (Smeets et al., 2006), emotional disclosure (Keefe et al., 
2008) and activity encouragement (Smeets et al., 2006). The advice to stay 
active may have assisted some of the catastrophisers in this study. 
Pain catastrophising has been shown to have a negative impact on quality of 
life and pain related suffering (Geelen et al., 2016, Wade et al., 2011). 
Similarly this study population classified as catastrophisers reported 
significantly (p=0.002) poorer quality of life at baseline compared to non-
catastrophisers. However, at six months and 12 months follow-up there were 
no significant differences between catastrophisers and non-catastrophisers. 
Again, the small number of patients that could still be classified as 
catastrophisers at six months (n=5) and 12 months (n=7) could have 
influenced the statistical analysis. The wide 95% confidence interval in the 
group of catastrophisers (mean 84.86; 95% CI 76.66 – 93.05) compared to 
the non-catastrophisers (mean 85.2; 95% CI 82.25 – 87.92) illustrates the 
point. A larger study is therefore required to investigate findings on the effect 
of catastrophising on function and quality of life of patients with cervico-
brachial pain. 
Depression has also been shown to be associated with high pain 
catastrophising (Park et al., 2016). Five of the seven patients who could still 
be classified as catastrophisers at 12 months, had moderate to extreme 
anxiety and depression on the dimensions of the EQ5D at baseline, however, 
only three still reported moderate anxiety and depression at 12 months follow-
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up. Although the influence of depression and anxiety does not seem to have 
played such an important role in catastrophising in this study population, no 
firm conclusion can be made due to the low number of patients who could still 
be classified as catastrophisers. Information on the influence of depression on 
catastrophising in an acute cervico-brachial pain population is not known. 
However, Wirth et al. (2016) found depression at baseline and continued 
anxiety to be predictors of poor treatment outcomes in acute neck pain. 
The demographic factors that had a negative influence on catastrophising 
were longer duration of pain (p=0.04) and the presence of paraesthesia 
(p=0.01). No studies could be identified that evaluated the effect of the 
duration of pain and paraesthesia in patients with high pain catastrophising. 
The components of catastrophising such as magnification and helplessness 
could contribute to duration of pain playing a role and result in higher 
catastrophising. Therefore, the longer pain is present the more 
catastrophisers would worry about the pain, the seriousness of the problem 
and their ability to manage it. It is possible that the presence of paraesthesia 
is seen as a threatening symptom and therefore it could have a negative 
impact on catastrophising. 
Catastrophising should be evaluated in patients with cervico-brachial pain. 
Other treatment options should be considered for those patients still 
presenting with high catastrophising scores at one-month follow-up as they 
tend to have poor treatment outcomes (Wirth et al., 2016). Even though only a 
small percentage of patients continue to catastrophise at 12 months follow-up, 
they have significantly more pain (p=0.02) at follow-up than non-
catastrophisers. 
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7.11 The upper limb neurodynamic test outcomes 
The upper limb neurodynamic test 1 (ULNDT1) (Butler, 1991) evaluates the 
mechano-sensitivity of the median nerve (Greening et al., 2005). It is a valid 
way of identifying patients with peripheral neuropathic pain (Nee et al., 2012a) 
and a positive test was an inclusion criterion for this study. The elbow range of 
motion (ROM) was measured as described before (Basson et al., 2014). 
Groups were similar at baseline however, at 12 months follow-up the ROM of 
the left arm (p=0.03) and the right arm (p=0.0001) of the IG were significantly 
improved compared to the UC. A number of studies on NM for cervico-
brachial pain measured the elbow ROM of the ULNDT (Coppieters et al., 
2003b, Gupta and Sharma, 2012, Marks et al., 2011) and two of the three 
studies found a significant improvement in the group receiving NM 
(Coppieters et al., 2003b, Gupta and Sharma, 2012), whereas the other study 
reported a significant improvement in the group that received joint mobilisation 
(Marks et al., 2011). As the condition improves, it can be expected that 
mechano-sensitivity would also decrease. It seems however that a technique 
targeting the nerve improves neural mechano-sensitivity more than 
mobilisation and exercise only. Neural mechano-sensitivity can limit normal 
movement (Dilley et al., 2005) and therefore improvement in the ROM of the 
ULNDT is important for return to full function.  
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7.12  Significance of the study 
This study had a bigger study population than any of the studies identified in 
the systematic review. The systematic review identified 10 studies on nerve-
related neck and arm pain (cervico-brachial pain and cervical radiculopathy). 
Of these studies only four were low risk of bias studies. Studies had low 
numbers of study participants ranging from 20 to 40 participants with the 
exception of one study (Nee et al., 2012b) that had a study population of 60. 
The meta-analysis of the systematic review concluded that cervical lateral 
glides improve pain in cervico-brachial pain. The findings of this study support 
the meta-analysis. A meta-analysis could not be done for function or disability 
in the systematic review and in this study NM did not have an effect on 
function. The bigger study population in my study made it possible to 
investigate the impact of some of the demographic factors on pain, function 
and quality of life in this patient population.  
No studies could be identified that evaluated the effect of mobilisation along 
the course of the nerve. This technique is commonly used in clinical practice 
and has the advantage of being very gentle and therefore ideal for an acute 
population where there is often increased mechano-sensitivity of the nerves.  
There is a paucity of studies on cervico-brachial pain and especially in the 
acute / sub-acute population. The presence of neuropathic pain in an 
acute/sub-acute population with cervico-brachial pain has not been 
established. The presence of neuropathic pain has been studied in an acute 
whiplash associated disorder population (Sterling and Pedler, 2009). As 
mobilisation along the tract of the nerve is a gentle technique it had a good 
  180 
treatment effect even in this very sensitised population. The NM used in this 
study had a very positive outcome in patients with neuropathic pain. 
There was one study that treated patients over a six-month period and 
evaluated treatment at baseline and end of treatment. None of the other 
studies had a follow-up period of more than eight weeks. Therefore, this study 
could establish that treatment effect was maintained at one-year follow-up. It 
also highlighted the fact that despite a significant improvement in all treatment 
outcomes at least half of the study population still had pain and disability after 
a year. If patients had not been followed up at 6 months, the significant effect 
of NM would not have been visible. 
There are only a few studies that have assessed the impact of pain 
catastrophising on neck pain. Unfortunately at 6 months and 12 months the 
few patients who were still catastrophisers made it difficult to make any firm 
conclusions about the impact of catastrophising on cervico-brachial pain. 
Disability or function is not often measured in patients with cervico-brachial 
pain and none of the studies identified with the systematic review measured 
the quality of life of patients with cervico-brachial pain.  No other studies could 
be identified that established the effect of paraesthesia on the pain, function 
and quality of life of patients with cervico-brachial pain. 
 
7.13 Summary 
The addition of NM to the treatment had a significantly positive effect on pain 
when compared to the UC at six months follow-up especially in the group of 
patients with neuropathic pain. However, at 12 months there were no 
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significant between group differences in terms of pain, function and quality of 
life although both groups had a significant improvement in all primary 
outcomes. Despite the significant improvement in both groups in terms of all 
outcome measures, 50% - 60% of the population still had on-going pain and 
only around 30% had regained full function. The presence of neuropathic pain 
and pain catastrophising were associated with poor pain related treatment 
outcomes across the whole study population. 
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8 Chapter Eight – Conclusion 
 
This chapter contains the concluding statements of the different objectives of 
the study as well as recommendations for future research and clinical 
practice. The study limitations will also be discussed. 
 
8.1 Prevalence of neck pain and radiating arm pain 
in private physiotherapy practice in Pretoria, 
Gauteng, South Africa 
The retrospective survey of physiotherapy records revealed a high prevalence 
of neck pain and radiating arm pain seen in private physiotherapy practice in 
Pretoria. More than 50% of the survey population had radiating arm pain 
associated with their neck pain. This is similar to other studies in this field. As 
is the case in most musculoskeletal conditions, the majority of the population 
were women (63%). The median age (44) was also similar to population-
based studies (Vos et al., 2012).  
In my study shoulder pain was most commonly associated with neck pain. 
Radiating pain into the arm and hand was the second most common reported 
area of pain. Very few of the survey records reported pain in the lower arm 
associated with neck pain. Headache and pain in other areas such as the 
lower back or thoracic area were symptoms often reported with neck pain. 
Other symptoms that were often present were paraesthesia, burning and 
numbness. 
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8.2 The effect of neural mobilisation on the pain, 
function and quality of life of patients with 
cervico-brachial pain  
The patient population presented with a number of factors associated with 
poor treatment outcomes, such as high pain and functional limitation at 
baseline, presence of neuropathic pain, neurological changes, headaches and 
pain in other areas. The addition of neural mobilisation (NM) to the usual care 
resulted in improved pain at six months especially in the group of patients with 
a predominantly neuropathic pain component. Both groups improved 
significantly over the first six months and the improvement was still evident 
and maintained at 12 months follow-up. However, in the IG 50% of patients 
still had some pain at 12 months and more than 60% of the UC still had pain 
at 12 months follow-up. It is therefore evident that even though patients with 
cervico-brachial pain improve, their prognosis of being pain free is poor.  
Both groups improved significantly in terms of function and quality of life over 
the 12 month follow-up period, but there were no between group differences. 
However, a disquieting observation was the fact that only around 30% of the 
population had recovered full function at 12 months follow-up despite having 
improved significantly over the time period.  The measurement of disability is 
not routinely done in trials on cervico-brachial pain. Furthermore, quality of life 
is very rarely assessed.  
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8.3 Neuropathic pain 
More than 50% of the patient population could be classified with neuropathic 
pain. Using NM improved pain significantly for patients with neuropathic pain. 
Patients with neuropathic pain had more pain at six and 12 months follow-up 
compared to patients without neuropathic pain. They also had poorer function 
at 12 months follow-up.  
 
8.4 Pain catastrophising 
The number of patients who could be classified as catastrophisers was just 
over a quarter of the study population and this had decreased to less than 
10% at 12 months follow-up. They reported a poorer quality of life at baseline 
than non-catastrophisers. At 6 months and 12 months follow-up they also had 
significantly more pain than non-catastrophisers. Being a catastrophiser did 
not impact on function. Quality of life was also not affected, as is normally the 
case in chronic populations. 
 
8.5 Number of treatments and patient’s perception 
of change 
The mean number of treatments was four. In light of the patient population 
with high pain and disability at baseline, the number of treatments seems 
reasonable. In the UC more patients needed seven to nine treatments 
compared to the IG. The majority of patients reported being “better” to 
“completely recovered” at six weeks follow-up. 
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8.6 The upper limb neurodynamic test 
The range of motion of the elbow during the upper limb neurodynamic test 1 
(ULNDT1) had improved significantly more in the IG at 12 months follow-up 
compared to the UC.  
 
8.7 Study limitations 
The retrospective survey to establish the prevalence in physiotherapy private 
practice was a sample of convenience and included just over 1300 records. 
Therefore the findings, while useful, are not representative of a broader 
private practice population. 
The presence of neuropathic pain and pain catastrophising was only 
measured at baseline, six months and 12 months. If these were also 
measured at three weeks and six weeks like the other outcomes, it might 
have given a clearer picture of the changes in these parameters. The Global 
Rating of Change was only measured at six weeks, as this was the primary 
end-point. If this was measured at six months and 12 months as well, it may 
have made it possible to see differences that could not otherwise be 
identified. 
As not all the patients who were followed up were prepared to come in to the 
practices for the re-assessments, the dropout rate for re-measurements of the 
upper limb neurodynamic test was high. Therefore, these results should be 
interpreted with care. 
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8.8 Research recommendations 
From the retrospective survey it is clear that there is a need for a more 
representative survey to establish the prevalence of neck and radiating arm 
pain in the general population of South Africa. This is important in light of the 
impact neck pain has globally with no information on local prevalence and the 
impact thereof. 
Although there is an increase of studies on NM as is evidenced by the 
systematic review, of the 20 additional studies identified in our review, only 
eight were low risk of bias studies. There is a need for high quality studies 
with bigger study populations to investigate the effect of NM on neuro-
musculoskeletal conditions. As a number of studies have found positive 
neurophysiological changes when using NM as a treatment technique, future 
studies should endeavour to establish what changes are responsible for 
positive treatment outcomes.  
There is a need for more studies to establish the optimal treatment approach 
for cervico-brachial pain especially in an acute/sub-acute population. 
Furthermore, there is very little information on the presence of neuropathic 
pain in this population and the best management strategies to employ in this 
population. 
In light of the findings of this study, that paraesthesia had a significant impact 
on pain, function and quality of life; future studies should investigate this 
further and attempt to find treatments that will effectively address the 
presence of paraesthesia. 
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There is a need for a core set of outcomes measures that can be used in neck 
pain studies. These should include outcomes that not only assess pain, but 
disability or function and also quality of life. 
 
8.9 Clinical Recommendations 
As neuropathic pain is so prevalent in patients with cervico-brachial pain, 
clinicians should routinely screen for the presence of neuropathic pain. In the 
presence of neuropathic pain, mobilisation along the course of the nerve 
should be added to the management of these patients. Complaints of 
paraesthesia should be taken seriously and re-assessed if present.  
Given the fact that at least 50% of the population still reported some pain after 
12 months and only 30% had recovered full function, clinicians should 
consider including pain neuroscience education as part of the treatment 
approach for patients with cervico-brachial pain. 
In the presence of pain catastrophising in the acute/sub-acute population, re-
assessment should be done at one-month follow-up. If pain catastrophising is 
still present, alternative treatment strategies such as a cognitive-behavioural 
therapy should be considered. 
 
8.10 Concluding paragraph 
Cervico-brachial pain is prevalent and these patients have a complex pain 
presentation with associated factors such as neurological deficit and 
neuropathic pain. These are prognostic factors associated with poor treatment 
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outcomes. However, both groups improved significantly in terms of pain, 
function and quality of life. The addition of mobilisation along the course of the 
nerve to usual care resulted in a significant improvement in pain at six-month 
follow up and this was more pronounced in patients with neuropathic pain. 
The presence of neuropathic pain and pain catastrophising had a negative 
influence on pain-related outcomes.  
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9 Appendices 
 
Appendix 2.1: Example search strategy (PubMed/ MEDLINE) 
 
Treatment 
technique 
Management 
type 
Condition Type of study 
Nerve 
tissue/therapy[mh] 
Conservative 
intervention[tw] 
Radiculopathy[mh] Randomized 
controlled 
trial[mh] 
Nerve treatment[tw] Conservative 
approach[tw] 
Musculoskeletal 
pain[mh] 
Clinical 
trial[mh] 
Neural 
treatment[tw] 
Conservative 
management[tw] 
Referred pain[mh] Randomised 
control*[tw] 
Neurodynamic*[tw] Conservative 
therap*[tw] 
Nerve 
tissue/injuries [mh] 
Randomized 
control*[tw] 
Nerve stretch*[tw] Physical 
approach[tw] 
Radicular pain[tw] Randomised 
control trial[tw] 
Nerve tension[tw] Physical 
intervention[tw] 
Nerve pain[tw] Randomized 
control trial[tw] 
Neural tension[tw] Physical 
management[tw] 
Neuropathy[tw] Controlled 
clinical trial[tw] 
Nerve mobili*[tw] Physical 
therapy[tw] 
 Randomi*[tw] 
Neural mobili*[tw] Physiotherapy[tw]  RCT[tw] 
Nerve modalit*[tw] Manual 
therapy[tw] 
 Trial[tw] 
Neural modalit*[tw]   Placebo[tw] 
Nerve glid*[tw]   Group*[tw] 
Neural glid*[tw]    
 
Search strategy in the PubMed Advanced Search Builder: 
#1 Nerve tissue/therapy[mh] OR Nerve treatment[tw] OR Neural treatment[tw] 
OR Neurodynamic*[tw] OR Nerve stretch*[tw] OR Nerve tension[tw] OR 
Neural tension[tw] OR Nerve mobili*[tw] OR Neural mobili*[tw] OR Nerve 
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modalit*[tw] OR Neural modalit*[tw] OR Nerve glid*[tw] OR Neural glid*[tw] 
  Number of articles found 9022 
#2 Conservative intervention[tw] OR Conservative approach[tw] OR 
Conservative management[tw] OR Conservative therap*[tw] OR Physical 
approach[tw] OR Physical intervention[tw] OR Physical management[tw] OR 
Physical therapy[tw] OR Physiotherapy[tw] OR Manual therapy[tw] 
 Number of articles found 61848 
#3 Radiculopathy[mh] OR Musculoskeletal pain[mh] OR Referred pain[mh] 
OR Nerve tissue/injuries [mh] OR Radicular pain[tw] OR Nerve pain[tw] OR 
Neuropathy[tw] 
       Number of articles found 
57929 
#4 Randomized controlled trial[mh] OR Clinical trial[mh] OR Randomised 
control*[tw] OR Randomized control*[tw] OR Randomised control trial[tw] OR 
Randomized control trial[tw] OR Controlled clinical trial[tw] OR Randomi*[tw] 
OR RCT[tw] OR Trial[tw] OR Placebo[tw] OR Group*[tw])    
   Number of articles 3446845 
#1 AND #2 AND #3 AND #4     Number of articles 26  
Appendix 2.1 Search Strategy 
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Appendix 2.2 Joanna Briggs Institute Meta Analysis of Statistics Assessment 
and Review Instrument for critical appraisal (JBI-MAStARI)  
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Appendix 2.3 JBI Grades of level of evidence 
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Appendix 2.4 Excluded studies  
 
1. Bahrami et al. (2006) Reason for exclusion – article in Arabic, could 
only locate abstract in English 
2. Beneciuk et al. (2010) Reason for exclusion – healthy population 
3. Coppieters et al. (2004) Reason for exclusion – case report 
4. Castellote-Caballero et al. (2013) – healthy population 
5. Day et al. (2014) – not a randomised controlled trial 
6. De-la-Llave-Rincon et al. (2012) Reason for exclusion – not a 
randomised controlled trial 
7. Ferreira et al. (2016) Reason for exclusion – design of a trial.  
8. Leonelli et al. (2013) Reason for exclusion – other language (Italian) 
9. Lorentzen et al. (2012) Reason for exclusion – not neuro-
musculoskeletal condition 
10. Madenci et al. (2012) Reason for exclusion – massage techniques 
used not aimed at neural tissue 
11. Rodriguez Torres et al. (2015) Reason for exclusion – rheumatologic 
condition and treatment not aimed at peripheral nervous system 
12. Rozmaryn et al. (1998) Reason for exclusion – not a randomised 
clinical trial 
13. Sansare et al. (2013) Reason for exclusion – healthy population, not 
neural mobilisation 
14. Saranga et al. (2003) Reason for exclusion– healthy population 
15. Savva and Giakas (2013) Reason for exclusion – case report 
16. Schafer et al. (2011) Reason for exclusion – not a randomised clinical 
trial 
17. Sharma et al. (2011a) Reason for exclusion – not a randomised clinical 
trial 
18. Sharma et al. (2016) Reason for exclusion – healthy population, not 
testing treatment effect 
19. Sterling et al. (2010) Reason for exclusion – treatment not aimed at 
peripheral nervous system  
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20. Szlezak et al. (2011) Reason for exclusion – not neural mobilisation, 
healthy population 
21. Veras et al. (2012a) Reason for exclusion – not a neuro-
musculoskeletal condition  
22. Villafane et al. (2013) Reason for exclusion – not neuro-
musculoskeletal condition 
23. Villafane et al. (2012) Reason for exclusion – not a neuro-
musculoskeletal condition 
24. Young et al. (2009) Reason for exclusion – manual technique used not 
neural mobilisation 
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Appendix 3.1 Consent Form Prevalence 
 
Consent – Prevalence       
 
By signing below, I …………………………………..…………. agree to take part 
in a research study entitled “The prevalence of cervico-brachial pain in 
physiotherapy practice in Gauteng, South Africa” 
 
I declare that: 
 
• I have read the information sheet and consent form and it is written in a 
language with which I am fluent and comfortable. 
• I have had a chance to ask questions and all my questions have been 
adequately answered. 
• I understand that taking part in this study is voluntary and I have not 
been pressurised to take part. 
 
Signed at (place) ......................…........…………….. on (date) 
…………....……….. 2012. 
 
 
   
Signature of participant  
 
 
Declaration by Researcher  
 
I ………………………………………………… declare that: 
 
• I explained the information in this document to 
………………………………….. 
• I encouraged him/her to ask questions and took adequate time to 
answer them. 
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• I am satisfied that he/she adequately understands all aspects of the 
research, as discussed  
 
Signed at (place) ......................…........…………….. on (date) 
…………....……….. 2012. 
 
 
 
   
Signature of Researcher  
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Appendix 3.2 Information of Prevalence study 
 
INFORMATION FOR PARTICIPATING PHYSIOTHERAPISTS   
 
Study title: Prevalence of neck and radiating arm pain in physiotherapy 
practice in Gauteng.  
 
Hello, I am Annalie Basson, a physiotherapist doing my PhD at the 
University of the Witwatersrand 
 
Introduction: 
I am doing research on the prevalence of neck/shoulder/arm pain (also 
referred to as cervico-brachial pain) in physiotherapy practices in Gauteng. In 
this study we want to find out how many of the neck pain patients that we see 
in physiotherapy practice will have cervico-brachial pain. Currently the 
prevalence of neck/ shoulder/ arm pain in Gauteng is unknown.  
 
Participation:  I am requesting permission for access to your patient records 
from January 2011 to December 2011.  
 
What is involved in the study – This study is a retrospective study. The 
main aim of this study is to establish how many of the neck pain patients 
treated in physiotherapy practice in 2010 have shoulder/arm/hand (cervico-
brachial) pain. If you agree to participate in the study you will be required to 
make your patient records of the year 2010 available to us for analyses. 
Firstly files of all patients treated for neck pain will be retrieved. The data 
needed on each patient is; age, gender, area of pain and whether pain was 
due to injury or of insidious onset. We will collect the data in the practice of 
participating physiotherapists. We would like to involve as many practices as 
possible in the Gauteng area. 
 
The participant will be given pertinent information on the study while 
involved in the project and after the results are available. 
 
Confidentiality: Confidentiality of files will be maintained. Organizations that 
may inspect and/or copy your research records for quality assurance and data 
analysis include groups such as the Research Ethics Committee. 
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Contact details of researcher – Please contact me at telephone number 
0832289934 for any further information. 
 
Contact details of REC administrator and chair – for reporting of 
complaints / problems. Prof Cleaton Jones 0117171234 
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Appendix 4.1 Numerical Pain Rating Scale (NPRS) and physical 
measures 
 
Numerical Pain rating Scale                   PT no 
 
 
             Please indicate on the line the intensity of your pain today 
 
 
  
         0          1        2          3         4          5         6         7        8          9         10 
No Pain                                          Moderate Pain                        Worst Possible 
 Pain  
 
 
Reflexes: 
 
 
Sensation: 
 
 
Muscle Power: 
 
 
ULNDT1: L 
 
ULNDT1: R 
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Appendix 4.2 Patient Specific Functional Scale (PSFS) 
 
Patient Specific Functional Scale   Patient number    
Initial Assessment 
I am going to ask you to identify three important activities that you are unable to do 
or are having difficulty with as a result of your neck/shoulder/arm pain problem. 
Today, are there any activities that you are unable to do or having difficulty with 
because of your neck/shoulder/arm pain problem? (Clinician: show scale to patient 
and have the patient rate each activity). 
Follow-up Assessments: 
When I assessed you on (state previous assessment date), you told me that you had 
difficulty with (read all activities from list at a time). Today, do you still have difficulty 
with: (read and have patient score each item in the list)? 
 
Patient-specific activity scoring scheme (Point to one number): 
0  1  2  3  4  5  6  7  8  9  10 
Unable to          Able to 
perform          perform 
activity         activity to  
same level 
as before 
Activity Initial                                              
(Date) 
  
1 
 
    
2 
 
    
3 
 
    
Total score 
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Appendix 4.3 EuroQual 5D Instrument 
 
 
 
 
      
 
 
 
 
 
 
 
 
 
 
  Health Questionnaire 
    
 
           English version for South Africa 
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Patient Number ______ 
By placing a tick in one box in each group below, please indicate which 
statements best describe your own state of health TODAY. 
 
Mobility 
I have no problems in walking about  
I have some problems in walking about  
I am confined to bed  
Self-Care 
I have no problems with self-care  
I have some problems washing or dressing myself  
I am unable to wash or dress myself  
Usual Activities (e.g. work, study, housework, family or 
leisure activities) 
I have no problems with performing my usual activities  
I have some problems with performing my usual activities  
I am unable to perform my usual activities  
Pain/Discomfort 
I have no pain or discomfort  
I have moderate pain or discomfort  
I have extreme pain or discomfort  
Anxiety/Depression 
I am not anxious or depressed  
I am moderately anxious or depressed  
I am extremely anxious or depressed  
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To help people say how good or bad their state of health is, we have 
drawn a scale (rather like a thermometer) on which the best state 
you can imagine is marked 100 and the worst state you can imagine 
is marked 0. 
 
We would like you to indicate on this scale, in 
your opinion, how good or bad your own health 
is today. Please do this by drawing a line from 
the box below to whichever point on the scale 
indicates how good or bad your state of health is 
today. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Your own 
state of health 
today 
9 0 
8 0 
7 0 
6 0 
5 0 
4 0 
3 0 
2 0 
1 0 
100 
Worst  
imaginable 
state of health 
0 
Best 
imaginable 
state of health 
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Appendix 4.4 Global Rating of Change Scale 
 
Global Rating of Change         PT no  Appendix 8 
 
With respect to your neck and shoulder/arm pain, how would you describe yourself now 
compared to when you started with treatment? 
 
 
  
         -5       -4       -3         -2        -1         0         1         2        3          4         5 
 
Very much worse                          Unchanged                          Completely recovered  
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Appendix 4.5 Neuropathic Pain Diagnostic Questionnaire (DN4) 
DN4 Questionnaire        Patient number    
  
Please complete the questionnaire by ticking one answer for each item in the 4 questions 
below: 
INTERVIEW OF THE PATIENT 
Question 1:  Does the pain have one or more of the following characteristics? 
 
1 – Burning      
2 – Painful cold 
3 – Electric Shocks  
 
Question2: Is the pain associated with one or more of the following symptoms in the same 
area? 
 
 
4 – Tingling 
5 – Pins and Needles 
6 – Numbness 
7 - Itching  
 
 
EXAMINATION OF THE PATIENT 
Question 3: Is the pain located in an area where the physical examination may reveal one or 
more of the following characteristics? 
 
8 – Hypoesthesia to touch 
9 – Hypoesthesia to prick  
 
Question 4:  In the painful area, can pain be caused or increased by 
 
 
10- Brushing   
Yes No 
  
  
  
Yes No 
  
  
  
  
Yes No 
  
  
Yes No 
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Appendix 4.6 Pain Catastrophising Scale (PCS) 
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Appendix 4.7   RCT Demographic Questionnaire 
Patient Information  Patient Number________    
Please answer and tick where applicable 
Age: 
Male / female 
For how long have you had the pain and/ or symptoms?  ______ 
Have you had neck and / or arm pain before?      Yes / No 
Is the pain due to an injury or accident?     Yes / No 
Or, did the pain start without any specific incident   Yes/ No 
Schooling and Education: - Less than 12 years 
- 12 Years 
- College / University  
What is your occupation?  
How many hours a day do you sit?     _______ 
Do you participate in sport or do exercises?    Yes / No 
Do you have headaches?      Yes / No 
Do you have any dizziness?      Yes / No 
Do you have any pins and needles?     Yes / No  
Please indicate the area of your pain on the pictures below 
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Appendix 5.1 Consent Form Patient RCT 
 
Consent – Patients        
 
By signing below, I …………………………………..…………. agree to take part in a research 
study entitled “The effect of neural mobilisation on cervico-brachial pain 
 
I declare that: 
 
 I have read the information sheet and consent form and it is written in a 
language with which I am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been 
adequately answered. 
 I understand that taking part in this study is voluntary and I have not 
been pressurised to take part. 
 I may choose to leave the study at any time and will not be penalised or 
prejudiced in any way. 
 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2014. 
 
 
 
......................................................................   
Signature of participant  
 
Declaration by physiotherapist 
 
I ………………………………………………… declare that: 
 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer 
them. 
 I am satisfied that he/she adequately understands all aspects of the 
research, as discussed above 
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Signed at (place) ......................…........…………….. on (date) …………....……….. 2014. 
 
 
 
......................................................................   
Signature of physiotherapist  
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Appendix 5.2 Patient Information leaflet RCT 
 
INFORMATION FOR PATIENTS     
 
Study title: Neural mobilisation for cervico-brachial pain 
 
Hello, I am Annalie Basson, a registered physiotherapist studying at the 
University of the Witwatersrand 
 
Introduction: 
I am doing research on the influence of neural mobilisation on neck and 
shoulder/arm pain (also referred to as cervico-brachial pain). Neural 
mobilisation is a gentle technique that is applied along the nerves in the arm. 
Research is just the process to learn the answer to a question. In this study 
we want to learn if adding neural mobilization to usual physiotherapy for neck 
pain will have an effect on the pain, function and quality of life of patients with 
cervico-brachial pain. Currently neck/ shoulder/ arm pain is treated in the 
same way as neck pain alone and there is not a lot of research on the 
treatment of neck/ shoulder/ arm pain. I would like to see if we can improve 
the treatment outcomes by adding neural mobilizations. 
 
Invitation to participate:  I am inviting you to take part in this research study  
 
What is involved in the study – This study is a randomized clinical trial 
Patients will be randomly assigned to a group that receive usual 
physiotherapy for neck pain and a second group that will receive usual 
physiotherapy as well as neural mobilization. The usual physiotherapy will 
consist of mobilization of the neck, exercises and advice. This is according to 
research the best way to treat a neck. The treating physiotherapists will 
evaluate your problem and ask you to complete certain questionnaires. The 
questionnaires that you will be asked to complete will ask questions about the 
pain that you have, how the pain affects your daily activities and your quality 
of life such as dressing yourself. There is another questionnaire on how the 
pain makes you feel. The questionnaires will take about 10 to 15 minutes to 
complete. The first treatment will take about an hour and thereafter between 
half an hour and three quarters of an hour. The questionnaires and certain 
measurements will be done again at three weeks, six weeks, 6 months and 12 
months. The initial re-assessments will be arranged at times when you are 
receiving treatment. The follow-up assessments will be arranged at a time 
suitable to you. The follow up assessments will take 15 to 20 minutes. I need 
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102 patients for this study. We will be treating patients in four different private 
practices in Johannesburg and Pretoria.   
 
Benefits: Physiotherapy (as described above) has been shown to be effective 
in relieving pain and function in patients with neck pain when compared to 
patients that receive only normal care from their doctor. In clinical practice we 
have found neural mobilisations to be effective in treating arm pain. However, 
there is no research to support this finding. 
 
The participant will be given pertinent information on the study while 
involved in the project and after the results are available. 
 
Participation is voluntary, refusal to participate will involve no penalty or 
loss of benefits to which you would otherwise be entitled, and you may 
discontinue participation at any time without penalty or loss of benefits to 
which you are otherwise entitled. 
 
Confidentiality: Efforts will be made to keep personal information 
confidential.  Absolute confidentiality cannot be guaranteed.  Personal 
information may be disclosed if required by law. 
Organizations that may inspect and/or copy your research records for quality 
assurance and data analysis include groups such as the Research Ethics 
Committee. 
If results are published it may lead to cohort identification. 
 
Contact details of researcher/s – Please contact me at telephone number 
0832289934 for any further information or to report any study related adverse 
events. 
 
Contact details of REC administrator and chair – for reporting of 
complaints / problems. 
Prof Cleaton Jones 0117171234 
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Appendix 5.3 Treatment recording sheet 
Treatment Recording Sheet     Appendix 11 
Patient Number: __________ 
Date Treatment Outcome 
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Appendix 5.4 Ethical Consent form 
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Appendix 6.1 
 
Demographics  NPRS Mixed Effect = p 95% Conf Interval   Fixed effect = p 95% Conf Interval 
Age    0.9007  -.0153609    .0174488  0.9331  -.0191382    .0208461 
Gender   0.4215   -.7504157    .3139368  0.5105  -.8626698    .429669 
Duration of pain (days) 0.2373   -.0040245    .0135823  0.3625  -.0057502    .0156966 
Had neck pain before 0.4000   -.3385814    .8478083  0.4843  -.4623806    .9736396 
Accident/injury  0.3855   -.279396      .7228287  0.4662  -.3795446    .8270399 
Gradual onset  0.4715   -.6708521    .3105682  0.5489  -.7719431    .4110825 
Education   0.7143  -.4503818    .6573109  0.7565  -.5691604    .7824948 
Hours sitting/day  0.1450      0.5080 
Exercise   0.3463  -.7060903     .24789  0.4557  -.798625    .3590481 
Area of pain   0.1105      0.3269 
Dizziness   0.0504  -.0009765    1.065003  0.0985  -.1025388    1.197857 
Headache   0.0249*  .0681796     1.01083  0.0629  -.0292057    1.109123 
Pins and Needles  0.0020*  .2594739    1.157325  0.0116*  .1593464    1.256762 
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Neuropathic pain and NPRS 
Group             N      mean        Std Dev  95% Conf Interval 
 
Baseline 
Intervention  32    7.0875      1.6358  6.4977    7.6772 
Usual Care    13    7.1154 0.8193  6.6202    7.6105    
p = 0.9538 
6 months 
Intervention   9    2.9111     1.5235     1.7400    4.0821 
Usual Care     4     5.5    1.2909  3.4457    7.5542 
p = 0.0134 
12 months 
Intervention 7    2.9285 2.2440  0.8531    5.0039 
Usual Care 4    3.75     2.3629  -0.0099   7.5099 
P = 0.5802 
 
Table 7. Neuropathic pain and PSFS 
Group          N      mean         Std Dev 95% Conf Interval 
 
Baseline 
Intervention 32      14.5      6.4257  12.1832    16.8167 
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Usual Care 13      13.9230     6.3569  10.0816    17.7645 
P = 0.7856 
6 months 
Intervention 9     24.1111    3.6552     21.3014    26.9208 
Usual Care 4     23.25     5.7373     14.1206    32.3793 
P = 0.7466  
12 months 
Intervention 7       23.8571 4.8107  19.4079     28.3063 
Usual Care 4       24      4.2426     17.2490     30.7509 
P = 0.9618 
 
Neuropathic pain and health state 
Group           N      mean     Std Dev 95% Conf Interval 
 
Baseline 
Intervention 32      71     20.6100     63.5692   78.4307 
Usual Care 13    68.9230     15.50517      59.5534    78.2927  
P = 0.7454 
6 months 
Intervention 9    83.1111     14.2341     72.1697    94.0524 
Usual Care 4    79.5     15.4164       54.969     104.031 
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P = 0.6879 
12 months 
Intervention 7     77.5714    12.8174     65.7173    89.4255 
Usual Care 4 83.75         11.08678     66.1084    101.3915 
P = 0.4424 
Patients with no pain at 6 weeks between groups 
Results 
  Category 1 Category 2    Row Totals 
Group 1 UC 2  (4.53)  [1.42] 24  (21.47)  [0.30]    26 
Group 2 IG 
13  (10.47) (Doth 
et al.) 
47  (49.53) (Bossu
yt et al.) 
   60 
Column Totals 15 71    86  (Grand Total) 
The chi-square statistic is 2.46. The p-value is .116778. The result is not significant at p < .05. 
 
Patients with no pain at 6 months between groups 
  Category 1 Category 2    Row Totals 
Group 1 UC 7  (9.07)  [0.47] 19  (16.93)  [0.25]    26 
Group 2 IG 23  (20.93)  [0.20] 37  (39.07)  [0.11]    60 
Column Totals 30 56    86  (Grand Total) 
The chi-square statistic is 1.0397. The p-value is .307893. The result is not significant at p < .05. 
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Patients with no pain at 12 months between groups 
  Category 1 Category 2    Row Totals 
Group 1 UC 10  (12.09)  [0.36] 16  (13.91)  [0.32]    26 
Group 2 IG 30  (27.91)  [0.16] 30  (32.09)  [0.14]    60 
Column Totals 40 46    86  (Grand Total) 
The chi-square statistic is 0.9707. The p-value is .324497. The result is not significant at p < .05. 
 
Demographics DN4 
Demographics  DN4 Mixed Effect = p 95% Conf. Interval   Fixed effect = p 95% Conf. Interval 
Gender  0.2005   -.9450815     .202576  0.2199   -.9683493    .2276116 
Age    
Had pain before 0.3027   -.2819883    .8979934  0.3240   -.3098382    .9269332 
Duration of pain 0.6109   -.0071231    .0120145  0.6104   -.0074142    .0125112 
Accident / injury 1.0000   -.4825505    .4825275  0.9968   -.5058978    .5079756 
Gradual onset 0.9546   -.4734617    .5014993  0.9570   -.4968905    .5246238 
Education 0.4994   -.354606    .7243536  0.5170   -.3819343    .7551827 
Hours sitting per day  0.4148    
2    0.266    -2.718309    .7532119 
3    0.935    -1.206745    1.311967 
4    0.427    -1.874362    .7952548 
5    0.397     -.8372212    2.096713 
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6   0.351        -1.95241     .698947 
7   0.751       -1.612858    1.166986 
8   0.565        -1.60407    .8791441 
9   0.835       -1.933369    1.565596 
10   0.585       -.9815596       1.732 
11   0.829       -1.381388    1.718733 
12   0.777       -1.575004    2.096156 
16   0.670       -2.857188    1.843833 
Exercise  0.5499   -.6093008    .3262543  0.5798   -.6252658    .3517578 
Headache  0.0684   -.0308445    .8386445  0.0838   -.0546712    .8629553 
Dizziness  0.0650   -.0357109    1.144102  0.0720   -.0523239    1.181063 
Paraesthesia  0.0001   .6690612    1.651187  0.0001   .6475926    1.672298 
Area   0.1749 
2   0.028         .094278     1.65092 
3   0.520       -.4622191    .9097483 
4   0.699       -1.244469    .8383358 
5   0.756       -.9204903     .670617 
6   0.183       -.3331343    1.723449 
7   0.164       -.2050672    1.187303 
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Demographics PCS 
Demographics  PCS Mixed Effect = p 95% Conf. Interval   Fixed effect = p 95% Conf. Interval 
Gender  0.7401   -3.340092    2.380107  0.7465   -3.496789    2.514983 
Age  0.3212   -.0425546    .1290025  0.3340   -.0462948    .1352423 
Duration of pain  0.0319   .0052353    .1110784  0.0435   .0017341    .1130548 
Had pain before 0.8058   -2.47826    3.187703  0.8197   -2.660718    3.357858 
Accident / injury  0.4997   -4.002524     1.97935  0.5107   -4.134126    2.086218 
Gradual onset  0.6601   -2.385884    3.726237  0.6705   -2.498583    3.842464 
Education  0.6244   -3.974884    2.401497  0.6305   -4.136277    2.523526 
Hours sitting per day 0.9560    
2   0.898      -10.47692    9.192835  
3   0.747      -5.969375    8.309006 
4   0.832      -8.332626      6.7162 
5   0.676      -6.424773     9.87189  
6   0.946      -7.386854    6.894682 
7   0.796      -6.499044    8.448644 
8   0.898      -6.194899    7.054556 
9   0.913      -9.036602    8.085306 
10   0.401      -4.085475    10.15823 
11   0.635      -6.577116    10.71067 
12   0.409      -13.37063    5.493782 
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16   0.878      -13.25761    11.34195 
Exercise  0.2278   -3.84352    .9204699  0.2333   -4.07819    1.001843 
Headache  0.1118   -.4904247    4.625459  0.1293   -.6168581     4.74647 
Dizziness  0.2133   -.988009    4.402726  0.2610   -1.235717    4.524488 
Paraesthesia  0.0089   .8591798    5.835271  0.0126   .737457     5.96132 
Area   0.0602 
2   0.001       2.299533    9.662523 
3   0.114      -.8316131    7.528752 
4   0.572      -6.163534     3.40927 
5   0.610       -3.11505    5.286796 
6   0.903      -5.309298    4.689384 
7   0.168      -1.106892     6.23223 
 
 
Demographics and PSFS 
Demographics  Fixed effect = p 95% Conf. Interval 
Had pain before 0.8412       -2.16 - 1.76 
Accident   0.0167*      -3.59 - 0.36 
Gradual onset  0.0292*    0.18 - 3.36 
Education  0.3650      -2.29 - 0.84 
Hours sitting per day 0.2268 
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2   0.835      -6.02 - 4.86 
3   0.632      -5.02 - 3.05 
4   0.556      -5.58 - 3.01 
5   0.509      -5.90 - 2.93 
6   0.399      -2.37 - 5.93 
7   0.344      -5.95 - 2.08 
8   0.813      -3.45 - 4.39 
9   0.458       -3.12 - 6.93 
10   0.721      -3.40 - 4.91 
11   0.916      -4.67 - 4.19 
12   0.975      -4.98 - 4.83 
16   0.237   -2.70 - 10.94 
Exercise  0.9711      -1.60 - 1.54 
Headache  0.5788   -1.99 - 1.11 
Dizziness  0.7029   -1.44 - 2.13 
Paraesthesia  0.0010*      -3.58 - 0.92 
Area of pain  0.1098 
2   0.073      -4.29 - 0.19 
3   0.665      -2.43 - 1.55 
4   0.042        0.11 - 5.91 
5   0.494      -1.49 - 3.08 
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6   0.675      -2.23 - 3.44 
7   0.959      -2.07 - 1.96 
 
 
Demographics and Health State 
Demographics  Fixed effect = p 95% Conf. Interval 
Gender   0.936       -3.03 - 3.29 
Age   0.058      -0.19 - 0.003 
Duration of episode 0.225      -.084 - 0.02 
Had pain before 0.249       -1.44 - 5.54 
Accident/ injury 0.792       -2.52 - 3.30 
Gradual onset 0.654       -2.11 - 3.36 
Education  0.621      -4.15 - 2.48 
Hours sitting per day 0.0196* 
2   0.019      -24.95 - 2.28 
3   0.986      -8.47 - 8.32 
4   0.207        -14.35 - 3.12 
5   0.068      -17.64 - 0.64 
6   0.928      -8.10 - 8.88 
7   0.176      -14.04 - 2.58 
8   0.081      -14.75 - 0.85 
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9   0.432      -14.65 - 6.28 
10   0.082      -15.95 - 0.96 
11   0.340      -13.60 - 4.71 
12   0.858      -11.11 - 9.25 
16   0.811      -16.02 - 12.54 
Exercise  0.510       -1.86 - 3.75 
Headache  0.033*       -5.76 - 0.24 
Dizziness  0.000*      -9.33 - -3.11 
Paraesthesia  0.000*    -9.39 - -4.08 
Area of pain p=0.0000 
2   0.000      -15.53 - -6.86 
3   0.004      -9.74 - -1.85 
4 0.514       -7.37 - 3.69 
5  0.005      -10.94 - -1.94 
6 0.000       -15.65 - -4.59 
7 0.010       -8.70 - -1.20 
   
Occupation desk job Category 1 Category 2 Marginal Row Totals 
Usual Care 17   (16.02)   [0.06] 9   (9.98)   [0.1] 26 
Intervention Group 36   (36.98)   [0.03] 24   (23.02)   [0.04] 60 
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Marginal Column Totals 53 33 86    (Grand Total) 
Chi
2
 = 0.2224 p = 0.637214 
Occupation House wife 
 Category 1 Category 2 Marginal Row Totals 
UC Group 1 1   (2.42)   [0.83] 25   (23.58)   [0.09] 26 
IG Group 2 7   (5.58)   [0.36] 53   (54.42)   [0.04] 60 
Marginal Column Totals 8 78 86    (Grand Total) 
Chi
2
 = 1.3149. The p-value is .251501 
Occupation Allied Health 
 Category 1 Category 2 Marginal Row Totals 
UC Group 1 4   (2.42)   [1.03] 22   (23.58)   [0.11] 26 
IG Group 2 4   (5.58)   [0.45] 56   (54.42)   [0.05] 60 
Marginal Column Totals 8 78 86    (Grand Total) 
Chi
2
 = 1.6341. The p-value is .201143 
 
Occupation Miscellaneous  Category 1 Category 2 Marginal Row Totals 
UC Group 1 4   (5.14)   [0.25] 22   (20.86)   [0.06] 26 
IG Group 2 13   (11.86)   [0.11] 47   (48.14)   [0.03] 60 
Marginal Column Totals 17 69 86    (Grand Total) 
Chi
2
 = 0.4514. The p-value is .501687 
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Upper limb neurodynamic test elbow range of movement Usual Care 
 
UC LEFT B UC RIGHT B  UC L 6M UC R 6M UC L 12M UC R 12M 
 
145 70 140 83 173 80 
 
80 75 70 72 70 80 
 
100 80 140 148 110 80 
 
80 80 90 156 120 90 
 
130 110 110 90 153 180 
 
120 152 125 160 80 91 
 
92 68 170 135 145 180 
 
65 88 145 110 91 143 
 
80 115 90 160 110 
 
 
30 155 70 
 
182 
 
 
153 135 173 
 
153 
 
 
180 80 125 
   
  
80 
    Mean 96 80 125 135 120 90,5 
       SD 46,63421491 31,43073192 35,96526102 29,46466811 34,85377618 44,89352483 
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Upper limb neurodynamic test elbow range of movement Intervention group 
IG L EFT B IG RIGHT  B IG L 6M IG R 6M IG L 12M IG R 12M 
152 90 160 90 120 156 
120 85 120 90 120 100 
80 128 165 85 153 140 
110 70 150 160 143 153 
85 80 100 150 187 150 
110 137 160 170 142 120 
155 128 110 135 145 170 
145 105 135 90 172 130 
80 110 142 90 96 123 
135 90 120 160 130 165 
137 60 137 136 145 180 
80 90 125 140 120 172 
143 160 140 90 150 180 
60 128 130 136 180 158 
123 98 90 135 155 135 
130 131 90 140 172 132 
80 80 150 141 120 160 
90 85 180 130 172 135 
155 134 155 140 165 150 
128 123 140 110 170 90 
  229 
60 90 152 180 90 
 138 80 90 100 128 
 60 130 103 120 112 
 145 115 165 155 170 
 70 125 170 143 
  118 95 87 
   90 145 134 
   137 90 102 
   80 110 100 
   126 55 102 
   100 90 170 
   100 90 90 
   80 
     135 
     85 
     128 
     
      Mean     110 98 134 136 145 150 
      SD 
29,81032209 26,20781856 28,6289753 28,14823855 26,81252006 24,72049012 
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ULNDT Left Category 1 Category 2 Marginal Row Totals 
UC Group 1 13   (12.7)   [0.01] 13   (13.3)   [0.01] 26 
IG Group 2 29   (29.3)   [0] 31   (30.7)   [0] 60 
Marginal Column Totals 42 44 86    (Grand Total) 
Chi
2 
0.0202. The p-value is .887075. 
 
ULNDT Right Category 1 Category 2 Marginal Row Totals 
UC Group 1 12   (10.58)   [0.19] 14   (15.42)   [0.13] 26 
IG Group 2 23   (24.42)   [0.08] 37   (35.58)   [0.06] 60 
Marginal Column Totals 35 51 86    (Grand Total) 
Chi
2
 =0.4597. The p-value is .497774. 
 
ULNDT Bilateral Category 1 Category 2 Marginal Row Totals 
UC Group 1 1   (2.72)   [1.09] 25   (23.28)   [0.13] 26 
IG Group 2 8   (6.28)   [0.47] 52   (53.72)   [0.06] 60 
Marginal Column Totals 9 77 86    (Grand Total) 
Chi
2
 = 1.7425. The p-value is .186827 
 
Neurological no changes Category 1 Category 2 Marginal Row Totals 
UC Group 1 7   (6.05)   [0.15] 19   (19.95)   [0.05] 26 
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IG Group 2 13   (13.95)   [0.07] 47   (46.05)   [0.02] 60 
Marginal Column Totals 20 66 86    (Grand Total) 
Chi
2 
= 0.2808. The p-value is .596164. 
 
Neurological  Myotome Category 1 Category 2 Marginal Row Totals 
UC Group 1 11   (11.79)   [0.05] 15   (14.21)   [0.04] 26 
IG Group 2 28   (27.21)   [0.02] 32   (32.79)   [0.02] 60 
Marginal Column Totals 39 47 86    (Grand Total) 
Chi
2
 = 0.1391. The p-value is .709209. 
 
Neurological sensation Category 1 Category 2 Marginal Row Totals 
UC Group 1 16   (16.33)   [0.01] 10   (9.67)   [0.01] 26 
IG Group 2 38   (37.67)   [0] 22   (22.33)   [0] 60 
Marginal Column Totals 54 32 86    (Grand Total) 
Chi
2
 = 0.025. The p-value is .874337 
Neurological reflexes Category 1 Category 2 Marginal Row Totals 
UC Group 1 8   (7.86)    18   (18.14)   [0] 26 
IG Group 2 18   (18.14)   [0] 42   (41.86)   [0] 60 
Marginal Column Totals 26 60 86    (Grand Total) 
Chi
2
= 0.0051. The p-value is .943131 
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Neurological 2 changed Category 1 Category 2 Marginal Row Totals 
UC Group 1 9   (9.37)   [0.01] 17   (16.63)   [0.01] 26 
IG Group 2 22   (21.63)   [0.01] 38   (38.37)   [0] 60 
Marginal Column Totals 31 55 86    (Grand Total) 
Chi
2
 = 0.0331. The p-value is .855615 
 
Neurological 3 changed Category 1 Category 2 Marginal Row Totals 
UC Group 1 4   (3.63)   [0.04] 22   (22.37)   [0.01] 26 
IG Group 2 8   (8.37)   [0.02] 52   (51.63)   [0] 60 
Marginal Column Totals 12 74 86    (Grand Total) 
Chi
2
 = 0.0636. The p-value is .800938  
 
Pain free at 12 months Category 1 Category 2 Marginal Row Totals 
UC Group 1 10   (12.09)   [0.36] 16   (13.91)   [0.32] 26 
IG Group 2 30   (27.91)   [0.16] 30   (32.09)   [0.14] 60 
Marginal Column Totals 40 46 86    (Grand Total) 
Chi
2
 = 0.9707. The p-value is .324497 
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Global rating of change measured at 6 weeks – between groups  
ranksum groc,by(group) 
Two-sample Wilcoxon rank-sum (Mann-Whitney) test 
       group     |      obs    rank sum    expected 
-------------+-------------------------------- 
Intervention|       59        2633        2537 
    Protocol   |       26        1022        1118 
-------------+--------------------------------- 
    combined |       85        3655        3655 
unadjusted variance    10993.67 
adjustment for ties     -188.53 
                     ---------- 
adjusted variance      10805.14 
Ho: groc2(group==Intervention) = groc2(group==Protocol) 
             z =   0.924 
    Prob > |z| =   0.3557 
 
Number of treatments –between groups 
Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    3.916667    .2295804    1.778322    3.457277    4.376056 
Protocol |      26    4.692308    .4599974    2.345536    3.744925     5.63969 
---------+-------------------------------------------------------------------- 
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combined |      86    4.151163     .214085    1.985343    3.725504    4.576821 
---------+-------------------------------------------------------------------- 
    diff |            -.775641    .4612129               -1.692813    .1415313 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =  -1.6817 
Ho: diff = 0                                     degrees of freedom =       84 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.0482         Pr(|T| > |t|) = 0.0963          Pr(T > t) = 0.9518 
 
Number of treatments per group 
Two-sample Wilcoxon rank-sum (Mann-Whitney) test 
       group     |      obs    rank sum    expected 
-------------     +--------------------------------- 
Intervention  |       60      2501.5        2610 
    Protocol    |       26      1239.5        1131 
-------------+--------------------------------- 
    combined |       86        3741        3741 
unadjusted variance    11310.00 
adjustment for ties     -370.90 
                     ---------- 
adjusted variance      10939.10 
Ho: norx(group==Intervention) = norx(group==Protocol) 
             z =  -1.037 
    Prob > |z| =   0.2996 
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Number of DN4 + at Baseline Category 1 Category 2 Marginal Row Totals 
UC Group 1 13   (13.6)   [0.03] 13   (12.4)   [0.03] 26 
IG Group 2 32   (31.4)   [0.01] 28   (28.6)   [0.01] 60 
Marginal Column Totals 45 41 86    (Grand Total) 
Chi
2
 = 0.0808. The p-value is .776223 
 
Number of +DN4 at 6 months Category 1 Category 2 Marginal Row Totals 
UC Group 1 4   (3.93)   [0] 22   (22.07)   [0] 26 
UC Group 2 9   (9.07)   [0] 51   (50.93)   [0] 60 
Marginal Column Totals 13 73 86    (Grand Total) 
Chi
2
 = 0.0021. The p-value is .963525 
 
Number of DN4+ at 12 months Category 1 Category 2 Marginal Row Totals 
UC Group 1 4   (3.33)   [0.14] 22   (22.67)   [0.02] 26 
IG Group 2 7   (7.67)   [0.06] 53   (52.33)   [0.01] 60 
Marginal Column Totals 11 75 86    (Grand Total) 
Chi
2
 = 0.2248. The p-value is .635415 
 
PCS+ at Baseline Category 1 Category 2 Marginal Row Totals 
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UC Group 1 5   (6.95)   [0.55] 21   (19.05)   [0.2] 26 
IG Group 2 18   (16.05)   [0.24] 42   (43.95)   [0.09] 60 
Marginal Column Totals 23 63 86    (Grand Total) 
cHI
2 
= 1.0738. The p-value is .300088 
 
PCS + at 6 months Category 1 Category 2 Marginal Row Totals 
UC Group 1 1   (1.51)   [0.17] 25   (24.49)   [0.01] 26 
IG Group 2 4   (3.49)   [0.08] 56   (56.51)   [0] 60 
Marginal Column Totals 5 81 86    (Grand Total) 
Chi
2
 = 0.2635. The p-value is .607708. 
 
PCS + at 12 months Category 1 Category 2 Marginal Row Totals 
UC Group 1 2   (2.12)   [0.01] 24   (23.88)   [0] 26 
IG Group 2 5   (4.88)   [0] 55   (55.12)   [0] 60 
Marginal Column Totals 7 79 86    (Grand Total) 
Chi
2
 = 0.01. The p-value is .920468 
 
NPRS Baseline 
Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60        6.87    .2118029    1.640618    6.446183    7.293817 
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Protocol |      26    7.019231    .2138309    1.090328    6.578838    7.459624 
---------+-------------------------------------------------------------------- 
combined |      86    6.915116    .1607652    1.490876    6.595472    7.234761 
---------+-------------------------------------------------------------------- 
    diff |           -.1492308    .3517494                -.848723    .5502615 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =  -0.4243 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 
 Pr(T < t) = 0.3362         Pr(|T| > |t|) = 0.6725          Pr(T > t) = 0.6638 
 
 
 
 
NPRS 3 weeks 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60     3.37948    .2688833    2.082761    2.841446    3.917514 
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Protocol |      26    3.741842     .521669    2.660001    2.667444    4.816239 
---------+-------------------------------------------------------------------- 
combined |      86    3.489031    .2439998    2.262761    3.003894    3.974168 
---------+-------------------------------------------------------------------- 
    diff |           -.3623615    .5329713               -1.422233    .6975105 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =  -0.6799 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
  
Pr(T < t) = 0.2492         Pr(|T| > |t|) = 0.4984          Pr(T > t) = 0.7508 
 
NPRS 6 weeks 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    2.950316    .3309773     2.56374    2.288032      3.6126 
Protocol |      26    3.523077    .4920071    2.508754    2.509769    4.536385 
---------+-------------------------------------------------------------------- 
combined |      86    3.123476    .2745696    2.546254    2.577558    3.669394 
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---------+-------------------------------------------------------------------- 
    diff |           -.5727612    .5981373               -1.762223    .6167005 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =  -0.9576 
Ho: diff = 0                                     degrees of freedom =       84 
 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.1705         Pr(|T| > |t|) = 0.3410          Pr(T > t) = 0.8295 
 
NPRS 6 months 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    1.540377    .2626107    2.034174    1.014894     2.06586 
Protocol |      26    2.647692    .4584332     2.33756    1.703531    3.591853 
---------+-------------------------------------------------------------------- 
combined |      86    1.875147     .234792    2.177371    1.408317    2.341976 
---------+-------------------------------------------------------------------- 
    diff |           -1.107315    .4998742                -2.10137   -.1132607 
------------------------------------------------------------------------------ 
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    diff = mean(Interven) - mean(Protocol)                        t =  -2.2152 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 
 Pr(T < t) = 0.0147         Pr(|T| > |t|) = 0.0295          Pr(T > t) = 0.9853 
 
NPRS 12 months 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60     1.33954    .2653804    2.055628    .8085146    1.870565 
Protocol |      26    2.370043    .5072743    2.586602    1.325292    3.414794 
---------+-------------------------------------------------------------------- 
combined |      86    1.651087    .2441761    2.264396      1.1656    2.136575 
---------+-------------------------------------------------------------------- 
    diff |           -1.030503    .5228692               -2.070286    .0092793 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =  -1.9709 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
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 Pr(T < t) = 0.0260         Pr(|T| > |t|) = 0.0520          Pr(T > t) = 0.9740 
 
PSFS Baseline 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    13.58333    .8424781    6.525807    11.89754    15.26913 
Protocol |      26    14.26923     1.22858    6.264552    11.73892    16.79954 
---------+-------------------------------------------------------------------- 
combined |      86     13.7907    .6921716    6.418936    12.41448    15.16692 
---------+-------------------------------------------------------------------- 
    diff |           -.6858974    1.514224               -3.697097    2.325302 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =  -0.4530 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
  
Pr(T < t) = 0.3259         Pr(|T| > |t|) = 0.6517          Pr(T > t) = 0.6741 
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PSFS 3 weeks 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    20.92939    .8771085    6.794053     19.1743    22.68448 
Protocol |      26    20.75341    1.426372    7.273097    17.81574    23.69107 
---------+-------------------------------------------------------------------- 
combined |      86    20.87619    .7440048    6.899617     19.3969    22.35547 
---------+-------------------------------------------------------------------- 
    diff |            .1759826     1.62949               -3.064436    3.416401 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =   0.1080 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 
 Pr(T < t) = 0.5429         Pr(|T| > |t|) = 0.9143          Pr(T > t) = 0.4571 
 
PSFS 6 weeks 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
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   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    22.75731    .9608929    7.443044    20.83457    24.68005 
Protocol |      26    22.32593    1.385342    7.063888    19.47276     25.1791 
---------+-------------------------------------------------------------------- 
combined |      86    22.62689    .7862858    7.291715    21.06355    24.19024 
---------+-------------------------------------------------------------------- 
    diff |             .431378    1.721568               -2.992149    3.854905 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =   0.2506 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 
 Pr(T < t) = 0.5986         Pr(|T| > |t|) = 0.8028          Pr(T > t) = 0.4014 
 
PSFS 6 months 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    25.55664    .6944617    5.379278    24.16703    26.94626 
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Protocol |      26     25.2716    .9985225    5.091486    23.21511     27.3281 
---------+-------------------------------------------------------------------- 
combined |      86    25.47047    .5678114    5.265666     24.3415    26.59943 
---------+-------------------------------------------------------------------- 
    diff |            .2850388    1.243295                -2.18739    2.757468 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =   0.2293 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 
 Pr(T < t) = 0.5904         Pr(|T| > |t|) = 0.8192          Pr(T > t) = 0.4096 
 
PSFS 12 months 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    26.38526    .7309055    5.661569    24.92272    27.84779 
Protocol |      26    26.72498    .8927453    4.552126    24.88634    28.56362 
---------+-------------------------------------------------------------------- 
combined |      86    26.48796    .5743358    5.326171    25.34603     27.6299 
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---------+-------------------------------------------------------------------- 
    diff |           -.3397254    1.257428                -2.84026    2.160809 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =  -0.2702 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 
 Pr(T < t) = 0.3938         Pr(|T| > |t|) = 0.7877          Pr(T > t) = 0.6062 
 
EQ5D Health state Baseline 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    72.43333    2.534883    19.63512    67.36104    77.50562 
Protocol |      26    72.38462    3.131024    15.96515    65.93615    78.83308 
---------+-------------------------------------------------------------------- 
combined |      86     72.4186    1.995855     18.5088    68.45031     76.3869 
---------+-------------------------------------------------------------------- 
    diff |            .0487179    4.371542               -8.644573    8.742009 
------------------------------------------------------------------------------ 
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    diff = mean(Interven) - mean(Protocol)                        t =   0.0111 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
  
Pr(T < t) = 0.5044         Pr(|T| > |t|) = 0.9911          Pr(T > t) = 0.4956 
 
EQ5D Health state 3 weeks 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    80.66938    1.427559    11.05782    77.81285    83.52592 
Protocol |      26    79.17925    2.950915    15.04677    73.10173    85.25678 
---------+-------------------------------------------------------------------- 
combined |      86    80.21888    1.329177    12.32628    77.57612    82.86164 
---------+-------------------------------------------------------------------- 
    diff |            1.490129    2.906769                 -4.2903    7.270558 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =   0.5126 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
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 Pr(T < t) = 0.6952         Pr(|T| > |t|) = 0.6095          Pr(T > t) = 0.3048 
 
EQ5D Health state 6 weeks 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    84.05784    1.427413     11.0567    81.20159    86.91408 
Protocol |      26    82.96154    2.324108    11.85067    78.17495    87.74813 
---------+-------------------------------------------------------------------- 
combined |      86     83.7264    1.212427    11.24358    81.31577    86.13703 
---------+-------------------------------------------------------------------- 
    diff |            1.096297    2.652898               -4.179281    6.371874 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =   0.4132 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 
 Pr(T < t) = 0.6598         Pr(|T| > |t|) = 0.6805          Pr(T > t) = 0.3402 
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EQ5D Health state 6 months 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    85.28644    1.415494    10.96437    82.45404    88.11883 
Protocol |      26    83.72292    2.091442     10.6643    79.41551    88.03032 
---------+-------------------------------------------------------------------- 
combined |      86    84.81375    1.168461    10.83586    82.49053    87.13696 
---------+-------------------------------------------------------------------- 
    diff |            1.563518    2.553602                 -3.5146    6.641636 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =   0.6123 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 
 Pr(T < t) = 0.7290         Pr(|T| > |t|) = 0.5420          Pr(T > t) = 0.2710 
 
EQ5D Health State 12 months 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
  249 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
Interven |      60    86.14834    1.444462    11.18876    83.25798     89.0387 
Protocol |      26    83.19382    2.621993     13.3696    77.79372    88.59391 
---------+-------------------------------------------------------------------- 
combined |      86    85.25511    1.281944    11.88826    82.70626    87.80396 
---------+-------------------------------------------------------------------- 
    diff |            2.954525     2.78929               -2.592284    8.501335 
------------------------------------------------------------------------------ 
    diff = mean(Interven) - mean(Protocol)                        t =   1.0592 
Ho: diff = 0                                     degrees of freedom =       84 
Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 
 Pr(T < t) = 0.8537         Pr(|T| > |t|) = 0.2925          Pr(T > t) = 0.1463 
 
Domains of the EQ5D (Chi-square test) 
Mobility Baseline 
 Category 1 Category 2 Row Totals 
Group 1 UC 3  (3.63)  [0.11] 23  (22.37)  [0.02] 26 
Group 2 IG 9  (8.37)  [0.05] 51  (51.63)  [0.01] 60 
Column Totals 12 74 86  (Grand Total) 
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The chi-square statistic is 0.181. The p-value is .67049. The result is not significant at p < .05. 
Mobility 3 weeks 
 Category 1 Category 2 Row Totals 
Group 1 UC 1  (2.12)  [0.59] 25  (23.88)  [0.05] 26 
Group 2 IG 6  (4.88)  [0.26] 54  (55.12)  [0.02] 60 
Column Totals 7 79 86  (Grand Total) 
 
The chi-square statistic is 0.9187. The p-value is .337807. The result is not significant at p < .05. 
Mobility 6 weeks 
 Category 1 Category 2 Row Totals 
Group 1 UC 1  (1.81)  [0.37] 25  (24.19)  [0.03] 26 
Group 2 IG 5  (4.19)  [0.16] 55  (55.81)  [0.01] 60 
Column Totals 6 80 86  (Grand Total) 
 
The chi-square statistic is 0.5628. The p-value is .453147. The result is not significant at p < .05. 
Mobility 6 months 
 Category 1 Category 2 Row Totals 
Group 1 UC 4  (3.29)  [0.16] 19  (19.71)  [0.03] 23 
Group 2 IG 7  (7.71)  [0.07] 47  (46.29)  [0.01] 54 
Column Totals 11 66 77  (Grand Total) 
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The chi-square statistic is 0.2583. The p-value is .611277. The result is not significant at p < .05. 
Mobility 12 months 
 Category 1 Category 2 Row Totals 
Group 1 UC 2  (3.34)  [0.54] 22  (20.66)  [0.09] 24 
Group 2 IG 9  (7.66)  [0.24] 46  (47.34)  [0.04] 55 
Column Totals 11 68 79  (Grand Total) 
The chi-square statistic is 0.899. The p-value is .343048. The result is not significant at p < .05. 
Self care baseline 
 Category 1 Category 2 Row Totals 
Group 1 UC 7  (6.35)  [0.07] 19  (19.65)  [0.02] 26 
Group 2 IG 14  (14.65)  [0.03] 46  (45.35)  [0.01] 60 
Column Totals 21 65 86  (Grand Total) 
The chi-square statistic is 0.1267. The p-value is .721927. The result is not significant at p < .05. 
Self care 3 weeks 
 Category 1 Category 2 Row Totals 
Group 1 UC 4  (4.34)  [0.03] 20  (19.66)  [0.01] 24 
Group 2 IG 11  (10.66)  [0.01] 48  (48.34)  [0.00] 59 
Column Totals 15 68 83  (Grand Total) 
The chi-square statistic is 0.0451. The p-value is .831905. The result is not significant at p < .05. 
Self care 6 weeks 
 Category 1 Category 2 Row Totals 
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Group 1 UC 4  (4.27)  [0.02] 21  (20.73)  [0.00] 25 
Group 2 IG 10  (9.73)  [0.01] 47  (47.27)  [0.00] 57 
Column Totals 14 68 82  (Grand Total) 
The chi-square statistic is 0.0293. The p-value is .86419. The result is not significant at p < .05. 
Self care 6 months 
 Category 1 Category 2 Row Totals 
Group 1 UC 2  (1.76)  [0.03] 20  (20.24)  [0.00] 22 
Group 2 IG 4  (4.24)  [0.01] 49  (48.76)  [0.00] 53 
Column Totals 6 69 75  (Grand Total) 
The chi-square statistic is 0.0503. The p-value is .822474. The result is not significant at p < .05. 
 
 
Self Care 12 months 
Category 1 Category 2  Row Totals 
Group 1 UC 1  (0.94)  [0.00] 23  (23.06)  [0.00] 24 
Group 2 IG 2  (2.06)  [0.00] 51  (50.94)  [0.00] 53 
Column Totals 3 74 77  (Grand Total) 
The chi-square statistic is 0.0068. The p-value is .934198. The result is not significant at p < .05. 
Usual activities baseline 
  Category 1 Category 2 Row Totals 
Group 1 UC 14  (15.12)  [0.08] 12  (10.88)  [0.11] 26 
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Group 2 IG 36  (34.88)  [0.04] 24  (25.12)  [0.05] 60 
Column Totals 50 36 86  (Grand Total) 
The chi-square statistic is 0.2823. The p-value is .595226. The result is not significant at p < .05. 
Usual activities 3 weeks 
 Category 1 Category 2 Row Totals 
Group 1 UC 13  (11.45)  [0.21] 12  (13.55)  [0.18] 25 
Group 2 IG 25  (26.55)  [0.09] 33  (31.45)  [0.08] 58 
Column Totals 38 45 83  (Grand Total) 
The chi-square statistic is 0.557. The p-value is .455452. The result is not significant at p < .05. 
Usual activities 6 weeks 
Category 1 Category 2  Row Totals 
Group 1 UC 10  (7.07)  [1.22] 15  (17.93)  [0.48] 25 
Group 2 IG 16  (18.93)  [0.45] 51  (48.07)  [0.18] 67 
Column Totals 26 66 92  (Grand Total) 
The chi-square statistic is 2.3334. The p-value is .126628. The result is not significant at p < .05. 
Usual activities 6 months 
 Category 1 Category 2 Row Totals 
Group 1 UC 8  (6.84)  [0.20] 14  (15.16)  [0.09] 22 
Group 2 IG 15  (16.16)  [0.08] 37  (35.84)  [0.04] 52 
Column Totals 23 51 74  (Grand Total) 
The chi-square statistic is 0.4079. The p-value is .523061. The result is not significant at p < .05. 
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Usual activities 12 months 
 Category 1 Category 2 Row Totals 
Group 1 UC 5  (3.43)  [0.72] 19  (20.57)  [0.12] 24 
Group 2 IG 6  (7.57)  [0.33] 47  (45.43)  [0.05] 53 
Column Totals 11 66 77  (Grand Total) 
The chi-square statistic is 1.2208. The p-value is .269207. The result is not significant at p < .05. 
Pain Baseline 
Moderate 
 Category 1 Category 2 Row Totals 
Group 1 UC 20  (18.14)  [0.19] 6  (7.86)  [0.44] 26 
Group 2 IG 40  (41.86)  [0.08] 20  (18.14)  [0.19] 60 
Column Totals 60 26 86  (Grand Total) 
The chi-square statistic is 0.9047. The p-value is .341533. The result is not significant at p < .05. 
Extreme 
  Category 1 Category 2 Row Totals 
Group 1 UC 11  (7.86)  [1.25] 15  (18.14)  [0.54] 26 
Group 2 IG 15  (18.14)  [0.54] 45  (41.86)  [0.24] 60 
Column Totals 26 60 86  (Grand Total) 
The chi-square statistic is 2.5762. The p-value is .108483. The result is not significant at p < .05. 
Pain 3 weeks 
Moderate 
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 Category 1 Category 2 Row Totals 
Group 1 UC 18  (18.37)  [0.01] 7  (6.63)  [0.02] 25 
Group 2 IG 43  (42.63)  [0.00] 15  (15.37)  [0.01] 58 
Column Totals 61 22 83  (Grand Total) 
The chi-square statistic is 0.041. The p-value is .839557. The result is not significant at p < .05. 
Extreme 
 Category 1 Category 2 Row Totals 
Group 1 UC 3  (2.11)  [0.38] 22  (22.89)  [0.03] 25 
Group 2 IG 4  (4.89)  [0.16] 54  (53.11)  [0.01] 58 
Column Totals 7 76 83  (Grand Total) 
The chi-square statistic is 0.5892. The p-value is .442729. The result is not significant at p < .05. 
 
Pain 6 weeks 
Moderate 
  Category 1 Category 2 Row Totals 
Group 1 UC 11  (13.01)  [0.31] 12  (9.99)  [0.41] 23 
Group 2 IG 32  (29.99)  [0.14] 21  (23.01)  [0.18] 53 
Column Totals 43 33 76  (Grand Total) 
The chi-square statistic is 1.0285. The p-value is .310508. The result is not significant at p < .05. 
Extreme 
Category 1 Category 2  Row Totals 
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Group 1 UC 1  (0.30)  [1.61] 22  (22.70)  [0.02] 23 
Group 2 IG 0  (0.70)  [0.70] 53  (52.30)  [0.01] 53 
Column Totals 1 75 76  (Grand Total) 
The chi-square statistic is 2.3351. The p-value is .126489. The result is not significant at p < .05. 
Pain 12 months  
Moderate 
Category 1 Category 2  Row Totals 
Group 1 UC 11  (8.10)  [1.03] 13  (15.90)  [0.53] 24 
Group 2 IG 15  (17.90)  [0.47] 38  (35.10)  [0.24] 53 
Column Totals 26 51 77  (Grand Total) 
The chi-square statistic is 2.2702. The p-value is .13188. The result is not significant at p < .05. 
 
Extreme 
  Category 1 Category 2 Row Totals 
Group 1 UC 1  (0.62)  [0.23] 23  (23.38)  [0.01] 24 
Group 2 IG 1  (1.38)  [0.10] 52  (51.62)  [0.00] 53 
Column Totals 2 75 77  (Grand Total) 
The chi-square statistic is 0.3394. The p-value is .560177. The result is not significant at p < .05. 
Anxiety depression baseline 
Moderate 
 Category 1 Category 2 Row Totals 
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Group 1 UC 10  (9.98)  [0.00] 16  (16.02)  [0.00] 26 
Group 2 IG 23  (23.02)  [0.00] 37  (36.98)  [0.00] 60 
Column Totals 33 53 86  (Grand Total) 
The chi-square statistic is 0.0001. The p-value is .991041. The result is not significant at p < .05. 
Extreme 
 Category 1 Category 2 Row Totals 
Group 1 UC 1  (0.91)  [0.01] 25  (25.09)  [0.00] 26 
Group 2 IG 2  (2.09)  [0.00] 58  (57.91)  [0.00] 60 
Column Totals 3 83 86  (Grand Total) 
The chi-square statistic is 0.0142. The p-value is .905247. The result is not significant at p < .05. 
Anxiety depression 3 weeks 
Category 1 Category 2  Row Totals 
Group 1 UC 7  (7.32)  [0.01] 18  (17.68)  [0.01] 25 
Group 2 IG 17  (16.68)  [0.01] 40  (40.32)  [0.00] 57 
Column Totals 24 58 82  (Grand Total) 
The chi-square statistic is 0.0279. The p-value is .867238. The result is not significant at p < .05. 
Anxiety depression 6 weeks 
 Category 1 Category 2 Row Totals 
Group 1 UC 10  (7.92)  [0.55] 12  (14.08)  [0.31] 22 
Group 2 IG 17  (19.08)  [0.23] 36  (33.92)  [0.13] 53 
Column Totals 27 48 75  (Grand Total) 
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The chi-square statistic is 1.2078. The p-value is .271762. The result is not significant at p < .05. 
Anxiety depression 6 months 
Category 1 Category 2  Row Totals 
Group 1 UC 7  (5.87)  [0.22] 15  (16.13)  [0.08] 22 
Group 2 IG 13  (14.13)  [0.09] 40  (38.87)  [0.03] 53 
Column Totals 20 55 75  (Grand Total) 
The chi-square statistic is 0.4225. The p-value is .515701. The result is not significant at p < .05. 
Anxiety and depression 12 months 
 Category 1 Category 2 Row Totals 
Group 1 UC 3  (3.84)  [0.18] 21  (20.16)  [0.03] 24 
Group 2 IG 9  (8.16)  [0.09] 42  (42.84)  [0.02] 51 
Column Totals 12 63 75  (Grand Total) 
The chi-square statistic is 0.3217. The p-value is .570593. The result is not significant at p < .05. 
 
GROC Two-sample Wilcoxon rank-sum (Mann-Whitney) test 
  Group          |  obs    rank sum    expected 
-------------+----------------------------------------- 
Intervention | 59        2633        2537 
Usual Care    | 26        1022        1118 
------------+--------------------------------- 
combined     | 85        3655        3655 
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 z =   0.924 
 Prob > |z| =   0.3557 
 
Patients that needed 7-9 treatments 
Category 1 Category 2  Row Totals 
Group 1 UC 6  (3.02)  [2.93] 20  (22.98)  [0.39] 26 
Group 2 IG 4  (6.98)  [1.27] 56  (53.02)  [0.17] 60 
     
Column Totals 10 76 86  (Grand Total) 
 
The chi-square statistic is 4.7538. The p-value is .029234. The result is significant at p < .05. 
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